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Abstract of the Thesis 
Linear Polymers to Target Vibrio cholerae Adhesion and Physiology 
Oliver Creese 
A key stage in bacterial pathogenesis is the ability of bacteria to adhere strongly 
and specifically to the host. Bacterial adhesion to host cells is a prerequisite for 
infection and disease, and with this in mind, synthetic polymers rationally designed to 
incorporate side-chain functionality targeting bacterial adhesion mechanisms have 
been reported to cluster bacteria via specific and non-specific multivalent interactions. 
Targeting bacteria in this way may have therapeutic value towards controlling drug 
resistant pathogens. However, progress in this area has been slow due to an 
incomplete understanding of polymer-bacteria interactions as well as technical 
difficulties in screening large libraries of polymers efficiently under standardised 
chemical and biological conditions in order to assess structure-activity relationships of 
these macromolecules.  
Here, poly(acryloyl hydrazide) is employed as a polymer scaffold capable of 
undergoing highly efficient post-polymerisation modifications of the side-chain under 
physiologically relevant conditions to facilitate the synthesis and in situ screening of a 
range of unexplored polymer chemistries towards sequestering V. cholerae. In 
particular, it was found that imidazole-functionalised polymers dramatically 
sequestered V. cholerae at sub-inhibitory concentrations, and suppressed the 
production of the Cholera toxin (Chapter 2), while glycopolymers resulted in 
accelerated biofilm production in a sugar-dependent manner (Chapter 3).  
Lastly, improved RAFT polymerisation of poly(Boc-acryloyl hydrazide) by 
choice of polymerisation temperature is reported (Chapter 1), as well as a synthetic 
route towards controlled end group fluorescent labelling (Chapter 4). 
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i. The rise of antibiotic resistance: the causes, consequences and solutions 
Resistance to antibiotics through their misuse has been predicted since the 
discovery of the first antibiotic ‘penicillin’ by Alexander Fleming.1 Development of 
resistance to antibiotics often relates to the specific nature of their mechanism against 
bacteria. Traditional antibiotics interfere with bacterial processes in a highly specific 
and selective manner, meaning that what works for one species of bacteria may not 
work for another. Antibiotics are classed based on their mechanism of action (Table 1), 
which generally involves the disruption of biosynthesis within the cell. However 
exceptions to this include antibiotics such as Polymyxin B, which interferes with the 
cell membrane resulting in the formation of pores.2 
Table 1. Common antibiotics listed by their mechanism of action  
 
Target Classes Examples 
Cell Wall Synthesis Beta Lactams Penicillins   
Cephalosporins   








Cell Membrane Polymyxins 
Nucleic Acid 
Synthesis 
Folate synthesis Sulfonamides 
  
Trimethoprim  
DNA Gyrase Quinolones  
RNA Polymerase Rifampin 




Clidamycin   
Linezolid   








Bacteria constantly mutate to gain evolutionary advantage,1 and these 
mutations can lead to changes in crucial processes targeted by antibiotics, or can 
render the antibiotic non-effective. Mutated genes which advantage the bacteria are 
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selected for and passed to the next generation. This process is known as evolutionary 
pressure, and is the main cause of antimicrobial resistance. Misuse of antibiotics, for 
example failing to complete a prescribed course resulting in incomplete eradication of 
the bacteria, speeds up this process. The three major ways resistance to antibiotics is 
conferred are:1 
1. Efflux pumps; membrane transport proteins which can remove or lower the 
concentration of the antibiotic within the bacterial cells. 
2. Inactivation by enzymes which can degrade or modify the antibiotic, rendering 
it ineffective (β-lactamases on β-lactam antibiotics).3,4 
3. Modification of molecular targets; random mutations can inactivate the binding 
site for certain antibiotics.  
The increasing occurrence of multi-drug resistant microbes, coupled with a 
significant slowdown in new antibiotics coming to market, may result in a “post-
antibiotic era” where common infections which were previously easily treatable may 
become life threatening. Worryingly, a review published by the World Health 
Organisation in 2017 highlighted that the vast majority of new drugs are modifications 
of existing classes of antibiotics, and thus expected to only offer a short-term solution 
to treating pathogenic bacteria.5 Indeed there have been no new classes of antibiotics 
discovered to treat Gram-negative bacteria since 1962, and no approved drug class 
since 1980 (Wellcome trust 2018). Antibiotic resistance is thought to be currently 
responsible for over 50,000 deaths per year in the US and Europe,6 and over 700,000 
globally, with that number predicted to rise to 10 million by 2050.7 
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i. a. Anti-adhesion therapy towards controlling pathogens  
There is an urgent need for new and innovative ways to combat and control 
microbial infection, and unsurprisingly research in this area is extensive. A key 
consideration for new therapies, is targeting pathogenic bacteria or bacterial processes 
in such a way that limits evolutionary pressure (i.e. resistant bacteria are not selected 
for by “survival of the fittest”). For this reason, one method proposed involves 
“disarming” rather than killing pathogens by targeting virulence factors.8,9 
Understanding why certain bacteria pose a threat to our health while others benefit it 
and the driving force behind a bacterium’s “switch” from a non-pathogenic to a 
pathogenic is key to designing new drugs or better control practices.10  
Bacterial adhesion to surfaces, inside and outside the body is a key process in 
microbial colonisation, infection and in particular is a prerequisite for many pathogens 
to deploy virulence factors such as toxins.11  Common examples of such pathogens 
include  Escherichia coli, Pseudomonas, salmonella, Klebsiella and Vibrio Cholerae.11 
As such, designing compounds that interfere with this process is a promising 
antimicrobial strategy.11-13 Bacteria adhere to surfaces initially through weak non-
specific interactions, which can allow them to “sample” the surface,12 followed by much 
stronger receptor-mediated interactions which can include recognition of moieties such 
as sugars, lipids and proteins on both the bacteria and the host.11 One of the most 
studied examples of a pathogen binding to a receptor is that of E. coli binding to 
mannose residues displayed on host cells via the bacterial adhesin FimH.11     
Strategies targeting bacterial adhesion include the use of anti-fouling 
surfaces,13,14 disruption of the bacterial or host surface receptor biogenesis,15-17 
competition-based receptor binding antagonists,18,19 and anti-adhesion antibodies and 
vaccines.20,21 
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i. b Artificial bacterial adhesion antagonists 
Targeting bacterial adhesion with materials which mimic natural binding sites 
for bacteria can offer a pathway to out-compete bacterial binding to surfaces and host 
cells.22 The advantage of this particular approach is that, although mutations would be 
expected to occur which could affect the binding to the antagonist, these mutations 
would also interfere with the bacteria’s ability to bind to the host, and therefore would 
likely be selected against.11 One of the major hurdles in designing anti-adhesion 
materials or biological inhibitors in general, which may contain ligands capable of 
binding to bacterial receptors, is to maintain a high enough affinity to be able to 
compete for the target. One method of increasing affinity is through multivalency; by 
presenting a target receptor with many copies of a ligand covalently linked together by 
means of a backbone or scaffold, the overall binding affinity to the receptor is greater 
than that of an equal concentration of monovalent ligands.23 The potential of highly 
potent multivalent biological inhibitors has driven research towards the synthesis of 
macromolecular architectures such as polymers, dendrimers,24,25 and 
nanoparticles.26,27 
i. c. Polymers for bacterial anti-adhesion applications 
Ability to take part in non-specific binding, long range and multivalent 
interactions make polymers very attractive as synthetic multivalent materials to target 
many biological functions, including bacterial adhesion.28 Compared with single 
molecules, multivalent compounds can cooperate in many different binding 
mechanisms, such as chelation, statistical (increasing the effective concentration at 
the active site) and steric stabilisation (Figure 1).23,29 
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Figure 1. Example of ligands (blue) binding to a receptor (red) via different binding 
modes available to multivalent materials resulting in greater receptor affinity over that 
of monovalent ligands. 
Increased affinity for a multivalent compound compared to its monovalent 
counterpart, often on orders of magnitude, is known as the “cluster glycoside effect”, 
for example the interaction between a protein (lectin) and carbohydrate is strengthened 
due to presentation of multiple copies of the carbohydrate to the protein. Protein-
carbohydrate interactions are one of the most important recognition motifs in biological 
systems and can be greatly strengthened if the carbohydrate ligand has 
multivalence.23,30 
In this regard, polymers have the potential to competitively block bacterial 
adhesion, for example, to host cells by displaying repeat units of chemical groups 
mimicking binding sites for bacterial adhesion (for example, a mannose-displaying 
polymer as an inhibitor of E. coli adhesion).  
i. d. Polymer-mediated bacterial aggregation 
Bacteria are already known to form aggregates in the presence of polymers in 
nature, via two proposed mechanisms; bridging,31 whereby bacteria aggregate via 
interactions between cell and polymer, dominated by multivalent interactions, and 
depletion aggregation, which is entropically driven. Depletion aggregation is an effect 
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whereby bacteria aggregate together due to osmotic forces between a non-adsorbent 
polymer and the bacterial cells to maximise the space available for the polymer to 
move (Figure 2).31 
 
Figure 2. Types of bacterial aggregation modes as a result of interactions with 
polymers. Bridging aggregation is mediated by multivalent “cross-linking” interactions 
with the polymer, and depletion aggregation is entropically driven in order to minimise 
bacteria-polymer interactions.  
These two proposed mechanisms result in different aggregated structures 
which are not considered traditional bacterial biofilms. Bridging aggregation forms 
disordered aggregates, and depletion aggregation resulting in laterally aligned layers 
of bacteria which can eventually result in a complete phase separation of bacteria and 
supernatant.32 
The outcome of the bacteria-polymer interaction depends on the chemical 
nature of the polymer; positively charged glycopolymer chitosan induces bridging type 
aggregation, whereas high molecular weight neutral polyethylene glycol (PEG), and 
more recently vitamin B5 derived polymethacrylate have been shown to induce 
depletion type aggregation in bacteria. 33,34 Aggregation of bacteria can be induced by 
a wide range of naturally occurring polymers present at infections sites such as mucin 
and DNA, and it has been proposed that this aggregation can advantage the bacteria 
by stimulating the production of stress-response phenotypes which are less 
susceptible to antibiotics.33 This example taken from nature demonstrates how 
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inducing aggregation of bacteria has the potential to change their phenotype, and with 
this in mind, assessment of these potential off-target effects when designing materials 
for anti-adhesion therapy should be carefully considered. 
i. e. Designing linear polymers to target bacteria  
Linear polymers are a class of macromolecular architecture that offer wide 
scope to examine the structure-activity relationships in biological applications owing to 
their “simple” and easily tunable chemistry.23 
For applications requiring multivalence, the most important chemical property 
of linear polymers, with respect to biological activity, are the functional groups 
associated with the repeated chain. These can be further broken down into side-chain 
and main-chain functionality. Recent work carried out by Yan and co-workers 
investigated the impact of side-chain functionality versus main-chain functionality on 
the antimicrobial activity (Figure 3).35 
 
Figure 3. Examples of synthetic polymers with cationic functionality on the side-chain 
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The authors reported that while all polymers tested were more active against 
bacteria compared to their corresponding monomers, main chain functionality provided 
slightly higher antimicrobial activity than side-chain functionality.35 It should be noted 
that polymer molecular mass was not consistent between the polymers tested. 
In order for a polymer to exhibit antimicrobial activity, which will not be discussed 
in detail here, polymers are generally synthesised to possess positively charged 
groups which are strongly attracted to the negatively charged phospholipids present in 
bacterial cell walls.36 The non-specific electrostatic interaction aided by hydrophobic 
moieties on the polymer can result in the disruption of the bacterial cell wall, eventually 
leading to cell death,37 although recently there have been suggestions that these 
interactions may be more specific than simple electrostatics.38 
Cationic linear polymers have also been researched for their application as 
bacterial sequestrants, by a mechanism of electrostatic attraction between polymer 
and bacteria similarly to that of antimicrobial polymers, but without conferring toxicity 
to the bacteria.  
In this respect, the location of the positive charge on the polymer chain may be 
less critical for polymers designed to interact with bacteria in a non-specific manner. 
However in order to mediate specific receptor binding, as described earlier, ability of 
multivalent ligands displayed on a polymer to fit into binding pocket of a receptor is key 
to their activity, and as such, the majority of research into polymers for receptor binding 
focuses on the chemical functionality of the side-chain.23  
It is well established that bacterial adhesion to the host cell is predominantly 
mediated through recognition and binding to the glycocalyx, a layer of highly 
heterogenous glycoconjugates which can include polysaccharides, glycolipids and 
glycoproteins which are expressed on the cell surface.39 As previously discussed, this 
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initial adhesion step is critical for the bacteria to successfully colonise and cause 
disease to the host whilst being able to withstand the body’s own mechanical and 
immunological clearance mechanisms.11 The bacterial receptors which bind to 
carbohydrates in the glycocalyx are called lectins, a class of proteins that bind to but 
do not have enzymatic activity on carbohydrate containing ligands.40 In fact, it has been 
suggested that the glycocalyx may serve as a barcode, enabling bacteria to distinguish 
between suitable and unsuitable binding sites via specific lectin binding interactions.41 
With this in mind, a common strategy is the synthesis of polymers displaying sugars 
on the side-chain, therefore offering a potential route to synthetic glycocalyx mimics 
designed to competitively bind bacterial lectins in a specific manner and inhibit the 
adhesion to biotic or abiotic surfaces.42 
Current research into targeting and binding bacteria focuses on polymers 
containing cationic groups, targeting the negatively charged cell wall, and also 
polymers containing carbohydrates (glycopolymers) to target and bind to bacterial 
lectins (Figure 4). 
 
Figure 4. Approaches taken in the design of polymers to aggregate bacteria.  
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While certain polymer chemistries have been well explored, as will be discussed 
later, predicting the contribution that a particular property makes to the overall 
observable activity, and hence determining the mechanism of action from first 
principles remains difficult for macromolecules.43 A common design goal for targeting 
bacterial adhesion is increasing the activity and selectivity towards a pathogen, while 
remaining innocuous to the host. Probing the relationship between structure and 
activity in these materials has become a vital element to furthering research in this 
area. In particular, it is often challenging to simultaneously probe how different 
chemistries effect a range of different biological properties. progress in this area has 
been slow, due to the technical difficulties in screening large libraries of polymers 
efficiently under standardised chemical and biological conditions, in order to better 
assess the structure-activity relationship of these macromolecules. 
More work needs to be carried out to determine the influence of chemical and 
physical factors involved with polymer-mediated bacterial aggregation, to improve 
specificity and activity. This will be best achieved through evaluation of structure-
activity relationships using large libraries of polymers with modulated properties.  
One of the challenges that faces polymer chemistry is reproducibility and 
uncertainty over the absolute chemistry. “Normalising” the biological effect to 
differences in the absolute polymer chemistry is difficult even with advanced controlled 
polymerisation techniques and some degree of uncertainty will still remain. For this 
reason, polymer scaffolds which are able to undergo a wide range of side group 
modifications after polymerisation are attractive ways of removing the uncertainty 
arising from variations in polymer structure and allowing access to a wide range of 
potential polymer functional groups. The strength of this strategy lies in the ability to 
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conduct high-throughput screening, akin to drug discovery methodologies, which may 
uncover ideal multivalent chemistries to target bacterial adhesion. 
i. f. Polymer scaffolds for biological high-throughput screening  
There is a great deal of interest in designing scaffolds to access a library of 
polymers with different functionalities all originating from the same parent polymer.43 
The synthesis of polymer scaffolds facilitates high-throughput screening approaches, 
towards addressing the uncertainty associated with evaluating the activity of polymeric 
materials in biology (Figure 5).44 
 
Figure 5. Description of the route taken in the synthesis of a polymer scaffold, and 
subsequent post-polymerisation modification towards the preparation of a library of 
functional polymers. 
A range of possible polymerisation methods are available to the polymer 
chemist in order synthesise polymers capable of undergoing further post-
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polymerisation modification, but there are some “design goals” which should be 
considered. 
 To begin with, the chemical group capable of undergoing post-polymerisation 
modification should not interfere with the ability of the monomer to be polymerised, 
which may require the use of protecting groups.45 Ligands should react with the 
polymer scaffold through easily-accessible functional groups; complicated synthetic 
routes to install the required functionality for the conjugation reaction reduces the 
efficiency of the scaffold for high-throughput screening applications. Ideally, ligands of 
interest for the screening application would be commercially available without the need 
for further purification or modification. Functional polymers which are designed to be 
used for biological applications in situ should be soluble or compatible with aqueous 
media. The use of toxic additives such as catalysts should be minimised where 
possible, to reduce the impact that impurities, not removed by purification, may have 
in biology. In addition, complicated purification steps may reduce the efficiency of the 
screening system and also remove certain polymer molecular weights in a non-
reproducible manner (for example dialysis or filtration). Finally, the conjugation reaction 
should be highly efficient and reproducible with the conjugates stable at physiological 
pH and concentration. 
These design goals align with the concept of “click-chemistry” a phrase first 
coined by Sharpless in 200146 to describe and characterise a broad group of “spring 
loaded” chemical reactions which are; “modular, wide in scope, give very high yields, 
generate only inoffensive by-products that can be removed by non-chromatographic 
methods, and be stereospecific”.46 More recently, updated guidelines on “click” 
reactions, specifically tailored to the application of polymer modification were outlined 
in 2011, which proposed that click reactions must proceed with fast time scales, result 
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in high yields with equimolar concentrations of reagents, and that purification (if 
required) must be able to be carried out on a large scale.47 
The principles of click-chemistry, which focus on the discovery of new 
properties, rather than new compounds have been incredibly influential in the field of 
polymer science, in particular post-polymerisation modification of polymer scaffolds.48 
However, post-polymerisation modification strategies often require time-consuming 
purification steps before biological testing can be carried out. This can limit the 
efficiency of polymer scaffolds as a tool for high-throughput screening of large libraries 
of polymer functionalities with potential therapeutic properties.  
Following the principles of click-chemistry set out by Sharpless, the ability to 
evaluate the activity of polymer chemistries in situ without the need to purify has the 
potential to greatly streamline combinatorial approaches towards the discovery of new 
therapeutic compounds.49 The major barriers to in situ screening of polymers are 
purification steps and solvent. But, by carefully choosing the chemistry by which to 
modulate the polymer it is possible to satisfy these requirements. 
ii. Important conjugation reactions for post-polymerisation modification 
ii. a. Copper(I)-catalysed azide-alkyne cycloaddition 
By far the most famous “click” chemistry reaction is the copper-catalysed azide-
alkyne cycloaddition (CuAAC),” as described by Sharpless.46 The “spring loaded” 
reaction between  azide and alkyne functional group catalysed by Cu(I) was reported 
in 2001 by Meldal and Sharpless independently,50,51 and proceeds to quantitative 
yields via the formation of a 1,2,3-triazole without the generation of by-products 
(Figure 6). 
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Figure 6. Copper(I)-catalysed azide-alkyne cycloaddition reaction (CuAAC) via the 
formation of a 1,2,3-triazole, and copper free strain promoted azide-alkyne 
cycloaddition (SPAAC). 
CuAAc can be applied to conjugate different chemical groups in wide range of 
solvents under mild condition, and thus has been applied to countless modifications of 
nanomaterials, including polymers.52 CuAAC has been particularly well established in 
the synthesis of glycopolymers,53-55 whereby sugars containing an azide functional 
group were “clicked” onto an alkyne containing polymer scaffold. It is also possible to 
“click” alkyne containing ligands onto polymer scaffolds displaying aizde groups, via 
direct polymerisation of azide-containing monomers.56 A limitation of this method is the 
use of copper ions, which are known to be toxic and, in some cases, limit this strategy 
for bioorthogonal reactions (chemical reactions that can occur inside a biological 
system).57 To address these issues, Bertozzi and co-workers reported a copper-free 
cycloaddition reaction by exploiting a strained alkyne system (SPAAC – strain 
promoted azide-alkyne cycloaddition) (Figure 6).58 The drawback of this approach is 
the low solubility in aqueous media, and the cost of producing the required ligands 
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ii. b. Thiol – X 
Thiol-X is a broad term to describe any thiol-based conjugation reaction, 
including the widely used thiol-ene reaction by the addition of a thiol to an alkene. 
These modifications are highly efficient and can be applied to a wide range of 
commercially available functional thiols. Thiol-ene reactions, for example, satisfy the 
requirements for “click-chemistry” and can offer advantages over CuAAC, on account 
of their readily available starting materials and lack of required catalytic Cu(I).60 Thiol-
X reactions were reported for the modification of polymers in notable work carried out 
by Hoyle,61 which has led to a large “toolbox” of possible thiol-X reactions for post 
polymerisation modification (Figure 7). 
 
Figure 7. Notable thiol-X reactions involved with polymer modification.48  
Thiol-X reactions are particularly well researched for modification of polymer 
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polymerisation,60,62 and have been employed in the installation of fluorescent 
probes.63,64 One of the major considerations is the reactivity of the thiol and the alkene 
under traditional radical polymerisation. This remains a challenge that can only be 
overcome if the vinyl group on the monomer designed to undergo polymerisation has 
a significantly different reactivity to the alkene designed for subsequent modification 
with thiols. Thiol-X modifications therefore, are often used in tandem to install 
subsequent functionality after an initial post-polymerisation modification, for example; 
side-chain modification of a synthetic polymer with a peptide,65 and the selective end 
group modification of glycopolymers with maleimide modified biotin.66  
ii. c. Activated esters 
The amide bond is one of the most fundamental chemical bonds found in nature, 
and probably best known as nature’s preferred method of linking amino acids to form 
peptides. Amide bonds have good stability towards acidic, basic, oxidising and 
reducing conditions, but the formation of these bonds, via the condensation of an 
amine and a carboxylic acid, requires forcing conditions such as heat, and the addition 
of a catalyst. In the case of activated esters, the energy required to form the amide 
bond is significantly lowered via the incorporation of a leaving group and thus makes 
this chemistry more compatible with post-polymerisation modification. The two most 
popular activated esters, N-hydroxysuccinimide (NHS) esters and Pentafluorophenyl 
(PFP) esters, offer leaving groups which are readily soluble in water, and in the case 
of PFP esters, offer the ability to monitor the post-polymerisation modification reaction 
by19F NMR (Figure 8).48,67 
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Figure 8. Common polymer modification reactions via NHS esters (top) and PFP 
esters (bottom). 
Polymers which containing PFP ester side chains have been used to install 
alkyne functionality onto the polymer backbone, followed by CuAAC in a two-step post-
polymerisation modification process for the synthesis of glycopolymers designed to 
bind bacterial toxins,53 or in a single step with the addition of glucosamine or 
galactosamine.66 One of the key limiting factors of using PFP esters for post-
polymerisation modification is that, while the resulting material may be stable and 
soluble in aqueous media, the PFP polymer is liable to hydrolyse and therefore, the 
modification reaction is generally carried out in the water miscible solvent e.g. DMF 
and 1 eq. TFA. This requirement limits the use of this method for in-situ biological 
screening as purification steps would be required. 
 Less reactive than PFP esters, but highly versatile, NHS-esters are one of the 
first examples of post-polymerisation modification. Notably, Whitesides and co-
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polymers via post-polymerisation modification to identify inhibitors for the influenza 
infection.68 On the downside, NHS esters are susceptible to ring opening side reactions 
with amines, instead of the desired substitution reaction, and also to intramolecular 
attack between an NHS ester and adjacent methacrylamide, resulting in the formation 
of a backbone glutarimide.69 
ii. d. Isocyanates 
Isocyanates are less commonly used in polymer side-chain modification, but 
offer a highly efficient synthetic for polymer modification and are compatible to react 
with a variety of nucleophiles; amines without the need for forcing conditions, alcohols 
with the addition of Sn(II) and thiols under basic conditions (Figure 9). 
 
Figure 9. Examples of polymer modification reactions via isocyanate containing 
ligands resulting in the formation of A) thiourethane, B) urea and C) urethane 
derivatives. 
Although isocyanate-containing polymers can be difficult to store due to their 
sensitivity to moisture,48 direct polymerisation of isocyanate monomers is an appealing 
strategy to access readily available ligands for post-polymerisation modification. 
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but was found to be more challenging to control, resulting in lower conversions and 
broad dispersity in the polymer molecular mass, attributed to loss of the RAFT agent 
and/or side reactions during the polymerisation process. Some improvement was 
achieved however through optimising the choice of RAFT agent (to contain a tertiary 
amine rather than carboxylic acid) and the use of low polymerisation temperatures 
(Scheme 1).70  
 
Scheme 1. Direct RAFT polymerisation of isocyanates reported by McCormick.70 
 
To overcome these polymerisation challenges, “blocking” of the reactive 
isocyanate group is favored in order to maintain the side-chain fidelity.45 McCormick 
and co-workers demonstrated in follow-up work that polymerisation with monomers 
containing isocyanates blocked with imidazole, dimethylpyrazole and triazole not only 
offered a route to highly controlled polymerisation, but allowed for temperature-
dependent selective modification of the polymer backbone.71 Modification of polymers 
with isocyanate containing ligands can also be achieved, although this strategy can 
limit the choice of ligand.72 
ii. e. Ring opening 
Ring opening reactions, such as the frequently used epoxide ring opening, are 
thermodynamically driven by the release of ring strain. Three-membered rings are 
under significant strain, and therefore undergo highly efficient reactions with a wide 
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Figure 10. Post-polymerisation modifications involving nucleophilic epoxide and 
aziridine ring opening. Bottom; example of a tandem post-polymerisation modification 
involving ring opening and subsequent thiol-ene reactions.  
Aziridines are a nitrogen containing analogue of epoxides and have lower 
reactivities due to the less electron-negative nitrogen atom. However, the interest in 
these functional groups as building blocks for polymer scaffolds lies in ability to 
substitute the nitrogen with further chemical groups which can broaden the scope for 
modification of the scaffold.74 It should be noted that unsubstituted aziridines are not 
able to be controlled via RAFT or atom transfer radical polymerisation (ATRP) 
controlled polymerisation techniques due to interactions between the nitrogen and the 
chain transfer agent (CTA). 
Ring opening of thiolactones allows for successive thiol-ene functionalisation in 
a one pot synthesis, which can be particularly useful for introducing controlled hetero-
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synthesis of poly(acrylamide-homocysteine thiolactone) as a polymer scaffold capable 
of undergoing sequential post-polymerisation modifications.75 Epoxide ring opening 
with amines has also been employed in the synthesis of hetero-functionalised 
glycopolymers for bacterial aggregation.76 
ii. f. Oximes, Hydrazones and Imines 
Amines, hydroxylamines, hydrazines and hydrazides can undergo highly 
efficient “click” reactions via condensation with aldehydes and ketones, with the only 
by-product being water.77 A key advantage of this method is the vast array of 
commercially available aldehyde containing molecules which can undergo conjugation 
(Figure 11). 
 
Figure 11. Examples of conjugation reaction with “amines” and aldehydes to form 
either imines, oximes, hydrazones or acyl hydrazones.  
The reaction of amines and carbonyls requires more forcing conditions 
compared with that of hydroxylamines, hydrazines and hydrazides owing to their lower 
nucleophilicity, and therefore the majority of this class of conjugation reaction focuses 
on the formation of oximes and hydrazones (including acyl hydrazones). The increased 
nucleophilicity and therefore reactivity of hydroxylamines and hydrazides compared to 
that of amines originates from the α-effect whereby the orbital containing lone pairs of 
electrons on a hetero atom (O in the case of hydroxylamines, N in the case of 






X = -CH2   -   amine                                                
X = -O      -   hydroxylamine







   23 
resulting in overlap and increase the HOMO of the nucleophile, rendering it more 
nucleophilic. The inductive effect of the hetero atom also dictates the hydrolytic stability 
of the resulting bond, which proceeds via the protonation of the nitrogen. Reversibility 
of the hydrazone or oxime bond is a key consideration when considering these 
linkages in post-polymerisation modification.78 Oximes are more stable than 
hydrazones and acyl hydrazones due to the higher electronegativity of the oxygen 
hetero atom (χo =3.5), compared with N in hydrazones (χN =3.0). Hydrazides are often 
employed for conjugation reactions instead of hydrazines due to the increased stability 
of the acyl hydrazone bond, which is rationalised as a result of increased resonant 
forms possible in the distribution of the electron density (Scheme 2).  
 
Scheme 2. A) Differences in stability of oximes and hydrazones due to the 
susceptibility of the N1 atom to be protonated. B) Major resonance forms of alkyl and 
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Oxime and hydrazone formation is a commonly employed bioconjugation 
technique due to its compatibility with aqueous media and mild reaction conditions. It 
is often described as being bioorthogonal due to the small size and inert nature of 
aldehydes and ketone functional groups at physiological pH.79 In this context, 
hydrazide-functionalised polymers are considered potentially useful scaffolds for 
combinatorial approaches to drug discovery and fulfil the requirements mentioned 
earlier for in situ screening.49  
When applied to post-polymerisation modification, polymers can be modified in 
water at physiological pH and used in situ without the need for further purification.80 It 
should be noted that the small molecule aldehydes can be completely consumed by 
employing this technique. Bertozzi demonstrated that poly(acryloyl hydrazide) could 
be prepared by activated-ester post-polymerisation modification of acetoxime acrylate 
with the addition of hydrazine.81 Poly(acryloyl hydrazone) was able to react with 
unmodified reducing sugars such as mannose, glucose and galactose resulting in near 
quantitative ligation efficiencies and good stability at physiological pH.81 A similar 
synthesis route was taken by Ojha and co-workers,82 who prepared poly(acryloyl 
hydrazide) by modification of poly(methyl acrylate) with hydrazine. More recently, a 
synthetic route to prepare poly(acryloyl hydrazide) by direct polymerisation of a boc-
protected hydrazide monomer was reported.83 This route avoided the use of excess 
toxic hydrazine during synthesis, and poly(acryloyl hydrazide) could be prepared by 
simple deprotection in acid. The dynamic nature of the acyl hydrazide linkage has led 
to its use in pH responsive polymer drug delivery systems,84 and templating of 
carbohydrate-functionalised polymers with lectins,85 further demonstrating the 
versatility of this conjugation strategy.  
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ii. g. Post-polymerisation modification toolbox: summary 
A vast toolbox of chemical reactions is available to the polymer chemist to 
efficiently modify a polymer scaffold. The choice of the chemistry is strongly dictated 
by the application for which the polymer is designed. Originally, post-polymerisation 
modification was (and still is) a way of accessing polymer functionalities which were 
not polymerisable from their corresponding monomers. In this regard, the modification 
should be quantitative, the bond stable, and the linker chemistry such that it does not 
impact on the overall functionality of the material. Post-polymerisation modification is 
now being increasingly employed for biological, combinatorial, and in situ applications, 
and therefore demands a greater need for water soluble precursors and conjugates, 
as well as non-toxic efficient modification methods. In this regard polymer scaffolds 
have become an attractive platform for high throughput screening of structure-activity 
relationships. In particular, poly(hydrazide) scaffolds undergo highly efficient and 
biocompatible “click-chemistry” modification with commercially available aldehydes 
allowing for in situ screening. 
iii. V. cholerae: A relevant pathogenic target for anti-adhesion therapy 
When designing materials to interfere with or sequester bacteria, or any 
microorganisms for that matter, it is necessary to consider the way that the material 
will interact with the organism in a physical and chemical sense, but also to predict 
how the microorganism will respond to this interaction. 
 Bacteria are highly adapted to surviving in environmental niches by regulating 
specific genes in response to external cues. Studying the interaction between bacteria 
and materials designed to target bacterial adhesion can help design new and “better” 
materials for the application, but could also offer a means of studying less well 
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understood bacterial regulatory pathways. In this respect, an understanding of certain 
regulatory pathways and “natural” responses in V. cholerae is necessary to interpret 
the activity of the polymer. 
V. cholerae, is a motile Gram-negative pathogen responsible for the disease 
cholera, associated with watery diarrhea and dehydration, which, if left untreated can 
result in hypotonic shock and death.86 Worldwide 1.3 – 4.0 million people contract 
cholera each year resulting in 21,000-143,000 deaths (World Health Organisation 
2018). Outbreaks of cholera are generally restricted to countries where significant 
numbers of people are without access to clean water and good sanitation. The disease 
is spread orally via hyper-infective V. cholerae present in stools of the infected persons 
if allowed to enter the water system.87 Where cholera is endemic, outbreaks follow a 
seasonal pattern which is thought to be linked to changes in water temperature as well 
as blooms of plankton, and chitin rain, both of which V. cholerae adhere to and use as 
a sole carbon source.88 The need to find new methods to control this pathogen is 
currently of high importance since a significant outbreak of cholera is currently ongoing 
in Yemen and is responsible for what has been described by the UN as the “biggest 
humanitarian crisis in the world”.89 As sea levels rise and we experience more frequent 
extreme weather events, these outbreaks, caused by bacterial contamination of water, 
are expected to become more common,90 and potentially even more serious with the 
rise of antimicrobial resistance. 
Evaluation of how best to target V. cholerae adhesion with polymers requires 
an understanding of how these bacteria detect and adhere to surfaces, and at what 
point this leads to pathogenicity. The key processes in the V. cholerae virulence 
program are: adhesion, toxin production, biofilm formation and finally, dispersal 
(Figure 12).91,92 
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Figure 12. V. cholerae stages of infection: Motile V. cholerae bind the cell surface 
initially via non-specific interactions, followed by strong and specific adhesion resulting 
in microcolony formation, biofilm formation and virulence. At a critical population 
triggered by QS, V. cholerae disperse from biofilms in order to re-infect the host. 
iii. a. Targeting V. cholerae surface adhesion mechanisms with polymers. 
Since the observation that E. coli adhesion to epithelium cells could be inhibited 
by targeting type-1 pilus mannose-binding protein (FimH) with mannose-containing 
glycosides,93 there has been widespread research into the FimH lectin as a promising 
anti-adhesion target for new therapeutics.94 However, less research has been 
conducted into targeting lectins associated with V. cholerae adhesion. 
V. cholerae have a number of appendages which are employed in the initial 
attachment to surfaces, and these may serve as potential targets for anti-adhesion 
polymers. The most commonly studied appendage is the type IV pili which can be 
visualised as tiny hairs protruding from the bacterial cell surface. Type IV pili are 
generally much longer than the V. cholerae cell (7 microns vs 1.3 microns) but less 
than 10 nm in diameter, which explains their significant attachment and sensing 
capabilities and their inability to be visualised using optical microscopy.95 V. cholerae 
adhesins such as type IV pili are believed to possess lectin functionality in order to bind 
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to sugars and therefore offer a promising target for anti-adhesion therapy with 
glycopolymers.96 V. cholerae use a combination of a type IV pili, MSHA (mannose 
sensitive haemagglutinin), and their polar flagellum synergistically to “scan” a surface 
via chemo and mechanosensing.97 Utada and co-workers demonstrated through 
tracking and modelling the movements on V. cholerae, that orbiting bacteria, 
characterised by repetitive tight circular motions, were associated with irreversible 
attachment to the surface and microcolony formation. On the other hand, V. cholerae 
lacking the genes to produce flagella and MSHA were not able to form orbiting motions 
and had significantly decreased biofilm formation (Figure 13).98  
 
Figure 13. V. cholerae use MSHA pilus and polar flagellum synergistically to scan 
surfaces for suitable adhesion sites. Stronger interactions with the pilus and flagellum 
result in orbiting motility, initial attachment and finally, microcolony formation. The 
MSHA pilus is believed to possess lectin functionality at its tip (red dot) in order to bind 
carbohydrates.  
The cause of bacterial attraction to a surface and a switch to orbiting motility is 
thought to be due to hydrodynamic forces,99 and drag forces experienced by the polar 
flagella.100 By orbiting in this way, V. cholerae spend more time over portions of the 
surface that interact more strongly with the MSHA pili, and eventually form strong and 
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specific attachments via other adhesins, for example, the toxin co-regulated pilus 
(TCP) and chitin regulated pilus (ChiRP).98  
Targeting MSHA with mannose containing polymers is an attractive means of 
targeting and sequestering V. cholerae via multivalent binding between the MSHA 
lectin and mannose side chains in the polymer which may reduce the bacteria’s ability 
to adhere to surfaces. In support of this statement, inhibition of orbiting motility and 
surface attachment was achieved by addition of a non-metabolisable mannose 
derivative, which corroborates the idea that MSHA binds mannosides,101 and this can 
interfere with V. cholerae’s ability to further bind surfaces. The selectivity for mannose 
over other glycans is not well understood, and indeed the name of the MSHA pilus 
originates from the observation that V. cholerae agglutinate red blood cells and this 
agglutination can be inhibited/reduced on addition of mannose. Early work on 
purification of the MSHA lectin from V. cholerae O1 strain reported a high affinity for 
both D-mannose and D-glucose.102  
More recent and detailed work on the MSHA pilus of closely related Vibrio 
parahaemolyticus employed a high-throughput glycan binding assay to identify the 
target glycan of MSHA. Glycans displaying highest activity towards binding compared 
with the MSHA mutant, contained terminal fucose, galactose and GalNAc, but 
interestingly not mannose,103 unlike the understood mannose binding MSHA of V. 
cholerae. Intriguingly, MSHA biosynthesis has been reported to be repressed during 
infection, which is thought to protect the bacteria from agglutination by the host’s 
mannose-displaying immunoglobulins and prevents V. cholerae from attaching to the 
surface of epithelial cells.104 Reports such as these are important for the rational design 
of mannose-containing anti-adhesion polymers and could account for any observed 
differences in activity ex vivo and in vivo. 
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The chitin-regulated pilus (ChiRP) and chitin-binding proteins (CBP) are 
important adhesins involved with surface colonisation of V. cholerae to chitinous 
surfaces, e.g. the shells of plankton, in their natural marine environment, where 
attachment and metabolism of this polysaccharide is vital for their survival.105,106 
Adhesion to GlcNAc, the carbohydrate monomer of chitosan, has been shown to be 
specific for certain Vibrios and can inhibit their adhesion to chitin.107 A GlcNAc-binding 
protein GbpA which is secreted by V. cholerae has been shown to be  crucial in binding 
chitin, but also human epithelial cells, it is not clear if this protein can bind sugars other 
than GlcNAc.108 GlcNAc containing polymers evidently have potential to target V. 
cholerae adhesion, and given the importance of chitin which naturally mediates this, it 
is unsurprising that antimicrobial polymers containing chitosan have been developed 
to target a range of microorganisms including V. cholerae.109,110 
The toxin co-regulated pilus (TCP) is a IV pili used by V. cholerae to colonise 
the intestine and is a major virulence factor.111 Conversely to MSHA and ChiRP, TCP 
filaments contain glycine-rich portions and serve to hold bacterial cells together in a 
microcolony during the deployment of the cholera toxin. TCP also behaves as a 
receptor for cholera toxin phage, which can infect non-pathogenic vibrios and provide 
the required genes to start producing the cholera toxin.112 More recently it has been 
demonstrated that TCP mediates the attachment of V. cholerae to Caco-2 cells and 
areas of the small intestine villi in an infant mouse model.113 It was reported that V. 
cholerae mutants lacking the genes to produce TCP were not able to form 
microcolonies and as such, were cleared from the intestine in less than 24 hours. The 
specific role of TCP in cell attachment was probed by electron microscopy which 
revealed that the initial attachment of V. cholerae to epithelial cells in vivo was in fact 
independent of TCP, and rather that TCP plays a crucial role as a colonisation factor.113 
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As a result it may be challenging to specifically target the TCP by multivalent 
glycopolymers to inhibit adhesion. 
iii. b. Summary: targeting V. cholerae adhesion mechanisms with polymers  
V. cholerae adhere to surfaces via a number of mechanisms, many of which 
have been discussed here, and is believed to involve the binding of sugars, most 
notably via the mannose sensitive pilus (MSHA), chitin binding pilus or membrane 
proteins, although this is not well understood. Interestingly, in the case of MSHA, 
despite an accepted affinity for mannose, the specificity for a particular glycan has not 
been well established in V. cholerae, whereas fucose, galactose and GalNAc were 
recently found to have high specificity to the MSHA lectin of V. parahaemolyticus.103 
Interestingly, MSHA has been shown to be important for attachment of V. cholerae to 
chitin beads suggesting that MSHA may not have specific lectin activity towards 
mannose.88 Although clearly mannose and GalNAc both have the potential to act as 
ligands to inhibit V. cholerae adhesion via the described adhesion mechanisms, there 
may also be merit to screening polymers containing a wide range of different sugars 
and mixtures thereof, in order to establish the most efficient glycan for sequestering V. 
cholerae in this way. 
iii. c. V. cholerae gene regulation in response to polymer-mediated aggregation 
After initial attachment of the V. cholerae cell to a surface, regulation of key 
virulence and biofilm genes occur. This is associated with a phenotypic switch from a 
motile to a sessile state of the bacteria.114 Polymers that sequester bacteria have been 
proposed as potential means to artificially control bacterial phenotypes, and by doing 
so, control pathogenicity.115,116 The regulatory network in V. cholerae is complex (and 
not fully understood) and beyond the scope of this introduction. However, a general 
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understanding of key processes in V. cholerae is important for interpreting the way that 
bacteria will respond to polymer-mediated aggregation.  
To simplify this model, focus will be drawn to the impact quorum sensing has 
on different bacterial responses (Figure 14). In particular, regulation of biofilm 
formation and virulence, can be modulated in a quorum sensing (inter-bacterial 
communication) dependent manner by polymers.116,117 This is rationalised as being 
due to the artificially high concentration of confined bacteria within aggregates, and 
therefore, an increased concentration of quorum sensing molecules (autoinducers).118 
Other environmental stimuli that influence virulence and biofilm formation include 
nutrient availability, chitin di- and oligosaccharides  and nitric oxide,91 and It has been 
suggested that the environment of the gut (for example temperature and pH) may be 
a direct cue for the production of virulence factors in V. cholerae.87 A much more 
comprehensive review of the various inputs and regulatory pathways in V. cholerae 
surface colonisation has been published by Dang and Lovell.91 
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Figure 14. Simplified regulatory pathways in V. cholerae. Green arrows describe 
positive regulation, and red arrows describe suppression of the pathway. At high 
autoinducer (QS molecule) concentration (red squares and green circles), HapR is 
expressed and represses vpsR transcription, a regulator of biofilm factors. HapR also 
represses aphA, a regulator involved in the expression of virulence factors such as the 
Cholera toxin. At low cell density, hapR is downregulated and thus does not repress 
the synthesis of biofilm and virulence factors.87,91,119 Biofilm formation can be triggered 
(or suppressed) as a result of carbohydrate availability using the Phosphoenopyruvate 
Phosphotransferase System (PTS). PTS sugars (for example, mannose, glucose) 
transported by the PTS can increase biofilm formation in V. cholerae via repression of 
cAMP, although this process is not yet fully understood.91  
A well-studied pathway which governs both the production of virulence factors 
and the production of biofilm is the quorum-sensing (QS) pathway, which can be simply 
described as a system for bacterial cell-to-cell communication.120 At low bacterial cell 
density, V. cholerae regulates its genes in a way that benefits the individual bacteria, 
while at high cell density genes are regulated to benefit the bacterial community. 
Information about cell density is imparted to the bacteria by means of small signaling 
molecules which are released and detected by the bacteria, known as autoinducers.120 
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The autoinducer concentration and thus the relative density of bacterial cells can be 
deduced. Key regulators HapR and AphA are either activated or deactivated 
depending on cell density. At low cell density, aphA is expressed and hapR is 
downregulated. AphA leads to the expression of genes which encode virulence factors 
and biofilm and colonisation factors are not suppressed.87 At high cell density HapR is 
expressed and represses the production of biofilm and virulence genes (Figure 14).119 
Low cell density represents a motile state for V. cholerae seeking to colonise and infect 
the host. When cell density reaches a certain level, it is beneficial for V. cholerae to 
dissipate from a biofilm-associated community in order to infect a new host.92 
 As discussed earlier, Perez-Soto and co-workers recently demonstrated that 
aggregation of V. cholerae by cationic polymers caused an enhancement in QS,115 
which led to a decrease in virulence as predicted (Figure 14). However, a significant 
upregulation of biofilm related genes and increase in the formation of biofilm was also 
observed which cannot be explained simply through the quorum sensing pathway. The 
upregulation of biofilm production in polymer-mediated bacterial clusters therefore 
demonstrated the potential for polymers employed in this way to engineer 
combinations of useful bacterial phenotypes.  
iv. Linear polymers to aggregate bacteria, current state-of-the-art.  
Next, current efforts towards aggregating bacteria with linear polymers will be 
discussed, the design of which largely focuses on targeting specific lectins with 
glycopolymers, or targeting the negatively charged outer membrane with cationic 
polymers (Table 2). 
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Table 2. Linear polymers discussed in this section  
Polymer 
class 
Synthesis method Functional 
groups 
Target Determination of 
activity 
Ref. 
Cationic FRP Primary and 
tertiary amine 




Cationic RAFT Dopamine, 
tertiary amine 
V. harveyi  Microscopy 
Bioluminescence 
134 
Glycopolymer RAFT Glucose V. harveyi Microscopy 134 






















Cationic RAFT Dopamine, 
tertiary amine 




Cationic FRP Primary amine, 
Tertiary amine 









Biofilm staining (CV)  
138 
Cationic FRP Primary amine E. coli  




Glycopolymer FRP Glucose, N-
isopropylacryla
mide 




Glycopolymer RAFT Mannose E. coli Particle sizing 
Microscopy 









S. mutans  Microscopy 
Particle sizing 
55 
Glycopolymer ATRP Mannose 
Galactose 
S. mutans  Microscopy 
Particle sizing 
55 








E. coli Microscopy 









































Glycopolymer RAFT Glucose or / and 
mannose 
E. coli ConA 
Clustering, microscopy 
153 
Glycopolymer Self-assembly Glucose or / and 
Mannose 




Chitosan Natural polymer Primary amine E. coli  
 
Growth curves, Top10 
QS reporter strain (flu), 
microscopy 
128 
iv. a. Cationic polymers 
Cationic polymers are designed to interact or be attracted to the negatively 
charged bacterial cell via non-specific interactions. Cationic polymers have been 
extensively researched as antimicrobials, and the mechanism of action is believed to 
proceed via an initial attachment of the polymer to the bacterial cell wall, followed by 
insertion and/or disruption of the bacterial membrane via hydrophobic interactions with 
the polymer.121,35 Structure-activity relationships of these materials have been 
extensively researched, revealing the importance of balancing both charge and 
hydrophobicity of the polymer for optimal activity.122 Increasing the cationic portion of 
the polymer decreases the toxicity towards bacteria and can increase the agglutination 
of red blood cells, while increasing hydrophobicity can result in poor solubility and high 
toxicity to red blood cells.38 It was observed however, that polymers containing 
predominantly cationic groups at sub-inhibitory concentrations resulted in rapid 
aggregation of bacterial cells into clusters. This phenomenon was quickly identified as 
a possible route to control bacterial colonisation by inhibiting bacterial adhesion in a 
way that minimizes evolutionary pressure on the bacteria.11 
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Figure 15. Cationic polymers discussed in this section which demonstrate bacterial 
aggregation. Numbers indicate the corresponding reference. “Flu” denotes a 
fluorescent coumarin dye.  
iv. b. Cationic polymers for anti-adhesion 
Sequestering bacteria with sub-lethal concentrations of polymers has been 
proposed as a method of protecting cells against bacterial adhesion as a way of 
reducing infection and disease (Figure 16),11 However, there have been limited 
































































































































   38 
of anti-adhesion polymers focusing on reducing the adhesion to abiotic surfaces by 
repelling bacteria.123 
 
Figure 16. Potential therapeutic effect of polymers as bacterial anti-adhesives. 
The ability of the tertiary and primary displaying cationic methacrylamide 
polymers to competitively bind to, and reduce the adhesion of V. cholerae to Caco-2 
cell lines was assessed by Perez-Soto and co-workers.115 Colony forming units (CFUs) 
from washed Caco-2 cells (a model cell line for the small intestine), revealed the 
number of attached bacteria was significantly reduced in the presence of both tertiary 
and primary amine containing polymers. Overall however, the tertiary amine polymers 
displayed significantly higher activity. The overall protective effects towards the 
epithelial cells were assessed via a lactate dehydrogenase (LDH) assay which 
confirmed that the primary amine containing polymer, pAPMAm, was most effective at 
a concentration of 0.05 mg ml-1. At higher concentrations however, pAPMAm displayed 
increasing levels of cytotoxicity towards Caco-2 cells. Levels of cholera toxin activity 
towards Caco-2 cells were measured by cyclic adenosine monophosphate (cAMP) 
activity, where elevated cAMP is synonymous with production of the cholera toxin. 
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Lower levels of cAMP for polymer incubated samples agreed with the previously 
discussed finding that these polymers can suppress cholera toxin gene expression. 
Initial in vivo studies also indicated that these polymers reduce the accumulation of 
green fluorescent protein (GFP) expressing V. cholerae in the intestinal tract of 
zebrafish.115 For polymers designed for in vivo therapeutic application, cytotoxicity of 
the polymer towards host cells (including hemolysis) is inevitably a key consideration. 
In a particular study by Thoma et al. a primary amine bearing methacrylamide was 
found to be antimicrobial towards S. aureus in vivo but displayed significant cytotoxicity 
to HEp-2 cells at the minimum inhibitory concentration (MIC) of the polymer. However, 
cytotoxicity was found to be partially overcome by employing polymers with lower 
degree of polymerisation (DP).124 
iv. c. Chitosan: cationic linear polymers found in nature 
Chitosan is a linear cationic glycopolymer based on a backbone of repeating N-
acetyl-D-glucosamine (GlcNAc) and randomly distributed deacetylated D-
glucosamine, found and derived from the chitinous shells of crustaceans.125 Chitosan 
has attracted attention from researchers due to its antimicrobial properties,126 as well 
as the observation that the marine bacteria V. cholerae can be commonly found 
adhered to the chitinous surfaces of shellfish.88 Cationic glycopolymers have been 
synthesised by modification of chitosan to incorporate quaternary amines and 
guanidinium functional groups along the backbone to increase both solubility and 
antimicrobial activity against E. coli and S. aureus.110,127 Chitosan has also been shown 
to induce clustering of E. coli, which was found to be dependent on the degree of 
acetylation (DA) on the carbohydrate backbone,31 while more recently Qin and co-
workers demonstrated that chitosan could aggregate E. coli at non-toxic doses, and 
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could suppress quorum sensing (inter-bacterial communication). Interestingly, 
increasing the polymer concentration resulted in an attenuation of the aggregation 
ability and also of the quorum sensing suppression.128 
iv. d. Off-target effects: the biological outcome of bacterial aggregation by 
cationic polymers  
Given that naturally occurring cationic polymers can interfere with bacterial 
regulatory pathways, such as quorum sensing, and that polymer-driven aggregation in 
nature can drive changes in bacterial phenotype,33 current research into the 
aggregation activity of cationic polymers has focused on addressing how bacteria 
respond to their aggregated state, and whether, through complex regulatory pathways, 
certain bacterial responses are triggered which could lead to useful applications. To 
this end, the bacterial responses studied has focused primarily on biofilm formation, 
which can be easily measured,129 is associated with persistent infection,130 and can be 
a hallmark for environmental responses.92,114 A secondary focus has been to address 
whether quorum sensing (the way in which bacteria sense their relative population by 
the release and detection of small molecules autoinducers),131 is affected by bacterial 
clustering, which not only controls biofilm formation in bacteria,132 but can also control 
gene regulation involved with virulence and competence (Figure 17).131 
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Figure 17. Proposed mechanism by which bacterial aggregation by polymers results 
in the accumulation of signalling molecules within the cluster, leading to enhanced 
quorum sensing which controls the regulation of bacterial genes. 
iv. e. Impact on quorum sensing of bacteria 
Physically confining individual bacteria has been shown to increase quorum 
sensing owing to the decreased diffusion of signalling molecules.133 With this in mind, 
work carried out by Xue and co-workers identified that clustering bacteria in this way 
provided an opportunity to cluster and interfere with quorum sensing molecules which 
were expected to be at higher concentrations within confined clusters of bacteria.134 
By co-polymerising a di-methyl amino terminating acrylamide monomer designed to 
target the bacterial membrane, and a dopamine-containing acrylamide monomer 
designed to quench boron containing quorum sensing molecule AI-2, a polymer with 
dual functionality was synthesised. The copolymer was shown to not only cluster 
bacteria at a concentration of 0.25 mg ml-1, but was able to interfere with the normal 
patterns of quorum sensing. The authors noted that they suspected that both cell 
clustering, and QS molecule quenching may impact the quorum sensing regulation.134 
This observation that quorum sensing in bacteria can be affected by dual action 
cationic polymers was continued by Lui and co-workers who employed the same 
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copolymer alongside a homopolymer of dimethylamino methacrylamide, pDMAPMa 
and evaluated the ability to predict aggregation effects and quorum sensing effects 
using computer modelling. The cationic homopolymer significantly increased the onset 
of quorum sensing in V. harveyi and the effect of positive charge was dominant in the 
dual action polymer with poor reduction in quorum sensing observed compared to a 
model quorum sensing quenching molecule. It was concluded therefore, that clustering 
via cationic polymers increases the onset of quorum sensing and that these materials 
may not be suitable for quorum sensing reduction applications.118 However, 
enhancement in quorum sensing has also been shown to trigger useful changes in 
bacterial phenotypes. For example, Perez-Soto and co-workers demonstrated that for 
V. cholerae, upregulation of quorum sensing induced by bacterial aggregation with 
cationic polymers was co-regulated with the downregulation of virulence gene 
expression, but an increase in biofilm production.116 An enhancement of quorum 
sensing by polymers in E. coli was also reported by Zhang and co-workers who 
synthesised cationic conjugated polymers displaying dendronized primary amine 
groups to aggregate the bacteria. The authors noted that the cationic polymers 
prolonged the time that quorum signalling molecules were being produced, and 
rationalised that the increase in production of the signalling molecules could also 
impact planktonic, non-adhered bacteria at low cell density. The authors also found 
that bacteria treated in this way produced roughly 50% more biofilm, and displayed a 
higher tolerance to antibiotics.117 
iv. f. Impact on biofilm production 
 The potential of surface-bound cationic polymers to adhere and trigger biofilm 
formation was revealed by Pernagallo and co-workers,135 who employed a high-
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throughput microarray assay to asses a number of polymers for their affinities towards 
Salmonella enterica serovar Typhimurium (S. Typhimurium) and E. coli. In the case of 
polymers that were most efficient at binding bacteria, including cationic acrylates 
containing imidazolium groups, early stages of biofilm formation in the form of 
microcolonies could be detected.135 However, for polymers in solution, the picture is 
less clear, with similar cationic polymers reported to both enhance, and reduce the 
production of biofilm upon clustering bacteria (Figure 18). 
 
Figure 18. Proposed mechanisms by which polymers may interfere with or enhance 
biofilm formation.  
Cationic polymers that cause aggregation of bacteria have been reported to 
upregulate biofilm formation in the cases of E. coli and V. cholerae,116,136 and reduce 
biofilm in the case of Pseudomonas aeruginosa,137 and S. aureus.138 The mechanism 
of this reduction was rationalised by Foster and et al. as inhibition of P. aeruginosa 
adhesion to surfaces,137 while the general rationale for an increase is due to a change 
in biofilm gene expression triggered by altered quorum sensing signalling.116,132 These 
findings initially suggest that different species of bacteria respond differently to this 
class of material. However due to the variability in polymer chemistry and experimental 
conditions employed it is hard to draw solid conclusions. In this respect, small 
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differences in the toxicity of the polymers towards bacteria could have large impacts 
on the production of biofilm for example, as a defence mechanism in response to 
stress. 139 To fully assess whether these findings are as a result of differences in the 
polymer chemistry, differences in the bacterial species or differences in experimental 
conditions, it would be beneficial to compare how each of these materials behave 
towards all four species of bacteria under identical biological conditions. This is one 
example of how non-standardised methods and materials lead to uncertainty over the 
mechanism of the observed biological activity. 
iv. g. Combinational approaches: Improving activity and specificity 
Aside from off-target effects, another concerted effort in the area of cationic 
polymers for bacterial sequestration has been focused on modulating the chemistry on 
the polymer side chains to increase specificity and activity towards a particular species 
of bacteria. Work has been recently carried out by Magennis et al. using a copolymer 
system based on methacrylamide, whereby portions of the polymer containing a 
tertiary amine monomer and zwitterionic sulfobetaine monomer could be modulated by 
varying molar ratios during synthesis. The selectivity for binding the Gram-positive oral 
pathogen S. mutans over Gram-negative E. coli was found to be increased with 
increasing proportions of the zwitterionic component, and significantly, when the 
polymer consisted of 100% zwitterionic side chains, bacterial binding was exclusive to 
S. mutans in mixed cultures. The aforementioned study highlights the strength of 
systematically modulating one aspect of the polymer chemistry while observing the 
biological effect, demonstrating crucially that, by choosing the right chemistry, charged 
polymers can display selectivity towards a particular bacterial species.55 
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A recent dynamic approach involves the direct polymerisation of monomers 
“templated” to a target, thus generating a polymer possessing the optimal 
complimentary chemistry for that target (Figure 19).  
 
Figure 19. Generating polymers with optimal affinity to a bacterial target by templating. 
This supramolecular polymerisation technique, known as templating, has been 
applied in the application of binding and aggregating bacteria selectively, and has the 
potential to be used in microbial detection. Work carried out by Magennis and co-
workers demonstrated that synthesising “bacteria-instructed” polymers afforded 
selective aggregation of bacterial strains and species. To achieve bacteria-instructed 
polymer synthesis, P. aeruginosa and E. coli were separately incubated with 
quaternary amine and sulfobetaine methacrylate monomers, whereby the monomers 
were allowed to interact with the microbial surface and assemble into an “ideal” 
conformation.140 Harnessing the reducing properties of the bacterial to generate Cu(I) 
species, ATRP style polymerisation proceeded from the surface-associated 
monomers. The group postulated that monomers on the surface of the bacteria would 
polymerise first and generate polymers with high affinity for that particular bacteria. 
Polymers synthesised in this way were isolated by washing bacterial cells with water 
and sodium chloride, before purifying by dialysis and recovering by lyophilisation. 
Templated polymers were then compared to the corresponding polymers synthesised 
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in the absence of bacteria and found that not only inter-species discrimination could 
be achieved but also inter-strain discrimination between clinical isolates and lab 
strains. This method highlights the potential for bacterial selectivity with cationic 
polymers but also offers a promising pathway towards simple detection methods for 
bacteria.140 
iv. h. Aggregation of bacteria by glycopolymers  
Bacterial aggregation by glycopolymers is believed to be driven by multivalent 
carbohydrate-protein interactions between the carbohydrate side-chain on the polymer and 
bacterial lectins.96 Given the specificity of these binding interactions, which may be 
influenced by the sequence of displayed glycans,141 synthetic strategies have focussed 
on controlling or defining the sequence of the glycopolymer side-chain via orthogonal 
reactions,53,81,142 controlled polymerisations such as iterative type polymerisations, 143-
145 and templating methods.85,146,147  
The synthesis of glycopolymers to directly bind bacteria has focused on 
modulating the nature and location of the carbohydrate displayed on the polymer chain 
in order to increase complimentary binding to specific bacterial receptors (Figure 
20).148  
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Figure 20. Glycopolymers discussed in this section which demonstrate direct bacterial 
aggregation. Numbers indicate the corresponding reference. 
iv. i. Homo-glycopolymers 
Glucose-displaying glycopolymers have been prepared from poly(2-
glucosyloxyethyl methacrylate) p(GEMA) via RAFT and demonstrated to be effective 
at aggregating E. coli, which is known to bind glucose via the lectin FimH.134 Bacterial 
aggregation could be controlled thermo-responsively by copolymerisation with a N-
Isopropylacrylamide (NIPAM) containing monomer, yielding polymers that can “shield” 
the sugar from the bacteria in a temperature dependent manner by altering the tertiary 
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was reported to reduce and then completely inhibit this binding effect, suggesting that 
there was competition for the FimH binding sites. Sucrose, which does not bind as 
strongly to FimH in E. coli, was not able to reduce the size of the clusters formed.149 
This work demonstrated that linear glycopolymers can induce and control aggregation 
of E. coli rationalised as being due to specific protein- carbohydrate interactions. 
In similar work, Yan and co-workers synthesised a methacrylate polymer 
displaying mannose on the side-chain with two different linker lengths, again designed 
to target the FimH lectin but with a stronger reported binding affinity compared with 
glucose (Kd = 2.3 μM) vs (Kd = 9.24 mM.150) The authors observed aggregation of E. 
coli upon exposure to 1-3 μM polymer concentration without antimicrobial activity and 
also explored the activity towards the FimH protein ex vivo by DLS measurement of 
glycopolymer-FimH complexes. The results of this provided evidence that a single 
glycopolymer could bind to multiple FimH proteins. Interestingly, star-shaped versions 
of the linear glycopolymer were assessed and found to have lower activity compared 
with linear glycopolymers, and more substantial was the discovery that the linker 
between the sugar and the polymer backbone was important for binding, with the 
longer linker and greater degrees of polymerisation (DPs) displaying higher activity 
with respect to suppressing bacterial adhesion to T84 cells.151 The potential for this 
compound to reduce adhesion to host colon cells was examined by residual adhesion 
of E. coli to T84 epithelial cells. T84 cells were chosen here as a cell line to model the 
colon epithelium and are known to contain a key glycoprotein involved with attachment 
of E. coli in Crohn’s disease patients. Polymer ligands were found to have a stronger 
inhibitory effect than their monovalent counterparts, in agreement with the principles 
of the cluster glycoside effect. The adhesion study was carried out by preincubating 
cells with glycopolymers prior to the addition of bacteria and also incubating the cells 
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with bacteria prior to adding the polymers. Then adhesion inhibition and ability of the 
glycopolymer to disrupt pre-adhered E. coli from the cell surface could be evaluated. 
The authors found that the most active glycopolymer reduced bacterial adhesion in 
both pre- and post-incubation studies by 45% and 47% respectively compared to non-
treated conditions. Ex vivo studies were also carried out using a colonic loop model 
which revealed that a concentration of 3.4 μmol (with respect to the mannose 
component of the polymer) resulted in a 61% decrease in E. coli adhering to the colonic 
mucosa. The authors reported that increased DP was beneficial for the anti-adhesive 
activity, and that 3-arm and 8-arm stars constructed from the same linear displayed, 
on average, lower overall anti-adhesion activity. Also noted was that the length of the 
linker separating the glycan and the polymer backbone is important and, in this case, 
glycopolymers with short linkers were not able to inhibit adhesion.151 Gouin and co-
workers built on this work in a later study by copolymerising the most efficient monomer 
employed in the previous study with a monomer capable of undergoing post-
polymerisation modification by epoxide ring opening. To this end, three scaffolds with 
different glycan/epoxide order were prepared and each underwent post polymerisation 
modification with either taurine, ethanolamine or (2-aminoethyl)trimethylammonium 
chloride (quaternary amine) resulting in a library of 27 compounds which were 
screened for ability to inhibit E. coli adherence to T84 cells. The authors acknowledged 
that these polymers exhibited some bacteriostatic activity, but this was not considered 
significant to the anti-adhesion assays. The results of this study, which investigated 
polymers containing both sugars and cationic groups, revealed very similar anti-
adhesion activities for the most active hetero-glycopolymer compared to the most 
active homo-glycopolymer in the previously described work. The authors concluded 
that there was no clear correlation between the density or order of the glycan and the 
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nature of the hetero group on the polymer,76 which suggests that presence of the 
mannose group in this case is the dominating contribution to the anti-adhesive effect 
compared to cationic groups.  
iv. j. Different sugars, different specificity 
In an earlier study, Disney and co-workers reported the synthesis of a 
fluorescent conjugated polymer comprising a poly(p-phenylene ethynylene) scaffold 
which could undergo post-polymerisation modification via carboxylic acid polymer 
groups and amine derivatised sugars to install mannosides and galactosides. An 
average loading of 25% sugars onto the polymer was achieved in this way, by means 
of a phenol sulfuric acid test. The prepared glycopolymers were tested for their ability 
to bind lectin ConA, as well as cluster E. coli, the first time such a study had been 
undertaken. The advantage of this approach was the formation of visible fluorescent 
clusters of bacteria without the need to further stain the bacteria or fluorescently label 
the polymer. The work confirmed that unbound mannose was not able to aggregate 
bacteria and that mannose- rather than galactose-displaying glycopolymers 
aggregated E. coli and could bind to ConA respectively, which is consistent with an 
aggregation mechanism of mannose specific multivalent binding. Importantly, it was 
shown that at concentrations of 10 μM or above of unbound mannose, bacterial 
aggregation was significantly decreased, indicating that the free sugar may bind to, 
and saturate bacterial lectins at these concentrations.152 
Another approach taken by Magennis and co-workers saw fluorescently-
labelled homo-glycopolymers of mannose and galactose prepared by CuAAC 
assessed with respect to their binding activity towards S. mutans and E. coli. 
Fluorescent microscopy determined that clustering via interaction with the mannose 
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polymer was favoured by E. coli while S. mutans displayed a greater affinity for the 
galactose polymer.55 However, in this study, polymer efficacy was determined only by 
relative levels of fluorescence quantified from fluorescent images, and therefore 
heavily reliant on the polymer labelling strategy. The results were consistent with 
previous research reporting that S. mutans binds galactose residues specifically, and 
demonstrated the potential to differentiate between bacterial species by displaying 
different sugars on the polymer.55 
In a similar approach by Xue and co-workers, a polymer scaffold was employed 
in the preparation of both homo- and hetero-glycopolymers by 2-stage post 
polymerisation modification.153 In this study three glycopolymers were explored; two 
homopolymers of glucose or mannose and one polymer containing a mixture of both 
mannose and glucose. Post-polymerisation modification proceeded by the installation 
of either a glucose or mannose residue via a Ugi reaction, followed by a second 
modification of either glucose or mannose by CuAAc. It is important to note that in the 
first stage of the post polymerisation modification, 45% sugar loading with respect to 
glucose was observed, but the second stage this conversion was not calculated. The 
binding efficiencies of these polymers to lectins was tested with ConA, which 
demonstrated that, while the mannose homo-glycopolymer bound more strongly than 
the glucose homo-glycopolymer, the polymer containing both glycans showed 
significantly greater activity than either. This discovery was rationalised as a synergistic 
effect of hetero-glycopolymers known as the “heteroglycocluster effect”.148 With 
respect to binding E. coli, modest levels of aggregation were reported, however greater 
levels of aggregation were observed for the glycopolymer containing both mannose 
and glucose residues.153 
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iv. k. Dynamic approaches to glycopolymers  
In a recent dynamic approach taken by Chen and co-workers, mannose and 
glucose were grafted onto cyclodextrin via thiol-ene and copper-catalysed azide-
alkyne cycloaddition (CuAAc) click chemistry, and self-assembled on a poly 
propyleneglycol chain resulting in a polyrotaxane.154 In this way, sugars tethered to the 
supramolecular polymer have increased degrees of freedom to access ligand 
orientations that best compliment bacterial receptors. Mannose and glucose homo-
glycopolymers and hetero-glycopolymers were prepared and evaluated with respect 
to binding activity of ConA, and E. coli. In agreement with the “heteroglycocluster 
effect”, polymers containing both glucose and mannose displayed the greatest activity 
towards bacterial aggregation and ConA binding, while the mannose homo-
glycopolymer displayed greater activity than the glucose homo-glycopolymer.154 
Templating polymers for bacterial aggregation has recently been reported for 
the preparation of glycopolymers,147 in an effort to generate polymers with the ability 
to discriminate between different strains of the same bacteria. As discussed previously, 
templating cationic polymers towards strain-selective aggregation of bacteria has been 
reported,140 and there are examples in the literature of glycopolymer synthesis based 
on templating bacterial lectins such as ConA. 85,146 However, until recently, templating 
glycopolymers has not been attempted for bacterial aggregation. Lou and co-workers 
designed a templating system employing a mannose containing monomer and an 
amphiphilic non-binding monomer to act as a spacer. Monomers previously incubated 
with E. coli were polymerised via bacteria mediated ATRP, and the resulting 
“templated” polymer was compared to a non-templated counterpart from the solution 
phase rather than the bacterial surface. It was noted that glycopolymers isolated from 
surface templating of bacteria resulted in a higher overall sugar content to those 
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isolated in the solution phase (50% vs 30%). Clustering of E. coli was assessed by 
microscopy for both the templated and untemplated glycopolymers, as well as 
homopolymers of each of the monomers. The templated polymer resulted in the 
greatest aggregation of E. coli by visual assessment, greater than the mannose 
homopolymer, suggesting that a greater density of the glycan does not always result 
in greater affinity. The templated polymer also displayed significant selectivity towards 
the templating strain in separate and mixed aggregation experiments employing a 
second E. coli strain as a control, whereas the mannose homopolymer displayed 
similar levels of aggregation for both strains. The potential therapeutic use for 
templated glycopolymers was demonstrated by their superior ability to supress E. coli 
adhesion to endothelial (blood vessel) cells.147 These results support the hypothesis 
that glycan conformation can be complimentary to that of the binding sites of the 
bacteria, and might offer a route towards specific therapies.  
iv. l. Linear polymers to aggregate bacteria: summary 
Both cationic polymers and glycopolymers administered in sub-inhibitory 
concentrations have been shown to cause aggregation of bacteria. The mechanism of 
aggregation is generally accepted to be different for both classes of polymers, but both 
are attributed to multivalent bridging type aggregation; cationic polymers are predicted 
to interact with the negatively charged phospholipid-rich outer membrane via 
electrostatic interactions, while glycopolymers are designed to interact with bacteria 
lectins. Conclusions cannot be drawn about differences in the morphology of the 
aggregation driven by glyco- or cationic polymers, only that the aggregates, in all cases 
appear to agree with a bridging mode of aggregation, and thus are driven by 
multivalent interactions. 
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 The antimicrobial effects of cationic polymers are well documented,155 and are 
driven by a combination of positively charged groups and hydrophobic groups which 
disrupt bacterial membranes. For this reason, it is important when assessing biological 
activity to distinguish between bacteriostatic and bactericidal effects, both of which may 
result in the aggregation of bacteria. Employing sub-inhibitory concentrations to 
achieve the desired therapeutic effect not only reduces evolutionary pressure which 
could lead to resistant strains, but also reduces the likelihood that these materials will 
cause cytotoxicity to host cells. Conversely, glycopolymers (and glycol-nanomaterials) 
are considered more biocompatible than cationic polymers and therefore research into 
their application as a non-toxic sequestrant or inhibitor rather than an antimicrobial is 
more well established. 
The aggregation of bacteria by polymeric materials can result in off-target 
effects as a result of bacteria responding to adhesion. These are often overlooked, 
especially in the case of glycopolymer research. Bacteria are highly adaptable and can 
withstand environmental changes by responding to environmental cues. As previously 
discussed, one of the ways bacteria perceive their surroundings is by quorum sensing. 
Detection of quorum sensing molecules by bacteria in response to population density 
triggers gene regulation responsible for toxin and biofilm regulation.120 Work with 
cationic polymers and quorum sensing quenchers suggests clustering results in an 
overall enhancement of quorum sensing phenotypes,117,118 while a quorum sensing 
molecule quencher can result in an oscillating pattern of quorum sensing expression 
and repression.134 Changes in gene expression and biofilm formation via incubation 
with polymers have been attributed to gene regulation by quorum sensing, and 
clustering by cationic polymers can also trigger an increase in biofilm 
formation.115,116,156 However, other studies have demonstrated that biofilm formation is 
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reduced or dispersed after treatment with cationic polymers.137,138 It is not clear from 
the current research if lectin specific aggregation by glycopolymers results in 
attenuation of quorum sensing and biofilm formation, although main-chain 
glycopolymers containing cationic side-groups, analogous to chitosans, have been 
shown to have anti-biofilm properties in vitro.157 
While there is some preliminary evidence that cationic polymers can reduce the 
virulence of V. cholerae,116 there are studies which suggest that bacterial aggregates 
may be less susceptible to antibiotics.33,117 Clearly, when designing these materials as 
antiadhesives, it is important to assess a range of relevant off-target effects and their 
possible implications. 
With respect to cationic polymers, the impact that molecular weight of the 
polymer has on the binding activity is not clear. However, in the application of 
antimicrobials, longer cationic polymers have been reported to be less efficient at killing 
bacteria via membrane penetration,122,158 whereas longer glycopolymers have been 
found to display greater binding than shorter linear glycopolymers in one study.151 With 
regards to the tertiary structure, linear polymers have been shown to possess a greater 
binding affinity to lectins compared to star-shaped polymers.151 Conversely, cationic 
dendrimers have been shown to exhibit greater clustering ability than their linear 
counterparts.24 
The specific requirements of the cationic side group have not been probed but 
modulation of the cationic and zwitterionic portion of a cationic polymer has been 
reported for bacterial discrimination.55,140 
 With respect to glycopolymers, the nature of the sugar has been shown to be 
highly important for bacterial aggregation, and consistent with a receptor-binding 
mechanism of action. Multiple studies have outlined the benefits of heterogeneity when 
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designing glycopolymers, with combinations of strongly binding sugars such as 
mannose, and weakly binding sugars such as glucose displaying a higher level of 
binding compared to corresponding homo-glycopolymers. This observation may in part 
be also linked to the density of strongly bound glycans on the polymer chain, with one 
study into binding ConA suggesting that a lower density of the glycan component of 
the polymer can increase lectin binding affinity, possibly as a result of steric crowding.53 
However, higher densities are expected to increase binding with respect to statistical 
binding modes.23 Lastly, there is strong evidence that a longer linking group separating 
the glycan and the polymer backbone benefits binding to bacterial receptors.53,151 This 
may be accounted for by an increase in the degrees of freedom afforded to the glycan 
to allow better access to the lectin binding pocket. 
iv. m. Conclusions 
Adhesion to surfaces is a critical step for the success of pathogenic bacteria, 
and targeting and interfering with this step offers a potential route to control pathogenic 
bacteria, without inducing evolutionary pressure which drives antibiotic resistance. 
Materials that contain multivalent groups able to crosslink and aggregate bacteria 
through specific interactions are ideal for this purpose and take advantage of the 
“cluster-glycoside effect”. In this regard, linear polymers are targeted as ideal 
nanomaterials capable of highly efficient bridging interactions with bacteria resulting in 
polymer engineered artificial microbial communities.  
Current research discussed here, includes examples of both sugar containing 
polymers designed to target bacterial lectins, and cationic polymers, designed to 
interact non-specifically with the negatively charged bacterial cell membrane. By 
sequestering bacteria in this way, Polymers are positioned as an anti-adhesion 
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therapeutics, but also as a way to control pathogenicity through aggregation driven 
phenotypic changes. 
A clear picture of structural and chemical requirements of these polymers for 
optimal activity and specificity is lacking. One of the greatest challenges in polymer 
science is controlling heterogeneity of the synthetic polymer so that the true nature of 
the structure-activity relationship can be deduced. Controlled radical polymerisation 
techniques such as RAFT polymerisation, have seen significant improvements in the 
control and predictability of molecular weight distributions, and an extensive choice of 
post-polymerisation conjugation strategies has allowed significantly greater scope to 
probe different polymer chemistries deriving from functional scaffolds. These 
polymerisation tools combined offer the potential for in situ and high-throughput 
screening of new polymer chemistries for many applications in nanomedicine, 
including bacterial anti-adhesion therapy. 
Glycopolymers and cationic polymers show a huge potential for ex vivo anti-
adhesion applications, such as wound dressings and oral treatments, but are currently 
unlikely to be a “silver bullet” for treating infections in a similar way to traditional 
antibiotics. This is due to a lack of absolute specificity towards a bacterial target. For 
example, in the same process whereby glycopolymers bind bacterial lectins and have 
been shown to cause agglutination of bacterial cells, they may bind host lectins and 
result in undesired agglutination for example, in blood cells. Furthermore, inhibition of 
carbohydrate-protein interactions in vivo is likely to have negative but unknown 
consequences to the host.141 That being said, with advances in control over the 
polymer side-chain chemistry, alongside sequence-controlled,143 and sequence-
defined,144 glycopolymers as well as bacterial instructed templating techniques,85,140 it 
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is conceivable that polymers could one day target and cluster bacteria in a species-
specific manner by the rational discovery of new polymer functionalities.  
v. Objectives 
This thesis represents an exploratory and multidisciplinary approach to 
optimising and evaluating the use of poly(acryloyl hydrazide) as a platform to screen 
rationally designed and unexplored polymer chemistries in the application of 
sequestering and modulating the physiology of V. cholerae. 
In particular we will explore the use of cationic functional groups such as 
aromatic amines, which have not yet been reported in the application of sequestering 
bacteria (Chapter 2), and a small library of glycopolymers containing distinct side-chain 
carbohydrate functionality which have yet to be synthesised or tested in our labs 
(Chapter 3). Poly(acryloyl hydrazide) allows access to both cationic and glycopolymers 
such that the synthesis, application and the biological responses of each class of 
functional polymer will be compared under standardised conditions (Chapters 2 and 
3). 
Outside of the direct application of sequestering V. cholerae, increasing the 
versatility of the scaffold will be explored. Specifically, optimisation of the RAFT 
polymerisation of poly(acryloyl hydrazide) in order to access controlled polymerisations 
at higher DPs (Chapter 1), and additionally, to install and quantify new -group 
functionality on the polymer for subsequent control over fluorescent labelling with 
commercially available fluorescent dyes (Chapter 4).  
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There are now a number of well-established controlled radical polymerisation 
(CRP) techniques to exert control over traditional radical chain growth polymerisation. 
Two of the most studied are atom transfer radical polymerisation (ATRP), and 
reversable addition-fragmentation chain transfer (RAFT) polymerisation. The general 
principles behind CRP involves the inclusions of an additional chemical agent into the 
polymerisation that provides an alternative chemical pathway to radical addition, and 
thus equilibrium, between active and dormant chains.1 
RAFT polymerisation, first reported by Moad, Rizzardo and Thang in 1998,2 has 
become increasingly popular as a polymerisation technique, a reflection on its 
compatibility with a wide range of monomers, ease of application, low dispersities (ĐM) 
and end group fidelity allowing for further chain extension or end group modification.3 
A RAFT agent takes the general form of Z(SR)C=S where Z and R substituents can 
be modified to tune the reactivity of the RAFT agent to match that of the monomer. The 
mechanism (Scheme 3) initially follows that of traditional radical addition 
polymerisation from generation of radicals (Step 1.) and addition of monomers to form 
a short polymer chain (Pn.) (Step 2.). At this point radicals add to the RAFT agent and 
addition-fragmentation equilibrium is set up (Step 3.). Upon fragmentation, the R. group 
proceeds to reinitiate dormant chains (Step 4.). This fragmentation is followed by the 
main addition-fragmentation equilibrium between propagating radicals and 
“deactivated” dormant chains associated with the RAFT agent (Step 5.), effectively 
“passing” the radical between propagating chains. In general, for a controlled 
polymerisation by RAFT, the propagation rate should be lower than the deactivation 
Chapter 1 
   70 
rate so that fewer than one monomer is added per cycle. In this way, all polymer chains 
should grow at similar rates to a similar degree of polymerisation (DP). However, if the 
poly-RAFT-adduct is too stable, and thus equilibrium is shifted away from 
fragmentation, very little propagation with occur and result in a retardation of the 
polymerisation.3  
 
Scheme 3. General mechanism of RAFT polymerisation detailing the steps outlined 
above. 
 
The requirement for a successful polymerisation by RAFT is to employ a RAFT 
agent containing Z and R groups best compatible with the monomer to afford 
favourable equilibrium. In an ideal RAFT polymerisation, the resulting polymers 
containing RAFT end-groups are ”living”, and can be chain-extended via the addition 
of further monomer.4 Degradation or loss of the RAFT agent can thus lead to 
termination reactions (Step 6.) resulting in “dead” polymer chains, characteristic of an 
uncontrolled polymerisation process and resulting in broad (ĐM) and low 
conversions.5,6 Degradation of the RAFT agent has been reported in the 
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polymerisation of acrylamides,5 and something we had observed in the preparation of 
poly(Boc-acryloyl hydrazide) (boc-Px).7 This chapter describes our efforts towards 
minimising degradation of the RAFT agent, and as such, affording improved control 
over the polymerisation of boc-Px which was reported in the following publication.  
The work presented here outlines improved control of poly(acryloyl hydrazide), 
the polymer predominantly employed throughout this thesis, which is important when 
evaluating polymer structure-activity relationships in biological systems in order to 
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All experiments presented in this chapter were designed by the author and Paco 
Fernandez-Trillo unless stated. All data presented in this chapter was independently 
analysed by the author and Paco Fernandez-Trillo and Andrey Romanyuk. 
All polymerisations reported in the paper were analysed using GPC by the 
author to determine Mn Mw and Đm and all NMR and conversion calculations were run 
by the author, unless specified below. Baseline correction of GPC traces were 
performed by Andrey Romanyuk. 
 
Experimental Contributions in this chapter:  
Pavan Adoni (University of Birmingham) carried out synthesis and 
characterisation steps towards the synthesis of small molecule analogue of a DP= 1 of 
N’-(tert-butoxycarbonyl)acryloyl hydrazide, (data presented in Scheme S1, Figure S3, 
Figure S5), chain extension of “living” and “dead” poly(boc-acryloyl hydrazide), (data 
presented in figure S6, S7 and S8), and polymerisation kinetics for conditions: DP150 
100oC, DP50 80oC and DP100 65oC. 
Andrey Romanyuk (University of Birmingham) carried out baseline correction of 
GPC data prior to final analysis and publication.  
Guanglong Su carried out monomer synthesis of N′-(tert-
butoxycarbonyl)acryloyl hydrazide (1), and performed some of the initial kinetic 
experiments. 
All co-authors contributed actively to discussions during the work and were 
involved with the proof reading of the final manuscript.  
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Correction to Figure 1 
 
Figure 1 from the original manuscript has been modified by replacement of the 
segmental line regression for Mn vs ρ plot with simple linear regression. The former 
being misleading as to the polymerisation progression past t(dead). The correction 
does not impact the conclusions of the work and the figure caption is unchanged from 
the original.  
 
Figure 1. A) Plot of conversion (ρ) vs. time and B) measured number average 
molecular mass (Mn) vs. conversion (●) and dispersity in molecular mass (ĐM) vs 
conversion (◯), for polymerisations of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) 
performed with different CTA:VA-044 ratios. Conditions: [M]=0.9M, [M]/[CTA]=50/1. Mn 
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Poly(Boc-acryloyl hydrazide): the importance of
temperature and RAFT agent degradation on its
preparation†
Oliver Creese, Pavan Adoni, Guanlong Su, Andrey Romanyuk and
Paco Fernandez-Trillo *
Poly(acryloyl hydrazide) is a versatile polymer scaffold readily functionalised through post-polymerisation
modification with aldehydes to yield polymers for biological applications. However, its polymerisation is
affected by nucleophilic degradation of the RAFT agent that leads to early termination, an issue often
overlooked in the polymerisation of primary acrylamides. Here we report the effect of temperature on the
RAFT polymerisation of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) and demonstrate that by carefully
selecting this polymerisation temperature, a balance between rate of polymerisation and rate of degra-
dation of the RAFT agent can be achieved. This way greater control over the polymerisation process is
achieved, allowing the synthesis of Boc-protected poly(acryloyl hydrazide) with higher degrees of poly-
merisation (DP) than those obtained previously, while still maintaining low dispersities (ĐM).
Introduction
Synthetic polymers are increasingly becoming an attractive
means of interfacing biological systems via multivalent
binding, displaying activities orders of magnitude higher than
those of their monovalent components.1–5 Thus, polymers are
now widely researched for biomedical applications including
as antimicrobials,6,7 as drug and gene delivery vehicles,2,8 as
biological sensors,9,10 or as “smart” biomaterials with anti-
fouling properties.11 Highly functional polymers developed for
specific applications generally involve the use of functional
monomers which either already possess the final desired func-
tionality, or have the capability of undergoing post-polymeris-
ation modification to introduce the desired functionality. This
latter approach can greatly broaden the scope of chemical
functionalities used. Post-polymerisation modification has
normally relied on click chemistries,12 and has now been
greatly expanded through the use of oxime13 and hydrazone
chemistry,14,15 reductive amination,16 and epoxide ring
opening.17
A common limitation when developing synthetic polymers
for biomedical applications is the need to screen large libraries
of compounds which is costly and time consuming. In this
regard, poly(acryloyl hydrazide) has been recently reported as a
versatile platform for the synthesis and screening of polymers
for biomedical applications.14,18–20 Functional polymers are
obtained by simple incubation of poly(acryloyl hydrazide) with
functional aldehydes, both under aqueous or organic con-
ditions,14 and this polymer has now been applied to the devel-
opment of glycan arrays,18 pH sensitive drug-delivery,21 and
nucleic acid delivery.20,22,23 In our laboratories poly(acryloyl
hydrazide) was prepared from Boc-protected precursor Boc-Px
(Scheme 1) following deprotection with TFA.14 Reversible
addition–fragmentation chain-transfer (RAFT) polymerisation
of N′-(tert-butoxycarbonyl) acryloyl hydrazide (1) resulted in a
small library of polymers. However, control over the polymeris-
ation was lost with increasing conversion and degree of poly-
merisation, possibly as a result of degradation of the RAFT
agent through intramolecular nucleophilic attack. This degra-
dation has been reported in the RAFT polymerisation of other
acrylamide derivatives,24,25 including closely related methacry-
loyl hydrazide,26 with better control reported when the poly-
merisation is carried out at low temperatures.25,27 This side-
reaction is often overlooked in the polymerisation of primary
and secondary acryl- and methacrylamides, and makes synthe-
sising highly functional polymers from this type of monomers
inherently challenging.28 The need for greater control over these
materials is more significant when looking to understand better
the nature of the structure–activity relationship throughout
post-polymerisation modification and biological screening.
Here, we report the effect of temperature and the decompo-
sition rate of the initiator on the polymerisation of N′-(tert-
butoxycarbonyl)acryloyl hydrazide (1), as a route to optimise
the preparation of poly(acryloyl hydrazide). Polymerisations
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c9py01222b
School of Chemistry, and Institute of Microbiology and Infection, University of
Birmingham, Edgbaston, B15 2TT Birmingham, UK.
E-mail: f.fernandez-trillo@bham.ac.uk























































































were carried out using 2,2′-azobis[2-(2-imidazolin-2-yl)
propane]dihydrochloride (VA-044) as a low temperature
initiator, so that the rate of generation of radicals could be
readily modified as a function of temperature. Our results
suggest that while increasing the temperature increases the
polymerisation rate, it also speeds up RAFT degradation and
thus, loss of control. Conditions have been identified for
which the polymerisation “outperforms” this side reaction and
polymers with good control over molecular mass and dispersi-
ties (ĐM) can be obtained. More importantly, these conditions
allowed us to prepare Boc-Px with higher degrees of polymeris-
ation and lower ĐM, not accessible with our previous con-
ditions.14 This improved control over the polymerisation of
Boc-protected poly(acryloyl hydrazide) will be of value when




(CTA)29 and N′-(tert-butoxycarbonyl)acryloyl hydrazide (1)14,20
were synthesised according to protocols described in the litera-
ture. 2,2′-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride
(VA-044) was purchased from Fluorochem and used without
further purification. All other chemicals were purchased from
Sigma-Aldrich®, Fisher Scientific®, VWR® or Acros®, and
used without further purification. All solvents were Reagent
grade or above, purchased from Sigma-Aldrich®, Fisher
Scientific® or VWR®, and used without further purification.
Polymethylmethacrylate standards were purchased from
Agilent®.
Characterisation
Nuclear Magnetic Resonance (NMR) spectra were recorded on
either a Bruker Avance III 300 MHz or a Bruker Avance III
400 MHz spectrometer. Chemical shifts are reported in ppm
(units) referenced to the following solvent signals: dimethyl-
sulfoxide (DMSO)-d6 H 2.50. Gel Permeation Chromatography
(GPC) was performed with a Shimadzu Prominence LC-20A
fitted with a Thermo Fisher Refractomax 521 Detector and a
SPD20A UV-vis Detector. Poly(N′-(tert-butoxycarbonyl)acryloyl
hydrazide) (Boc-Px) was analysed using 0.05 M LiBr in di-
methylformamide (DMF) at 60 °C as the eluent, and a flow rate
of 1 mL min−1. The instrument was fitted with a Polymer Labs
PolarGel guard column (50 × 7.5 mm, 5 μm) followed by two
PLGel PL1110-6540 columns (300 × 7.5 mm, 5 μm). Molecular
masses were calculated based on a standard calibration
method using polymethylmethacrylate standards.
RAFT polymerisation of N′-(tert-butoxycarbonyl)acryloyl
hydrazide (1)
In a typical kinetic experiment 2,2′-azobis[2-(2-imidazolin-2-yl)
propane]dihydrochloride (VA-044) (11.7 mg, 0.036 mmol),
2-ethylthiocarbonothioylthio-2-methylpropanoic-acid (CTA)
(40.3 mg, 0.18 mmol) and N′-(tert-butoxycarbonyl)acryloyl
hydrazide (1) (1.666 g, 8.950 mmol) were dissolved in DMSO
(10.0 mL) and a 100 µL sample was taken at this stage to calcu-
late conversion (ρ). The solution vessel was sealed with a
septum, securely fastened with electrical tape to maintain the
seal, and degassed by bubbling with argon for 25 minutes.
Using a cannula, 1 mL of the solution was transferred to
sealed glass vials containing stirrer bars, each degassed for
5 minutes. Vials were then left to react at a pre-set temperature
(30–150 °C) for the required amount of time. The reaction was
stopped by allowing the tube to cool using a water bath and
exposing it to air. 100 μL aliquots of each timepoint were taken
at this stage to calculate conversion (ρ) and for GPC analysis.
NMR and GPC analysis of each timepoint was carried out from
the crude mixture. The natural logarithm of the inverse of the
fractional concentration of monomer – ln(M0/Mt) – was plotted
against time, and the data fitted using GraphPad Prism
version 6.0 for Mac Os X, GraphPad Software, La Jolla
California USA, http://www.graphpad.com. The in-built seg-
mental line regression was used to fit the data to two intersect-
ing lines. This model was used to identify when a change in
the polymerisation kinetics was observed (tdead).
Results and discussion
As reported, our initial efforts to optimise the polymerisation
of Boc-protected acryloyl hydrazide 1 focused on reducing the
temperature of the polymerisation.14 RAFT polymerisation of
Scheme 1 RAFT polymerisation of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) and potential degradation by-products.
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acrylamides and methacrylamides often suffers from cleavage
of the RAFT agent through intramolecular addition–elimin-
ation of the weakly nucleophilic amides to the trithiocarbonate
group (Scheme 1).25 Under our previously reported conditions
for the polymerisation of 1, a change in the rate of polymeris-
ation was observed with increasing conversion (Fig. S1A†)
which we associated with this degradation of the terminal
trithiocarbonate in the growing chain. It has been proposed
that reducing the polymerisation temperature would signifi-
cantly reduce the rate of this side reaction.25 Thus, optimi-
sation of the polymerisation was at that time carried out under
the same conditions but using initiators with different
10 hours half-life decomposition temperatures (t10) (Fig. S1†).
This way, the rate of formation of radicals was kept as similar
as possible for all polymerisations while reducing the tempera-
tures to 50 °C (V-65) or 44 °C (VA-044). Despite the use of lower
temperatures, in all cases, a change in the kinetics of the poly-
merisation was observed, although this change was not as
obvious for the polymerisations performed at 44 °C (Fig. S1A,†
right). To identify when this change in rate of polymerisation
was occurring, the natural logarithm of the inverse of the frac-
tional concentration of monomer – ln(M0/Mt) – was plotted
against time, and the data fitted to a segmental line
regression. This function fits the data to two different lines,
before and after a breakpoint. In our case, we termed the
breakpoint tdead because we think that after this point, side
reactions have a predominant effect on the kinetics of the poly-
merisation resulting in an increasing number of dead polymer
chains. This change in kinetics was reflected on the relatively
high dispersity in molecular mass (ĐM = 1.38–1.95) obtained
for the polymers prepared under these conditions.14 Overall,
no clear benefit from reducing the temperature was observed,
with a tdead of approximately 4 and 4.5 hours for polymeris-
ations at 50 °C and 70 °C respectively. Interestingly, tdead for
the polymerisation performed at 44 °C was observed at
approximately 2.5 h, which would suggest degradation was
occurring faster at this temperature. This was not expected and
may suggest that other mechanisms beyond the simple degra-
dation of the RAFT agent may be at play. For instance, poly-
merisation decay can also be caused by diminishing initiator
efficiency at high monomer conversions, which has been
observed for some azo-initiators.30,31 However, this factor nor-
mally becomes significant at much higher conversions than
the ones we reported.
Attempts to perform the polymerisation at an even lower
temperature (30 °C) using VA-044 as the source of radicals
resulted in a very long induction period followed by a short
period of linear increase of the fractional concentration of
monomer until a change in kinetics was again evident
(Fig. S2†). The maximum conversion in this case was 50% – ln
(M0/Mt) = 0.83, worse than that observed for the polymeris-
ations performed at higher temperatures.
In order to determine if degradation of the RAFT agent was
indeed possible at low temperatures, we attempted to syn-
thesise a small molecule analogue which mimicked an n = 1
polymer (Scheme S1†). To this end, 2-bromopropionic acid (2)
was reacted with tert-butyl carbazate, and the resulting
bromine derivative 3 reacted under standard conditions for
the formation of the RAFT agent. 1H NMR analysis of this reac-
tion revealed a very complex mixture, where only traces of
something that could resemble trithiocarbonate 4 could be
identified (Fig. S4†). This observation was in line with our pre-
vious results, and suggested that hydrazide containing trithio-
carbonates such as 4 were very amenable to intramolecular
nucleophilic attack. Attempts to isolate this trithiocarbonate 4
were unsuccessful, with the main isolated product of this reac-
tion being tentatively assigned to a mixture of the 5- and
6-membered rings in a 6 : 4 ratio (Fig. S5†).
Seeing how lowering the temperature had no beneficial
effect on the kinetics of the polymerisation of 1, and a change
in kinetics was still observed, we decided to explore the use of
“Ultra-Fast” polymerisation conditions in an attempt to outrun
the side reaction.32–34 Our hypothesis was that by using a low
temperature initiator such as VA-044 at a significantly higher
temperature (e.g. 100 °C) than the reported t10 (44 °C), an
increase in the concentration of radicals in solution would be
achieved. This way, the concentration of propagating radicals
would be higher with a greater number of chains growing at the
same time, resulting in the synthesis of polymers with better
control over the molecular mass and ĐM. This methodology is
particularly suitable for fast-propagating monomers such as
acrylamides, and since the rate of polymerisation is directly pro-
portional to the concentration of these propagating radicals
(and the monomer concentration, Rp = kp[M][P•]), we postulated
that running the polymerisation under these conditions could
outperform the side reaction observed under standard RAFT
polymerisation conditions. In a first attempt, the polymeris-
ation conditions previously reported by us for the polymeris-
ation of 1 (Fig. S1†)14 were modified so that the initiator used
was VA-044 and the polymerisation temperature was 100 °C. A
shorter polymer was targeted this time and, as expected, the
polymerisation was very fast, reaching up to 70% conversion in
less than five minutes (Fig. 1A, CTA : VA-044 5 : 1 ●). The change
in reaction rate could not be suppressed and was again evident,
with a tdead of approximately 4.5 min. Before tdead, the poly-
merisation retained the features of a controlled polymerisation,
with the molecular mass of the polymer directly proportional to
the conversion and, comparable dispersities (Fig. 1B, left) to
those observed with our previous conditions.14
These results were promising and we therefore explored
decreasing the concentration of initiator in our polymeris-
ations, in an attempt to suppress termination, increase the
number of chains growing from the RAFT agent and thus opti-
mising the dispersities. However, while dispersities were
decreased, reducing the concentration of initiator in these
polymerisations resulted in slower reactions, with no effect
observed in tdead (Fig. 1A). As a result, the maximum conver-
sion obtained when the CTA : VA-044 ratio was increased to
10 : 1 or 15 : 1 (40% and 24% conversion respectively) was
lower than in the previous case (70%).
We decided next to run the polymerisations at 150 °C, in an
attempt to further increase the concentration of radicals
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during early stages of polymerisation, and thus the rate of
propagation. However, these conditions not only resulted in
lower conversions (Fig. S9†) but a colour change of the reaction
mixture from yellow to dark brown, suggesting that thermal
decomposition of the trithiocarbonate group was ocurring.35
Thermal decomposition of the RAFT agent was confirmed via
1H NMR where signals consistent with the β-elimination of the
trithiocarbonate could be observed (Fig. S10†).35,36
Having identified conditions to run the polymerisation of 1
at 100 °C, which resulted in similar conversions and dispersi-
ties to those previously reported, we decided to explore the use
of these conditions to prepare polymers of higher DP (Fig. 2),
which were harder to control using our previously reported
method.14 Three different DPs were targeted (i.e. [1]/[CTA] =
50, 100 and 150), by maintaining the concentration of 1 and
reducing the amount of RAFT agent and initiator used. As
Fig. 1 (A) Plot of conversion (ρ) vs. time and (B) measured number average molecular mass (Mn) vs. conversion (●) and dispersity in molecular mass
(ĐM) vs. conversion (○), for polymerisations of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) performed with different CTA : VA-044 ratios.
Conditions: [M] = 0.9 M, [M]/[CTA] = 50/1. Mn and ĐM calculated by GPC using 0.05 M LiBr in dimethylformamide (DMF) at 60 °C.
Fig. 2 (A) Plot of conversion (ρ) vs. time, (B) fractional concentration of monomer ln(M0/Mt) vs. time, and (C) measured number average molecular
mass (Mn) vs. conversion (ρ) (top) and dispersity in molecular mass (ĐM) vs. conversion (ρ) (bottom), for polymerisations of N’-(tert-butoxycarbonyl)
acryloyl hydrazide (1) performed at 100 °C with different 1 :CTA ratios. (D) GPC chromatograms of the resulting polymers at the highest conversion
obtained. Conditions: [M] = 0.9 M, [CTA]/[VA-044] = 5/1. Mn and ĐM calculated by GPC using 0.05 M LiBr in dimethylformamide (DMF) at 60 °C.
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expected, this resulted in slower polymerisations, while tdead
still remained at around 4.5 min (Fig. 2A). As a consequence,
polymerisations targeting 100 and 150 monomer units only
reached low conversions (∼40% and 30% respectively). In any
case, control over the molecular mass of the polymer was still
observed during the first stages of the polymerisation, with the
average molecular mass (Mn) increasing linearly with time
until the change in polymerisation rate was evident (tdead)
(Fig. 2B). A clear shift towards lower retention time was
observed in the gel permeation chromatograms when higher
DPs were targeted, suggesting that, at least during the initial
phase of the reaction, the polymerisation was maintaining fea-
tures of a controlled radical polymerisation. ĐM remained
similar across the three targeted molecular masses which
demonstrates an improvement compared to our previous con-
ditions where ĐM increased with increasing targeted DP.
At this point, our results suggested that a compromise
could be obtained between increasing the rate of propagation
by increasing the polymerisation temperature, and delaying
tdead by reducing the polymerisation temperature. Therefore,
we investigated polymerisations at intermediate temperatures
(Fig. 3). While a change in polymerisation rate was still evident
for the new temperatures investigated, higher conversions
could be achieved for the polymerisation performed at 65 °C
(90%) while the next highest conversions at 80 °C and 50 °C
were 77% and 80% respectively (Fig. 3B, ●). Temperature had
a significant effect on the time at which a change in polymeris-
ation rate was evident (tdead), with this inflection point hap-
pening sooner as the temperature was increased (Fig. 3B, ○).
With encouraging results from the polymerisations at
65 °C, we set out to probe the “livingness” of the polymer
before and after tdead and thus whether tdead was due to degra-
dation of the RAFT agent. To this end, we isolated and purified
two polymerisations of 1, one that had been stopped at inter-
mediate conversions (ρ = 47%, t = 30 min), before tdead
(Fig. S6A†) and one that was stopped at maximum conversion
(ρ = 85%, t = 120 min), after tdead (Fig. S6B†). As expected,
Boc-Px isolated before tdead was able to undergo complete
chain extension with further addition of 1 and initiator
(Fig. S6A†), thus demonstrating that at intermediate conver-
sions the RAFT agent was still present in significant amounts.
GPC analysis of Boc-Px isolated after tdead indicated that no
chain extension had occurred, instead showing a bimodal dis-
tribution of molecular mass and high dispersities (Fig. S6B†)
demonstrating that after tdead the RAFT group had been
degraded. To probe if the RAFT agent degradation was temp-
erature driven, we isolated and purified a second “living” Boc-
Px at intermediate conversions (ρ = 52% t = 30 min) (Fig. S7†).
This polymer was then heated for 90 minutes under standard
polymerisation conditions, but this time without addition of 1
and initiator. We anticipated that heating the polymer this way
should result in degradation of the RAFT agent, a hypothesis
that was confirmed upon attempting to chain extend this ter-
minated Boc-Px. In this case, high dispersities, together with a
shoulder at high molecular mass, were observed, indicating
that the Boc-Px which had been subjected to further heating
was “dead” (Fig. S7†). Additional evidence of the RAFT agent
degradation was obtained from NMR spectroscopy, where the
protons associated with both the R and Z end group of the
polymer chain could be observed for the “living” Boc-Px
whereas “dead” Boc-Px showed a loss of the Z group (Fig. S8†).
Seeing how running the polymerisations at 65 °C gave the
highest conversions (90%) at tdead of all the conditions evalu-
ated, we decided to target different degrees of polymerisation
using these conditions (Fig. 4). As before, targeting higher DPs
resulted in slower rates of polymerisation, in particular for
DP200 and DP300. While slower rates had a significant effect
on the maximum conversion achieved (approx. 90%, 89%,
68% and 55% for DP 50, 100, 200 and 300 respectively), little
effect was observed on the tdead, with most polymerisations
“stopping” after 1 h (Fig. 4A).
Under these optimised conditions, the polymerisations
retained features of a controlled polymerisation, with the
molecular mass of the polymers increasing linearly with con-
version, narrow dispersities in molar mass (Fig. 4C) and good
end group fidelity if isolated before tdead. In all cases, the dis-
persities obtained were similar or lower to those reported pre-
viously.14 This improvement was particularly the case when
targeting DPs of 100 and 200 with dispersities of <1.4 being
observed at maximum conversion.
Fig. 3 (A) Plot of fractional concentration of monomer ln(M0/Mt) vs. time for polymerisations of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) per-
formed at different temperatures. (B) Effect of temperature on the time at which deviation from linearity for the plot of ln[M]0/[M]t vs. time is
observed (tdead) (○), and the fractional concentration of monomer ln(M0/Mt) at this point (●). Conditions: [M] = 0.9 M, [M]/[CTA]/[VA-044] = 50/1/0.2.
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Here we have demonstrated the role of temperature and RAFT
agent degradation in the polymerisation of N′-(tert-butoxy-
carbonyl)acryloyl hydrazide (1). Our results highlight that the
polymerisation of this hydrazide monomer 1 via RAFT can be
severely hampered by the degradation of the chain transfer
agent and that, under some circumstances, this degradation
cannot be eliminated but rather outperformed if the rate of
polymerisation is tuned. We demonstrate that by using a low-
temperature initiator such as VA-044, optimal polymerisation
conditions can be achieved at 65 °C. This way, poly(N′-(tert-
butoxycarbonyl)acryloyl hydrazide)s with high degrees of poly-
merisation could be obtained while still maintaining low
dispersities. We believe that further improvement of the
polymerisation could be achieved through the choice of RAFT
agents such as pyrazole or quaternised pyridinium
dithiocarbamates,37,38 the use of photopolymerisation,39 or
the use of alternative controlled polymerisation techniques.
Our efforts in these directions will be reported in due course.
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Poly(Boc-acryloyl hydrazide): The importance of 
temperature and RAFT agent degradation on its preparation
Oliver Creese, Pavan Adoni, Guanlong Su, Andrey Romanyuk and  Paco Fernandez-Trillo*
School of Chemistry, and Institute of Microbiology and Infection, University of Birmingham, 
Edgbaston, B15 2TT Birmingham
Figure S1. A) Plot of fractional concentration of monomer ln(M0/Mt) vs time for polymerisations of N’-
(tert-butoxycarbonyl)acryloyl hydrazide (1) performed at different temperatures. Conditions: 
[M]=0.9M, [M]/[CTA]/[In]=100/1/0.2. 4,4'-Azobis(4-cyanovaleric acid) (V-501) - circles, 2,2'-
azobis(2,4-dimethylvaleronitrile) (V-65) - squares, and 2,2'-azobis[2-(2-imidazolin-2-
yl)propane]dihydrochloride (VA-044) - triangles. Adapted with permission from Crisan, D. N.; Creese, 
O.; Ball, R.; Brioso, J. L.; Martyn, B.; Montenegro, J.; Fernandez-Trillo, F. Polym. Chem. 2017, 8 (31), 4576–
4584 - Published by The Royal Society of Chemistry. B) For polymerisations carried out in S1A, effect of 
temperature on the time at which deviation from linearity for the plot of ln[M]0/[M]t vs time is observed 
(tdead), and the fractional concentration of monomer ln(M0/Mt) at this point.
Electronic Supplementary Material (ESI) for Polymer Chemistry.
This journal is © The Royal Society of Chemistry 2019
Figure S2. Plot of ln(M0/Mt) vs time for the polymerisation of N’-(tert-butoxycarbonyl)acryloyl hydrazide 
(1) at 30 ºC. Conditions: [M]=0.9M, [M]/[CTA]/[VA-044]=50/1/0.2.
Small molecule analogue of a DP= 1 of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1). 
Scheme S1. Attempted route for the synthesis of a DP= 1 analogue of N’-(tert-butoxycarbonyl)acryloyl 
hydrazide (1).
tert-butyl 2-(2-bromopropanoyl)hydrazine-1-carboxylate (3): 2-Bromopropionic acid (2) (10 
g, 59.9 mmol) and tert-butyl carbazate (6.56 g, 49.6 mmol) were dissolved in a 2:1 mixture of 
water/THF (180 ml). N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (13.3 g, 69.5 
mmol) was added in portions to the solution over 15 minutes and the mixture was left stirring for 
3h at room temperature. The solution was extracted into EtOAc (3 x 60 ml) and a basic work-up 
performed with NaCO3 (3 X 60 ml). The organic layer was further washed with water (2 x 60 ml), 
dried with Na2SO4, filtered and the solvent removed under reduced pressure to leave a white solid. 
This solid was then recrystallised using ethyl acetate to afford white crystalline material which was 
washed with ice cold diethyl ether and dried under reduced pressure (8.9 g, 64 %): 1H NMR 































Figure S3. 1H NMR (300 MHz, CDCl3) spectrum of tert-butyl 2-(2-bromopropanoyl)hydrazine-1-
carboxylate (3).
tert-butyl 2-(2-(((ethylthio)carbonothioyl)thio)propanoyl)hydrazine-1-carboxylate (4) (not 
isolated): Ethanethiol (0.49 ml, 6.59 mmol) was added to a suspension of K3PO4 (1.4 g, 6.59 mmol) 
in acetone (20 ml) and was left stirring at room temperature for 10 minutes. CS2 (1.09 ml, 6.59 
mmol) was then added and the reaction mixture was left for a further 10 minutes. tert-butyl 2-(2-
bromopropanoyl)hydrazine-1-carboxylate (1) (1.6 g, 5.99 mmol) was added in one portion and the 
mixture left to react for 13 hours. The solvent was then removed under reduced pressure and HCl 
(100 ml, 1 M) was added to the crude of the reaction. The resulting mixture extracted into DCM (2 x 
100 ml). The organic layer was then washed with water (2 x 100 ml) and brine (2 x 100 ml), dried 
with Na2SO4, filtered and the solvent removed under reduced pressure. The resulting orange oil was 
purified by column chromatography using a 7:3 ratio of diethyl ether and hexane, then dried under 
reduced pressure to leave a viscous orange liquid (0.12 g, 7 %) which consisted of two compounds, 
none of which is the title compound. a; 1H NMR (300MHz, CDCl3) δ (ppm) 10.3-9.7 (1H, s, NH), 4.66 
(q, 1H), 1.58 (d, 3H), 1.44 (s, 9H) and b; 1H NMR (300MHz, CDCl3) δ (ppm) 10.3-9.7 (1H, s, NH), 4.73 
(q, 1H), 1.59 (d, 3H), 1.44 (s, 9H).
Figure S4. A) 1H NMR (300 MHz, DMSO) spectrum of 2-((ethylthio)carbonothioyl)thio-2-
methylpropanoic acid (CTA). B) 1H NMR (300 MHz, CDCl3) spectrum of tert-butyl 2-(2-
bromopropanoyl)hydrazine-1-carboxylate (3). C) 1H NMR (300 MHz, CDCl3) spectrum of the reaction of 
ethanethiol with carbon disulfide and tert-butyl 2-(2-bromopropanoyl)hydrazine-1-carboxylate (3). 
Figure S5. 1H NMR (300 MHz, CDCl3) spectrum of the main fraction isolated following the reaction of 




























I t=120 + 60 min
t=120 min
A B
Figure S6. A) GPC traces (DMF LiBr 0.05M) of “living” Boc-Px after (t=30 min) and subsequent chain 
extension with (1)(t=30+60 min). B) “dead” Boc-Px (t=120 min) and subsequent inability to chain 
extend with (1) (t=120+60 min). 
Figure S7. GPC traces (DMF LiBr 0.05M) of isolated “living” Boc-Px after (t=30 min) after further heating 
(60 ºC t=90 min), and subsequent inability to chain extend with (1) (t=30+60 min).
Figure S8. Top: 1H NMR (300 MHz, CDCl3) of “living” Boc-Px after polymerisation reaction was stopped 
after 30 minutes,  before full conversion (47%). Bottom: 1H NMR (300 MHz, CDCl3) of “dead” Boc-Px 
after polymerisation for 120 minutes to maximum conversion (85%).
Figure S9. Plot of ln(M0/Mt) vs time (A) and conversion (ρ) vs time (B) for the polymerisation of N’-(tert-
butoxycarbonyl)acryloyl hydrazide (1) at 150 ºC. Conditions: [M]=0.9M, [M]/[CTA]/[VA-044]=50/1/0.2.
Figure S10. 1H NMR (300 MHz, CDCl3) spectrum showing vinyl region at varying time points in the 
polymerisation of N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) at 150 ºC. Conditions: [M]=0.9M, 
[M]/[CTA]/[VA-044]=50/1/0.2. New vinyl protons can be observed from 7 minutes, suggestive of β-
elimination products.
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2.1 Background 
With increasing rates of resistant bacteria reported for traditional antibiotics, and 
few new classes of antibiotics in the pipeline,1 we face the prospect of a “post-antibiotic 
era”,2 whereby previously simple to treat infections could prove life-threatening. 
Antimicrobial resistance (AMR) is currently estimated to be responsible for over 
700,000 deaths per year globally, and predicted to rise to over 10 million by 2050 
overtaking that of both cancer and diabetes combined.2,3 
In this regard, alternative broad-spectrum approaches to controlling pathogenic 
bacteria are urgently needed to address AMR. Targeting bacterial virulence in a way 
that “disarms” the bacteria, rather than kills bacteria, could offer a route to control 
pathogenic infection without inducing evolutionary pressure which can ultimately lead 
to resistance.4-6 A crucial step in the pathogenicity of many bacteria is adhering to 
surfaces, which is a prerequisite for survival and the ability to cause disease to the 
host. Targeting bacterial adhesion mechanisms, sometimes described as “anti-
adhesion therapy” has been positioned as a promising strategy by which to control 
bacteria. In this regard polymers have been explored as surface coatings to repel the 
adhesion of bacteria,7,8 and in solution as “drug-like” polymers which can induce 
clustering of bacteria, preventing their adhesion to host cells.9,10 Cationic polymers 
have been reported to sequester planktonic bacteria in this way as a result of non-
specific multivalent “cross-linking” of negatively charged bacteria and positively 
charged polymers which is often referred to in this context as bridging aggregation 
(Figure 21).11 
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Figure 21. Polymer-mediated aggregation of bacterial cells as an “anti-adhesion 
therapy” reduces their ability to colonise and cause toxicity to the host. 
The general design principles of cationic polymers reported to sequester 
bacteria are similar to those of more extensively researched cationic antimicrobial 
polymers (AMP). AMPs generally employ the use of primary, secondary, tertiary or 
quaternary amines to impart an overall cationic charge on the polymer while 
hydrophobicity is introduced in order to tune antimicrobial properties,12,13 although 
there has been difficulty in translating general design principles when targeting 
different bacteria.14,15 The impact of cationic polymer chemistry on the binding of 
bacteria is less well understood, and cationic portions of synthetic polymers for 
bacterial clustering have exclusively consisted of primary, tertiary or quaternary amines 
(Introduction). Previous work carried out in our labs determined that tertiary amine 
containing methacrylate polymers were less toxic to Vibrio cholerae, and exhibited 
similar clustering and anti-adhesion properties to primary amine containing polymers,9 
although methacrylate AMPs synthesised from closely related primary and tertiary 
amine containing monomers were found to exhibit opposite trends in toxicity towards 
Escherichia coli and Mycobacterium smegmatis and different mechanisms of action on 
the cell membrane.15 It is not clear if observed differences originate from the nature of 
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the side-chain or the architecture of the polymer itself. In this regard a better 
understanding of the structure-activity relationships of these materials is needed. 
Heterogeneity is a major hurdle in polymer chemistry,16 especially when designing 
polymers for biomedical applications. With this in mind, post-polymerisation 
modification of a polymer scaffold is an attractive means of generating new chemically 
distinct polymers originating from the same parent polymer so as to negate effects 
arising from different polymerisations.17 Further control over the material can be 
achieved using controlled polymerisation techniques (CRP) to reduce the dispersity in 
the polymer molecular mass, aiding predictability and reproducibility of these materials 
as well as allowing access to different degrees of polymerisation (DP). Popular 
examples of CRP techniques include reversible addition-fragmentation chain transfer 
(RAFT),18,19 and atom transfer radical polymerisation (ATRP).20 
Cationic polymers have been reported as being able to trigger additional 
bacterial responses as a consequence of aggregation, in particular, biofilm 
formation,21,22 or repression,23,24 where it has been proposed that increased biofilm 
formation may be a result of increased quorum sensing of bacteria sequestered into 
clusters (Figure 22).21,22  
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Figure 22. High cell density results in increased concentration and detection rates of 
quorum sensing molecules which influences how bacteria regulate certain genes. 
While enhanced quorum sensing has been reported and linked to an 
upregulation in biofilm production in both V. cholerae and E. coli after clustering with 
cationic polymers, this observation is easily justified in E. coli, which upregulate biofilm 
in response to quorum sensing,25 although, not easily explained for V. cholerae which 
downregulate biofilm formation in response to quorum sensing.26 These observations 
suggest that there may be mechanisms other than quorum sensing triggering bacterial 
responses. A greater certainty over the polymer chemistry, coupled with high-
throughput approaches to screening different polymer chemistries will broaden the 
understanding of interactions between synthetic cationic polymers and bacteria. 
2.2 Objectives  
The primary objective of this work was to evaluate the use of poly (acryloyl 
hydrazide) (Px) as a scaffold to screen a library of cationic polymers for their activity in 
sequestering and modulating the physiology of V. cholerae. The motivation behind this 
work was to relate polymer chemistry and biological activity and to explore the side-
chain chemical space outside of primary amines, dimethylamines and quaternary 
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amines. To this end, the versatility of Px was exploited so that the degree and nature 
of the side-chain functionalisation and the degree of polymerisation could be 
modulated in a controlled and systematic way.  
A secondary objective was to critically evaluate the methods used in comparing 
the activities of polymer on the clustering of bacteria. Heterogeneous growth, as is the 
case in either clustering or biofilm formation can hamper the interpretation of certain 
indirect measurements such as optical density and fluorescence during growth curves. 
Directly observing bacteria via optical methods therefore is a valuable means to 
corroborate the reported data. And further to this, traditional imaging workflows involve 
the pipetting of samples onto slides and imaging which involves a level of invasiveness 
and can lead to bias when it comes to evaluation. In this regard investigation into 
polymer activity will be carried out using time-lapse microscopy under standard 
assaying conditions in order to better interpret the activity of cationic polymers P1 and 
P2 (Figure 24) reported in our previous work9,22, and further novel cationic polymers 
generated from Px. 
2.3 Results and discussion 
2.3.1 Cationic polymers P1 and P2 induce different effects on growth and biofilm 
formation of V. cholerae 
It was previously reported in our labs that cationic polymers poly(N-(3-
aminopropyl) methacrylamide (P1) and Poly(N-[3-(dimethylamino)propyl] 
methacrylamide) (P2), cause aggregation of V. cholerae.9,22 Aggregation is understood 
to be driven by multivalent electrostatic interactions between the positively charged 
polymer and the negatively charged bacterial membrane and has been proposed as a 
means of inhibiting adhesion of bacteria to surfaces. It has been demonstrated 
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previously that polymers designed to bind bacteria can offer a protective effect towards 
host cells against pathogenic infection.9,10 We reported that V. cholerae aggregated 
after treatment with P1 and P2 resulted in an enhancement in quorum sensing due to 
a local increase in quorum sensing molecules within bacterial aggregates.22 Quorum 
sensing downregulates biofilm and virulence factor production in V. cholerae,26,27 to 
allow dissipation of the bacteria in response to high cell density.28 However, enhanced 
quorum sensing driven by P1 and P2 resulted in a downregulation of toxin genes but 
an upregulation of biofilm genes and increase in biofilm formation.22  
The role side-chain chemistry on these reported effects was not clear, and in 
order to better understand how bacteria respond after incubation with P1 and P2, time-
lapse microscopy was carried out to assess subtle differences in bacterial responses 
to these polymers, such as abnormal growth dynamics, clustering and biofilm 
formation. To evaluate this, we imaged V. cholerae growth in response to P1 and P2 
treatment every 30 minutes without shaking, using an oCelloScope high-throughput 
microplate imager which allowed for continual imaging on multiple samples during 
incubation without disturbing the sample (Figure 23). 
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Figure 23. Optical microscope images of V. cholerae growth progression in clear 
DMEM at 37 oC, taken at indicated timepoints with an oCelloScope (4X objective), 
treated with P1 or P2 at 0.5 and 0.05 mg ml-1. Each image represents the bottom of a 
96 well plate and samples were recorded in triplicate. Initial OD600 was 0.02. 
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Imaging growth in this way revealed large differences between the effects of 
both polymers, and we were surprised to observe nucleation of V. cholerae biofilm,29 
for samples treated with P1 at 0.05 mg ml-1 not replicated for P2. These biofilms which 
nucleated and grew at identical rates, were present in each of the triplicates tested and 
further observed in independent experiments. Growth curves based on image contrast 
during the time-lapse imaging (Figure 24) were in agreement with growth curves 
previously reported,9 suggesting that P1 was toxic at 0.5 mg ml-1 and P2 was non-toxic 
at both concentrations tested. Interestingly biofilm nucleation occurring at around 10 
hours, was represented in the growth curve by an initial delay in growth followed by 
accelerated growth after biofilms had nucleated (Figure 24). 
 
Figure 24. Growth curve estimates for V. cholerae incubated at 37 oC, dispersed in 
clear DMEM. Estimates cacluated from oCelloScope time lapse imaging data using 
the in-built software (Biosensesolutions) for A) P1 and B) P2. 
It was rationalized that the nucleation of biofilms by P1 would not be observable 
to the same extent while shaking occurred during the incubation process, as in our 
previously reported work,22 but could account for the reported bacterial clustering due 
to partially dispersed microcolonies. On account of these observations, and given P1 
had been previously shown to upregulate the production of key biofilm scaffolding 
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protein RbmA to a greater degree than P2,22 it was investigated whether this would 
translate to differences in biofilm accumulation measurable by traditional crystal violet 
staining, and thus further support our observation that P1 has a distinct effect on biofilm 
formation of V. cholerae to P2. The crystal violet assay, is a simple procedure which 
can be carried out in 96 well plates as described by O’Toole,30 whereby after incubation  
residual attachment of bacterial biofilm components to the sides and bottom of a 96 
well plate after washing can be quantified by staining with the triarylmethane dye; 
crystal violet (Figure 25).  
 
Figure 25. A) Image of crystal violet plate layout, showing polymer-modulated biofilm 
formation by crystal violet staining, for V. cholerae after 24-hour incubation (37 oC, 
clear DMEM). B) Assessment of biomass production by absorbance at 550 nm for the 
corresponding wells in A., indicating a significant increase in biomass for V. cholerae 
treated with 0.05 mg ml-1. Each point represents a biological replicate (n=3) as average 
of 3 technical replicates. Significance was calculated using a student’s t test (** 
P=0.0021). 
The results of the assay revealed a significant increase in biofilm formation for 
V. cholerae treated with P1 at 0.05 mg ml-1 which was not replicated for P2, correlating 
well with evidence of biofilm formation by microscopy (Figure 23). We suspect that 
although sequestering of bacteria with P2 resulted in a reported upregulation of biofilm 
controlling genes,22 this aggregation process may also restrict bacterial attachment to 
the surface of the well resulting in reduced staining by crystal violet. A similar 
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violet staining due to clustering of Pseudomonas aeruginosa incubated with a 
quaternary amine derivative of P2.23 Bacterial clustering with tertiary and quaternary 
amines such as P2 has been well established,23,32-38 however primary amines are less 
well researched for this use, and are reported as having higher antimicrobial activities 
than tertiary and quaternary amines despite possessing a lower overall positive 
charge.14 Higher antimicrobial activity for primary amine containing polymer is likely to 
be due to fact that primary amines interact more strongly with negatively charged 
phospholipids compared to sterically more hindered tertiary amines.31 Having 
considered that small differences in the chemical properties of polymers such as 
charge, sterics and hydrophobicity of the side-chain can result trigger different bacterial 
responses as we have seen here for P1 and P2, we decided to investigate the chemical 
properties of the side-chain by taking a post-polymerisation modification approach, in 
order to better evaluate structure-activity relationships, and facilitate the discovery of 
novel polymeric compounds which could sequester and control pathogenic bacteria. 
In Chapter 1, we reported the synthesis a highly versatile poly(acryloyl 
hydrazide) (Px) scaffold,32,33 by controlled Reversible addition-fragmentation chain 
transfer (RAFT) polymerisation18,19 which yielded polymers with improved control over 
the molecular mass. Px affords access to libraries of new functional polymers with 
potential biological applications via post-polymerisation modification with functional 
aldehydes (Scheme 4).32  
Chapter 2 
   85 
 
Scheme 4. Synthetic route for polyhydrazide scaffold (Px) and post-polymerisation 
modification with aldehydes (Px-“R”). 
This methodology allowed evaluation into the impact of the side-chain chemistry 
on bacteria, while negating differences in activity arising from uncertainty over polymer 
molecular mass and dispersity (Đm), which is often overlooked and can be especially 
challenging to control in polymer chemistry where differences in the molecular mass 
and shape of the molecular mass dispersity (Đm) impact the materials properties.34,35  
With this in mind, and before exploring different side-chain chemistries we 
prepared Px at different molecular masses to investigate the impact on toxicity towards 
V. cholerae. Px targeting DP50 and DP100 via RAFT, and Px prepared by free radical 
polymerisation were analysed by SEC (Figure 26).  
 
Figure 26. Molecular mass distributions (SEC, Lonza DPBS) for Px targeting DP50, 
DP100 and prepared by free radical polymerisation (FRP). Values calculated by a 
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Table 3. SEC data for Px described in Figure 26. 
Targeted DP Mpa (theo) Mnb (SEC) Đm (SEC) 
DP50 4094 6014 1.21 
DP100 7104 9509 1.32 
N/A (FRP) N/A 26695 5.6 
a Polymer molecular weight calculated by monomer conversion (g.mol-1); b Number average molecular 
weight was calculated by SEC (Lonza DPBS) using standard calibration methods with PEG/PEO (g.mol-
1).  
Smaller Đm was noted for polymers targeting DP50 and DP100 in agreement 
with our results for optimised polymerisation conditions (Chapter 1), and a significantly 
larger and highly disperse “free radical” polymer (FRP), when the RAFT agent was 
replaced with cysteamine ([1][CTA][In] = [100][2][0.4]). 
After preparing Px at different molecular masses, we assessed the impact 
molecular mass of the polymer had on the growth of a GFP-producing strain of V. 
cholerae by optical density (OD600) and fluorescence (GFP). GFP was used throughout 
this work as a proxy of bacterial growth so as to negate uncertainties in OD600 due to 
bacteria clustered by polymers (Figure 27). 
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Figure 27. Growth curves for V. cholerae incubated at 37 oC in clear DMEM treated 
with varying concentrations of Px prepared at different targeted molecular masses 
(DP100, DP50 and FRP). Growth measured by A) OD600 and B) fluorescence (GFP) 
in triplicates (n=1) and C) GFP expression from GFP growth curves at 15 hours.  
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In all cases Px displayed little growth inhibition towards V. cholerae except at 
the highest concentration, 0.5 mg ml-1 where growth was delayed prior to 10 hours, but 
recovered to similar levels after 15 hours. It was proposed that low toxicity may be as 
a result of the poorly protonated hydrazide group (pKa ~ 4) at physiological pH,36 which 
may also account for the observed inability for Px to form clusters of bacteria. GFP 
expression at 15 hours by fluorescence for V. cholerae incubated with different 
molecular mass Px (Figure 27 C) was compared in order to deduce whether the 
polymer molecular mass influenced toxicity towards the bacteria. However, no 
evidence was found for a correlation between Px molecular mass and bacterial growth 
(Figure 27).  
2.3.2 Post-polymerisation modification of poly(acryloyl hydrazide)  
Having established that molecular mass of poly(acryloyl hydrazide) (Px) did not 
impact the growth of V. cholerae, we next set out to investigate how modulating the 
side-chain chemistry of Px would affect its biological properties with the aim being to 
sequester V. cholerae. Hydrazide side chains present in Px are very amenable to 
reactions with aldehydes via hydrazide-carbonyl condensation to form acyl hydrazone 
polymer-aldehyde conjugates, and in this way, we prepared Px with different degrees 
of functional aldehyde loading. Two commercially available hydrophobic aldehydes 
possessing aromatic amines; Imidazole-4-carbaldehyde (IMI) and 2-amino-3-formyl 
pyridine (2A3FP) were chosen to modulate hydrophobicity and protonation of Px 
(Scheme 5).  
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Scheme 5. Synthetic routes taken in the post-polymerisation of Px to yield polymers 
with varying degrees of aromatic amine IMI or 2A3FP. 
 
IMI and 2A3FP have an estimated pKa of 6.03 and 6.19 respectively which 
corresponds to intermediate levels of protonation at physiological pH compared to P1 
and P2 (pKa ~ 8.3 and 7.5 respectively),31 but significantly more protonated than the 
hydrazide groups of Px.36 The conjugation reactions were carried out by combining 
stock solutions of a P45 and the aldehyde in 100 mM acetic acid buffer at different ratios 
(Table 4).  
Table 4. Representative experimental set up for the preparation of P45-IMI and P45-
2A3FP at different degrees of functionalisationa . Detailed experimental conditions for 
Px functionalisation can be found in the appendix.  
[aldehyde] / [hydrazide] Pxb Aldehydeb  Bufferb  Totalb  
0 300 0 300 600 
0.25 300 75 225 600 
0.5 300 150 150 600 
0.75 300 225 75 600 
1.0 300 300 0 600 
a Concentration for both aldehyde and Px stock was 0.12M. b Volumes reported in μL. 
Post-polymerisation modification was carried out in HPLC vials fitted with micro 
stirrer bars and heated at 60 oC for 24 hours. The loading efficiency of IMI or 2A3FP 
onto the polymer was evaluated by proton NMR by monitoring the reduction in the free 
aldehyde proton region (total = 1H), versus the residual proton signals for IMI (Figure 
28) or 2A3FP (Figure 29), which were visible as either sharp or broad signals 




























x= [aldehyde] / [hydrazide]
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Figure 28. Proton NMR (D2O) following the reaction of P45 with IMI. A) Expanded 
aldehyde region showing peaks involved with calculating degree of functionalisation. 
Peaks labelled 1 and 1.1 represent the aldehyde and the corresponding hydrate 
respectively. B) Stacked NMR spectrums for the reaction of P45 with different 
equivalents of IMI after 24 hours and in the absence of P45 (top) mono and dihydrazone 
impurities are denoted by *. All samples were incubated in 100 mM AcOH / D2O. 
 
 
Figure 29. Proton NMR (D2O) following the reaction of P45 with 2A3FP. A) Expanded 
aldehyde region showing peaks involved with calculating degree of functionalisation. 
B) Stacked NMR spectrums for the reaction of P45 with different equivalents of 2A3FP 
after 24 hours and in the absence of P45 (top) mono and dihydrazone impurities are 
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Table 5. Percentage loading in coupling reactions at varying equivalents of the 





IMI displayed similar loading efficiencies to our previously published results,32 
which was closely replicated for modification with 2A3FP which has not been 
previously reported with P45. Evidence of a hydrazone cleavage products were visible 
in the proton NMR for P45-IMI and P45-2A3FP (highlighted *) (Figure 28, Figure 29). 
At intermediate loading of P45-2A3FP, a new sharp peak at 7.92 ppm was visible 
(Figure 29) and was likely due to intramolecular cleavage of the C-N bond on the acyl 
hydrazone side-chain of the polymer by an adjacent unmodified hydrazide moiety to 
form a new monohydrazone species as proposed in our previous work.32  
At higher equivalents of aldehyde, the monohydrazone has been shown to react 
with free aldehyde to form a dihydrazone species,32 consistent with the presence of a 
new, sharp peak that was observed here at 8.73 ppm, visible between 0.5 and 1.0 
equivalents of 2A3FP, and the disappearance of the mono-hydrazide peak between 
0.5 and 0.75 equivalents of 2A3FP. The abundance of dihydrazone species remained 
largely unchanged between 0.75 and 1.0 equivalents of 2A3FP which highlighted the 
involvement of unreacted hydrazide moieties (29.5% and 24% respectively) of P45 on 
the formation of the cleavage product. Similar impurities were noted for P45-IMI at 7.78-
7.80 ppm and 8.55 ppm for the mono and dihydrazone respectively, which had been 
previously reported in our work,32 although in this case, the formation of the 
dihydrazone was not as favorable as compared with P45-2A3FP (Table 6). 
Entry x=0.25 x=0.5 x=0.75 x=1.0 
P45-IMIx 25% 50% 74% 77% 
P45-2A3FPx 25% 50% 70% 76% 
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Table 6. Relative abundance of mono and dihydrazone impurities for different 
[Aldhyde]/[Hydrazide] conjugation conditions, calculated by proton NMR (100 mM 
AcoH/D2O). 







P45-2A3FP0.25 100 0 100 0.25 
P45-2A3FP0.5 34 66 99 0.5 
P45-2A3FP0.75 4 96 94 0.75 
P45-2A3FP1.0 0 100 76 0.5 








P45-IMI0.25 100 0 100 <0.01 
P45-IMI0.5 100 0 100 0.3 
P45-IMI0.75 43 57 99 0.33 
P45-IMI1.0 54 46 77 0.67 
a Relative abundance (%) of proposed monohydrazone (7.92 ppm), b relative abundance (%) of 
proposed dihydrazone (8.73 ppm) (%). c Relative abundance (%) of proposed monohydrazone (7.78 
ppm), d relative abundance (%) of proposed dihydrazone (8.55 ppm). 
In all cases formation of the proposed hydrazone cleavage impurity was small, 
accounting for under 1% of the total proton signals, and we were encouraged by the 
efficient loading to very similar degrees for both aldehydes. With loading of the 
aldehyde quantified by NMR, next was studied the incorporation of the aldehyde onto 
the polymer by SEC (100 mM AcOH), in order to corroborate our calculated loading by 
NMR, and assess possible changes in the overall polymer architecture in response to 
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Figure 30. SEC (100 mM AcOH) trace (refractive index) for P45-IMIx and P45-2A3FPx 
at varying degrees of targeted functionalisation (x= [Aldehyde]/[Hydrazide]). 
Refractive index (RI) increased for the polymer region (20-25 minutes) in the 
SEC trace, with increasing functionalisation degree (x) for both P45-IMIx and P45-
2A3FPx. We also noted a slight shift in RT for the maximum RI signal towards earlier 
retention times with increasing x. which, rather than transitioning as a single polymer 
dispersity as seen in living radical polymerisation,37 resembled two distinct polymer 
species at intermediate loading, but a single species at maximum loading. The 
observation of two distinct polymer distributions was most noticeable for P45-2A3FP0.5 
and could indicate different polymer conformations accessible to Px at intermediate 
loading,38 uneven distribution of the modification, or structural changes in the 
polymer.39  
Having prepared and characterised an array of functional polymers based on 
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activity in situ, in order to probe various responses of V. cholerae as a function of 
degree of loading and nature of the aldehyde on the polymer.  
2.3.3 Impact of side-chain chemistry on V. cholerae 
To determine whether Px-IMIx and Px-2A3FPx imparted different toxic effects 
towards V. cholerae, growth curves for GFP expressing V. cholerae treated with P80-
IMI1.0 and P80-2A3FP1.0. Seeing how P80-IMI1.0 and P80-2A3FP1.0 were screened in situ 
without purification, contribution of the buffer (100 mM AcOH) and corresponding free 
aldehyde was also assessed in each case to account for this (Figure 31). 
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Figure 31. GFP based Growth curves for GFP expressing V. cholerae (37 oC, clear 
DMEM) treated with A), P80-IMI1.0, and the corresponding concentration of IMI (0.56 
and 0.056 mg ml-1 respectively), B) P80-2A3FP1.0, and the corresponding concentration 
of 2A3FP (0.71 and 0.071 mg ml-1 respectively) and C) unmodified polymer scaffold 
(P80) and representative concentrations of AcOH buffer (100 mM) added for 
concentrations 0.5 mg ml-1 and 0.05 mg ml-1 conditions. 
Growth curves revealed that the acetic acid buffer significantly increased the 
toxicity of the unmodified scaffold compared to that observed previously for P80 (Figure 
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27) , likely due to protonation of the hydrazide side-chain groups which is well known 
to increase the antimicrobial activities of nitrogen containing polymers.31 The pKa of 
the hydrazide groups is around 4, compared to the pKa of a primary amine at around 
10-11,36 which helps explain the low toxicity of Px in the absence of acidic buffer 
(Figure 27), where it remains almost entirely unprotonated. P80-2A3FP1.0 displayed 
higher levels of toxicity to V. cholerae at 0.5 mg ml-1 compared to P80-IMI1.0 which 
displayed little difference in toxicity at both 0.5 and 0.05 mg ml-1. Interestingly, no lag 
phase in the growth of V. cholerae treated with 0.5 mg ml-1 P80-IMI1.0 was observed, 
instead, an increase in observed fluorescence intensity was apparent at early time 
points (t < 5h), which we reasoned could be attributed to high-density clusters of 
fluorescent bacteria rather than dispersed bacteria. V. cholerae responded differently 
to aldehyde controls; IMI and 2A3FP, with 2A3FP displaying very little change in shape 
or intensity in the growth curve over the untreated sample, while IMI at the higher 
concentration (0.56 mg ml-1) resulted in a longer lag period in growth, followed by 
nearly linear growth progression which in this case increased even beyond that of the 
untreated V. cholerae after 20 hours. This interesting behavior may be in part due to 
IMIs analogy to the biologically important amino acid histidine and we were interested 
to observe further the effect of IMI. AcOH buffer was found to have an inhibitory effect 
on the growth of V. cholerae, even at the lowest concentration (representative of the 
concentration transferred for 0.05 mg ml-1 conditions). Owing to the low solubility of IMI 
and 2A3FP we were unable to increase the concentration of the polymer and the 
aldehyde or decrease the molarity of the buffer so as to minimize the concentration of 
AcOH transferred to biological samples. 
Since AcOH is understood to exhibit antibacterial properties and had previously 
been utilised in this regard as a biocide in wound treatment,40 we explored the use of 
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alternative buffers for conjugation reaction in an effort to reduce the background 
toxicity. To this end, we tested the use of Citric acid buffer (pH 2.4) and Phosphate 
buffer (pH 2.8) which were both found to be suitable alternatives for the synthesis of 
Px-IMI and Px-2A3FP, however no benefit was found with respect to toxicity over that 
of AcOH. 
Solubility issues were observed at 0.5 mg ml-1 for both Px-IMI and Px-2A3FP on 
addition of the polymer solution (100 mM AcOH) into the assay media (DMEM) 
resulting in the formation of a mucus-like precipitate(Figure 32). 
 
Figure 32. Polymer precipitates formed in DMEM (200 uL) during a growth curve 
assay.  
The appearance of precipitates is likely due to the poor solubility of the 
conjugate at above pH 3 owing to the increased hydrophobicity on conjugation of the 
aldehyde. Interestingly the aldehydes on their own were perfectly soluble at both 
concentrations in DMEM, and both Px-IMI and Px-2A3FP were readily soluble in 
deionised water probably owing to the absence of any buffering salts. Nevertheless, 
we reasoned that despite the issues with solubility, which are often overlooked when 
designing polymer for biological applications, the polymers may still yield interesting 
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way to a synthetic mucus which are researched for similar applications, especially with 
the potential to further modify these materials with glycans.41 
2.3.4 Impact of degree of functionalisation on V. cholerae 
With an understanding of how IMI and 2A3FP modulate the properties of Px and 
the toxicity towards V. cholerae, we next assessed how modulating degree of Px 
functionalisation modulated the biological response of V. cholerae in order to begin to 
evaluate the structure-activity relationship. We have seen how different side-chain 
chemistries of polymers result in different biological outcomes, for example in the case 
of P1 and P2, and that polymer architecture can also influence the activity.10 To this 
end, we synthesised Px-IMI, which we deemed to display more promising biological 
activity, and targeted different degrees of polymerisation (DP) and degrees of 
functionalisation (DF), in order assess the impact of each of these properties on V. 
cholerae. Px targeting DP50 and DP150 was prepared by RAFT and PFRP was 
prepared by FRP and each was functionalised with IMI to yield Px-IMIx with different 
degrees of functionalisation (Figure 33, Table 7). 
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Figure 33. Stacked proton NMRs (D2O) for A) P43 B) P81 C) PFRP after incubation with 
increasing equivalents of IMI and D) Molar mass distributions (SEC, Lonza DPBS) for 
unmodified Px.  
Table 7. SEC and aldehyde functionalisation data for polymers described in Figure 
13.  
Polymer properties (SEC) Functionalisation with IMI (NMR) 
Entry Target DP a Mn(SEC)  ĐM b0.25 eq. 0.5 eq. 0.75 eq. 1.0 eq. 
P43 50 6037 1.25 25% 50% 75% 81% 
P81 150 11908 2.45 25% 50% 75% 88% 
PFRP N/A 26306 4.31 25% 50% 74% 73% 
a Number average molecular mass (g.mol-1) calculated by SEC (Lonza DPBS) btargeted eq. of IMI based 
on [Aldhyde]/[Hydrazide]. 
 
To evaluate the impact that molecular mass and degree of functionalization (DF) 
had on the growth of V. cholerae, GFP growth curve data employing Px at different 
molecular masses and DF was compiled across multiple biological replicates. In order 
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untreated V. cholerae for each case in an effort to negate the unavoidable biological 
variation apparent when carrying out biological growth on different days and from 
different colonal stocks. Differences between samples were highlighted after 15 hours 
chosen as representative of the end portion of the stationary phase of the V. cholerae 
growth cycle and therefore representative of maximum growth across all growth 
curves. Each dataset was further baseline-corrected against the corresponding 
untreated sample in order to display the results as the mean percentage growth 
compared with that of the untreated sample (100 % growth). Firstly, as a control, the 
impact of the free aldehyde (IMI) at varying concentrations in AcOH buffer (100 mM), 
and buffer only, representative of the corresponding polymer conditions was tested 
(Figure 34). 
 
Figure 34. Relative growth of V. cholerae (37 oC, clear DMEM), for treated samples 
after 15 hours incubation. A) Impact of buffer concentration present in 0.5 and 0.05 mg 
ml-1 polymer and aldehyde conditions, and impact of increasing concentration of free 
aldehyde (IMI) representative of B),0.5 mg ml-1 C),0.05 mg ml-1polymer conditions at 
corresponding targeted degrees of functionalisation. Each point represents a biological 
replicate as a mean of three technical replicates. Significance was calculated using a 
student’s t test (** P = 0.0021, * P= 0.0277). 
Acetic acid (AcOH) buffer resulted in a 35% reduction in growth at 10 mM, while 
a 15 % reduction in growth was observed for 1 mM. Interestingly with increasing 
portions of IMI dissolved in 100 mM acetic acid, corresponding to the concentrations 
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added to the polymer at different equivalents, a recovery of growth was observed. 
Recovery on addition of IMI was most apparent at higher concentrations of the 
aldehyde and we rationalized that this could be as a result of the buffering effect of the 
amine. However, at the highest concentration of IMI (Figure 34B, 1.0) corresponding 
to an addition of 0.56 mg ml-1 of the aldehyde (1.0 eq.), a large distribution of values 
was observed, with two independent experiments displaying increased growth over 
that of the untreated. In order to evaluate the effect of IMI on the growth of V. cholerae, 
compared with that of the polymer-IMI conjugates, V. cholerae growth curves with IMI 
treatment at various equivalents, and the corresponding polymer conjugates were 
compared (Figure 35). 
 
Figure 35. Baselined-subtracted growth curves of V. cholerae at 37 oC (GFP) (clear 
DMEM) for A), IMI and B), PFRP-IMI. All conditions are representative of 0.5 mg ml-1 
Px-IMIx conditions. Growth was recorded in triplicate by fluorescence.  
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IMI was found to impart a delay in growth compared to untreated bacteria, in a 
dose dependent manner, but unlike the effect of AcOH, which caused an overall 
reduction in growth thought the life cycle, V. cholerae treated with IMI displayed growth 
recovery after 10 hours, which, for all but the lowest concentration resulted in an even 
greater accumulation of bacterial cells compared with the untreated. The 
aforementioned effect was not reproduced in the corresponding Px-IMI treated 
samples (Figure 35 B). Based on these observations, it was rationalised that V. 
cholerae may be responding to IMI beyond that of the effect of the buffer. In order to 
study this response in more detail, the experimental conditions in Figure 15 were 
reproduced but this time bacterial growth was fluorescently imaged every 30 minutes 
using a JuLI stage plate imager (Cambridge Bioscience) (Figure 36). 
 
Figure 36. Fluorescent images (JuLi Stage, 60 X objective) of GFP-V. cholerae at 5 
hours incubation at 37oC (clear DMEM) treated with A) 1 mM AcOH and B) 0.56 mg 
ml-1 IMI in AcOH (10 mM). 
A. B.
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Figure 37. Expanded fluorescent images (JuLi Stage, 60 X objective) of GFP-V. 
cholerae at 13 hours incubation at 37oC. Elongated V. cholerae highlighted here was 
measured at 21 microns in length.  
Images revealed that IMI induced elongation of the bacterial cells compared to 
cells treated with AcOH alone, with non-divided bacterial cells found at 21 μm after 13 
hours of growth (Figure 37). Elongation of V. cholerae is known upon treatment with 
the antibiotic cephalexin, which is employed in research to study the curvature of V. 
cholerae.42,43 Cephalexin disrupts the bacterial cell wall synthesis as a result of binding 
irreversibly to membrane bound proteins known as “penicillin binding proteins” which 
are vital for cell wall synthesis.44 Recent research into elongation of V. cholerae 
reported a strain (CVD112) which displayed elongation under nutrient-limited 
conditions which aided adhesion to chitinous surfaces.45 At this point, the mechanism 
of IMI on the elongation of V. cholerae is unknown, however it is plausible that 
interaction and disruption of the membrane may be involved, as has been reported for 
histidine rich peptides at acidic pH.46 or interaction of IMI with transmembrane signaling 
pathway by histidine kinase,47 as has been shown for imidazole.48 Furthermore, 
elongation of Caulobacter crescentus has been recently linked to a complex signaling 
pathway involving histidine kinase.49 
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2.3.5 Effect of polymer molecular mass and degree of functionalisation of 
toxicity to V. cholerae 
Having established the potential activity of IMI, we next investigated the effect 
loading this aldehyde onto the polymer backbone would have on the growth of V. 
cholerae (Figure 38). 
 
Figure 38. Relative growth of V. cholerae in treated samples after 15 hours incubation 
at 37oC (clear DMEM) for different Px-IMIx. A) Bacteria treated with 0.5 mg ml-1 Px-IMIx 
and B) bacteria treated with 0.05 mg ml-1 Px-IMIx. Each point represents a biologcal 
replicate as a mean of three technical replicates. 
The sequential addition of IMI onto the polymer scaffold for conditions at 0.5 mg 
ml-1 had a significant impact on the growth of V. cholerae with unmodified and 25% 
loaded polymers, displaying complete inhibition of growth at 15 hours, while there was 
some, but not statistically significant evidence of lower toxicity at 50% loading. At 75% 
loading, bacterial growth was restored to around 50%, similar to that of the 
corresponding AcOH control. In the case of Px-IMI1.0, a significant increase in GFP 
expression was observed, in some cases above that of the untreated condition. 
Although at higher concentrations of Px-IMI the effect of free IMI may be predominating, 
we reasoned that this could be indicative of non-homogeneous growth due to bacterial 
clustering. 
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At concentrations of 0.05 mg ml-1 there was no correlation between degree of 
IMI loading and toxicity, and any positive impact on growth would likely be overridden 
by the impact of AcOH, accounting for roughly 40% reduction in growth after 15 hours 
in all cases.  
Lastly, we assessed if there was a correlation between polymer molecular mass 
and toxicity as has been reported for some cationic antimicrobial polymers,50(Figure 
39).  
 
Figure 39. Growth of V. cholerae at 15 hours (GFP) in response to different molecular 
mass of Px-IMI at a concentration of A) 0.5 mg ml-1 and B), 0.05 mg ml-1 with varying 
degrees of functionalisation with IMI. Each point represents an individual biological 
replicate as a mean of three technical replicates. 
The data was unable to provide evidence of a significant correlation between molecular 
mass of Px-IMI and the toxicity to V. cholerae, although there was a visible trend at the 
highest loading of IMI. Further biological testing would be required to assess if this 
trend was statistically significant, and at this point we concluded, similarly to our 
previous test (Figure 27), that Px molecular mass did not influence to a great extent 
toxicity to V. cholerae. 
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2.3.6 Bacterial capture with Px-IMI and Px-2A3FP 
Having assessed the influence of polymer properties on toxicity to V. cholerae, 
the ability of these cationic polymers to sequester pathogenic bacteria was tested and 
possibly cause elongation to the bacterial cell. To this end, growth of V. cholerae 
treated with polymers was followed using time lapse microscopy under identical 
conditions to those carried out for growth curves described above. In order to best 
relate observed growth by microscopy to fluorescent growth curves, both growth 
curves and time-lapse fluorescent microscopy were carried out simultaneously under 
identical conditions. The importance of this experiment was two-fold; to ascertain, in a 
non-invasive manner the interaction between the polymer and the bacteria and to 
identify limitations or considerations that must be made when using spectroscopic 
methods to better interpret their results.(Figure 40, Figure 41). 
 
Figure 40. Growth curve (GFP) for V. cholerae at 37oC (clear DMEM) with PFRP-IMIx (0.5 mg 
ml-1) at varying degrees of functionalisation with IMI. Highlighted times represent those of 
the corresponding optical images for identical conditions (Figure 41). 
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Figure 41. Time-lapse optical microscope images (20 X objective) recorded by 
fluorescence (GFP) and differential interference contrast (DIC) for the growth 
progression of V. cholerae at 37 oC (clear DMEM) with PFRP-IMIx (0.5 mg ml-1). 
Conditions were carried out in triplicate and images displayed herein are 
representative of each replicate. Focal planes represent the bottom of the 96 well plate, 
Images were taken at fixed positions every 30 minutes and imaging parameters were 
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Optical imaging confirmed that PFRP-IMIx forms precipitates in the growth media, 
DMEM, and that appearance of the precipitate was strongly dependent on the degree 
of loading of imidazole; with small “droplet-like” precipitates visible for PFRP-IMI0.25, a 
very fine dispersion of fibers for PFRP-IMI0.5 and fibrous web-like precipitates for both 
PFRP-IMI0.75 and PFRP-IMI1.0. Indeed, the appearance of the fibers was very similar for 
both PFRP-IMI0.75 and PFRP-IMI1.0 which we rationalise as being due to similar levels of 
IMI loading on the polymer. The previously observed sharp increase in V. cholerae 
viability for PFRP-IMI1.0 compared with PFRP-IMI0.75 (Figure 38) may be accounted for by 
the increase in unreacted imidazole-4-carbaldhyde (IMI) when targeting 100% 
functionalisation. We were greatly encouraged to observe V. cholerae adhering to the 
fibers of PFRP-IMIx during incubation, and in the case of higher degrees of IMI loading, 
appearing to reduce the background fluorescence associated with non-adhered motile 
bacteria. Unfortunately, evidence of V. cholerae cell elongation with Px-IMI1.0 was not 
found. 
 These results taken together demonstrate how modulating the chemistry on Px 
modulates its properties, not only affecting the macroscopic appearance of the 
precipitate, but also the affinity that bacteria have to it. The growth of V. cholerae was 
followed in a similar way, this time in response to Px-2A3FP1.0 to evaluate if bacterial 
affinity for the polymer precipitate was comparable to that of PFRP-IMI1.0 (Figure 42). 
Precipitates of Px-2A3FP1.0 were less fiber-like compared to precipitates of 
PFRP-IMI1.0, and displayed lower levels of bacterial adhesion than for PFRP-IMI1.0, 
although this may be accounted for by the greater inhibition of growth at 0.5 mg ml-
1(Figure 31). 
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Due to previously observed toxicity towards V. cholerae for Px-2A3FP1.0 at 0.5 
mg ml-1, 0.05 mg ml-1 conditions of PFRP-IMI0.75 and P80-2A3FP0.75 with V. cholerae 
were also evaluated (Figure 43). 
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Figure 42. Optical microscope images (20 X objective) recorded by fluorescence 
(GFP) and differential interference contrast (DIC) for the growth progression of V. 
cholerae at 37 oC in clear DMEM with P80-2A3FP1.0 (0.5 mg ml-1). Conditions were 
carried out in triplicate and images displayed herein are representative of each 
replicate. Focal planes represent the bottom of the 96 well plate, imaging parameters 
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Figure 43. Optical microscope images (20 X objective) recorded by fluorescence 
(GFP) and differential interference contrast (DIC) for the growth progression of V. 
cholerae at 37 oC in clear DMEM with P80-2A3FP0.75 and PFRP-IMI0.75 (0.05 mg ml-1). 
Conditions were carried out in triplicate and images displayed herein are 
representative of each replicate. Focal planes represent the bottom of the 96 well plate, 
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75% polymer modification was targeted as this represented completed 
consumption of the free aldehyde in both cases. The results confirmed that at sub-
inhibitory concentrations V. cholerae adhere to P80-2A3FP0.75 precipitates, but to a 
lesser extent than for PFRP-IMI0.75, this observation was especially apparent at 0 hours 
(Figure 43) where bacteria were observed adhering to the imidazole-polymer 
precipitate independently of bacterial growth. However, these results should be treated 
with caution due to the different sized Px employed. We further assessed whether 
these materials could sequester and remove motile V. cholerae from liquid media, this 
time using a P45 in both cases. To this end, a simple flocculation assay (Figure 44) 
was constructed in order to measure changes in turbidity (OD600). Previous studies 
have demonstrated that on addition of cationic polymers, bacteria flocculate, resulting 
in an increase in OD600 followed by decreased OD600 as clusters of bacteria sediment 
to the bottom of the cuvette.51,52 
 
Figure 44. A) Description of a flocculation assay and B) a simulated example of 
bacterial turbidity after treatment of a polymer which induces bacterial clustering. 
P45-IMIx and P45-2A3FPx were added to cuvettes containing V. cholerae at initial 
OD600 of 1.0 and concentrations of 0.05 mg ml-1 were chosen so as not to impact the 
growth of V. cholerae during the experiment. OD600 was measured at varying 
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Figure 45. Effect of polymers on turbidity of planktonic V. cholerae in response to A), 
P45-IMIx at 0.05 mg ml-1 and B), the corresponding buffer and IMI controls. C), Optical 
images (100 X) of V. cholerae sampled from the flocculation assay after 20 minutes 
incubation, with and without the presence of P45-IMI1.0 (0.05 mg ml-1). 
 
Figure 46. Effect of polymers on turbidity of planktonic V. cholerae in response to A) 
P45-2A3FPx at 0.05 mg ml-1 and B) the corresponding buffer and IMI controls. C) 
Optical images (100 X) of V. cholerae sampled from the flocculation assay after 20 
minutes incubation, with and without the presence of P45-2A3FP1.0 (0.05 mg ml-1). 
Upon introduction of the polymer into the bacterial suspension, a very fine 
precipitate was observed, and after 10 minutes small clusters in samples treated with 
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P45-IMIx (x <0.25) were visible to the naked eye throughout the cuvette. In the case of 
P45-IMI0.5 these clusters remained small and did not sediment during the course of the 
experiment resulting in high turbidity throughout the experiment. For polymers P45-
IMI0.75 and P45-IMI1.0 sedimentation was apparent on visual inspection by reduction in 
the optical density. P45-2A3FPx followed a similar trend to P45-IMIx but a lower overall 
reduction in the turbidity was noted. Microscope images taken after 20 minutes 
incubation with polymers confirmed clusters of V. cholerae were formed, rather than 
simply polymer precipitates (Figure 45C, Figure 46C). These results taken together 
suggest that the polymer precipitate provides a nucleation point for further bacterial 
aggregation. In light of these encouraging results, we next investigated the impact of 
polymer concentration on the ability to aggregate and sequester V. cholerae (Figure 
47).  
 
Figure 47. Effect of polymers on turbidity of planktonic V. cholerae in response to A) 
P45-IMI0.75 and B) P45-2A3FP0.75. C) Corresponding images of V. cholerae (OD600 = 
1.0) dispersed in DMEM at timepoints indicated, a.) without the addition of polymers 
b.) with addition of P45-IMI0.75 (0.5 mg ml-1) c.) with addition of P45-IMI0.75. d.) P45-IMI0.75 
(0.5 mg ml-1) in DMEM without the addition of V. cholerae (t=3 hrs). 
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Strikingly, 0.5 mg ml-1 of P45-IMI0.75 resulted in the rapid formation of a mucus-
like precipitate, which visibly reduced the turbidity of the planktonic bacteria after just 
10 minutes. After sedimentation of the precipitate a significant drop in the optical 
density to 0.16 was observed after 25 minutes. Visual inspection of the cuvette 
confirmed that despite the slower sedimentation time for P45-2A3FP0.75 (0.5 mg ml-1 ) 
which obscured OD600 measurements until after 3 hours, a higher solution turbidity 
remained after 30 and 60 minutes (Figure 47B). At 0.05 mg ml-1 P45-IMI0.75 was able 
to reduce the optical density to 0.41 after 30 minutes while P45-2A3FP0.75 was not, 
further supporting our assessment that P45-IMI0.75 displays higher activity with respect 
to adhering V. cholerae regardless of DP. 
 It was concluded from this study that precipitates of imidazole containing 
polymer were able to sequester V. cholerae remarkably efficiently at a concentration 
of 0.5 mg ml-1 indicating that a strong degree of attraction was occurring between the 
polymer and the bacteria. Seeing how P45-IMIx displayed constantly higher affinity to 
V. cholerae, it was not clear if this effect was driven solely by the cationic charge on 
the polymer given that IMI and 2A3FP were expected to have similar degrees of 
protonation under physiological conditions. 
2.3.7 Effect of Px-IMIx on biofilm formation  
Previous work carried out in our labs has demonstrated that the regulation of 
virulence factors involved with toxin production and biofilm formation is affected in V. 
cholerae upon aggregation with cationic polymer, with toxin related genes being 
downregulated and biofilm related genes being upregulated.9 There is strong evidence 
to support that this regulatory change is a result of an enhancement of quorum sensing 
in aggregated bacteria.22  
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In order to establish if V. cholerae upregulated biofilm in response to adhesion 
to Px-IMIx we evaluated the production of biomass using crystal violet staining (Figure 
48). 
 
Figure 48. Crystal violet staining of residual biomass (abs 550 nm), indicating levels 
of biofilm formation for V. cholerae with polymers after 20 hours growth in clear DMEM 
(37 oC) for conditions at concentrations A) 0.5 mg ml-1, B) 0.05 mg ml-1 and C) 0.5 mg 
ml-1 without the addition of bacteria, D) 0.05 mg ml-1 without the addition of bacteria, 
and aldehyde controls at concentrations of E), 0.5 mg ml-1 and F), 0.05 mg ml-1. Data 
was recorded in triplicates and significance indicated (**) was measured using a 
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A significant increase in crystal violet staining was noted for V. cholerae 
incubated with polymers modified with 0.75 and 1.0 equivalent of IMI at 0.5 mg ml-
1(Figure 48, A). However, by comparing to corresponding control samples (Figure 48, 
C) without the addition of bacteria, it was determined that the increase was due to 
residual background staining of P40-IMI precipitate within the well. P40-IMI0.5, induced 
small clusters of bacteria according to the flocculation assay, but did not produce an 
insoluble precipitate to the same extent as higher DF polymers. This may help explain 
the observed reduction in crystal violet staining at 0.5 mg ml-1 (Figure 48, A) as a result 
of inhibition of bacterial adhesion to the surface of the well.23 At lower concentrations 
all P40-IMIx treated samples displayed a statistically significant increase in crystal violet 
staining over the untreated condition (Figure 48, B), regardless of the loading of DF, 
the buffer and the polymer backbone treated samples, indicating that changes in 
biofilm formation could be triggered even at low loading of IMI. Comparatively, IMI 
controls (Figure 48 E,F) displayed no difference in biofilm formation over that of the 
buffer. 
2.3.8 Adhesion to polymers alters V. cholerae gene expression  
We had thus far established that V. cholerae adhere to cationic polymer P-IMIx, 
(when x ≥ 0.75) to the extent that planktonic V. cholerae are quickly sequestered and 
sedimented as a result of the polymer-bacteria interaction. Increased levels of biofilm 
formation for V. cholerae after 20 hours incubation with Px-IMIx provides initial evidence 
that physiology of V. cholerae may be altered as a result of this binding step.  
V. cholerae regulate genes in response to their environment, in particular in 
response to adhesion characterised by a switch from motile to sessile lifestyle and 
associated with biofilm production, and in this regard, it was proposed that bacteria 
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adhered by polymers may undergo a similar change in physiology. In particular, we 
were interested to investigate changes in regulation of biofilm factors such as the major 
biofilm regulator VpsR, and biofilm matrix proteins RbmA and RbmC,53-56 but also the 
regulation of the cholera toxin (CTX) which is the causative agent of cholera. 
To this end reporter strains previously used in our labs, containing promoter 
regions for the aforementioned genes were chosen so that their expression could be 
monitored. Reporter strains possessed the pRW50 oriT plasmid so that gene 
expression could be measured by production of the enzyme β-galactosidase and its 
cleavage of ortho-Nitrophenyl-β-galactoside (ONPG) to yellow o-nitrophenol (Abs 420 
nm).57 
To evaluate whether bacterial adhesion to the imidazole-functionalised polymer 
trigger adhesion associated phenotypes, reporter strains were incubated with PFRP-
IMI0.75 (0.05 mg ml-1) and their transcriptional activity was monitored at various time 
points. (Figure 49). 
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Figure 49.V. cholerae A1552 pRW50-OriT transcriptional activity (abs 420 nm) for 
highlighted genes in response to incubation (37 oC clear DMEM) with 0.05 mg ml-1 
PFRP-IMI0.75 in clear DMEM. A) raw data (blank corrected) and B) growth corrected 
transcriptional activity based on estimated growth of V. cholerae with PFRP-IMI0.75. 
Initial OD600 of V. cholerae was 0.2. 
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The results suggested ctxAB was repressed during early timepoints on 
incubation with PFRP-IMI0.75. We rationalised that adhesion to the polymer drives the 
suppression of the Cholera toxin may be as result of enhanced quorum sensing as 
pointed to in previous work from our labs,9,22 and that suppression of this ctxAB was 
most noticeable at early time points due our earlier observation that bacteria exist 
predominantly in a polymer-adhered state at these time points (Figure 41,Figure 43). 
VpsR is the major biofilm regulator in V. cholerae and is responsible for the positive 
regulation of the Vibrio polysaccharide (VPS) and is also required for the synthesis of 
biofilm matrix proteins RbmA and RbmC.28,53 
Here, vpsR was induced by PFRP-IMI0.75, as was rbmA and rbmC (although 
delayed induction was observed for the latter) suggesting that V. cholerae were 
producing more biofilm in response to the polymer. In contrast to the observed 
suppression of ctxAB which largely recovered to levels of the untreated after 10 hours, 
upregulation of biofilm genes remained elevated throughout the course of the 
experiment which may suggest that biofilm production is triggered by these polymers 
rather than strictly dependent on adherence to the polymer. Furthermore, increased 
biofilm formation on adhesion to polymer cannot be explained solely by quorum 
sensing, seeing how enhanced QS represses the production of biofilm in V. cholerae,26 
and strongly suggests that other regulatory pathways may be involved.  
2.4 Conclusions  
We have established through the use of time-lapse imaging that cationic 
polymers P1 and P2 induce different responses of V. cholerae. Primary amine 
containing polymer P1, was toxic to V. cholerae at 0.5 mg ml-1 whereas tertiary amine 
containing polymer P2 displayed no inhibition of growth at this concentration. Notably 
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at 0.05 mg ml-1, which was reported to be sub-inhibitory for both polymers towards V. 
cholerae, P2 induced visible clusters of bacteria whereas V. cholerae treated with P1 
produced the visible nucleation of biofilms. This observation was consistent with crystal 
violet staining of biofilms which suggested a significant increase in biofilm formation 
for bacteria treated with P1 over that of P2. 
Two cationic polymers Px-IMIx and Px-2A3FPx were prepared by post-
polymerisation modification of polymer scaffold PX, in order to evaluate via in situ 
screening, the impact of increased hydrophobicity on toxicity and aggregation of V. 
cholerae. We established that the scaffold Px was more toxic than P1 and P2 towards 
V. cholerae under our reported conditions but that polymer molecular mass did not 
impact on this toxicity.  
It was found that toxicity towards V. cholerae was reduced by modifying Px with 
either IMI or 2A3FP, and in the case of IMI, was dependent on the degree of loading 
on the polymer. Polymers targeting higher degrees of modification with aromatic 
amines became insoluble and resulted in the formation of a mucus like precipitate. V. 
cholerae were observed to adhere quickly to polymer precipitates in the case of PFRP-
IMIx and to a lesser extent with Px-2A3FPx. We concluded by use of a flocculation 
assay that P45-IMIx displayed a greater activity towards sequestering V. cholerae than 
P45-2A3FPx which cannot be explained simply by protonation level of the amines. 
Notably P45-IMI0.74 reduced the concentration of planktonic V. cholerae in solution from 
OD600 = 1.0 to 0.16 after 25 minutes. 
Lastly, Px-IMI0.75 induced increased levels of biofilm production in V. cholerae 
while simultaneously suppressing the expression of the cholera toxin, indicating that 
bacterial adhesion to the polymer results in altered physiology. These conclusions 
taken together position Px-IMI0.75 as a promising means of sequestering V. cholerae, 
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and suppressing its virulence simultaneously, which may have a wide range of 
potential applications, such as in water treatment or as part of a wound dressing.  
2.5 Future work 
Further studies should be undertaken to assess the therapeutic value of Px-
IMI0.75. For example, by establishing whether this polymer offers a protective or 
cytotoxic effect towards bacterial attachment host cells such as Caco-2 cells, and 
further, in wound models as a potential topical treatment. The adhesion and 
sedimentation efficiency observed for Px-IMI0.75 should be compared with other 
methods of flocculating bacteria, especially in the application of water treatment to 
establish the suitability of Px-IMI0.75 to these applications.  
With respect to the synthesis of aldehyde-modified polymer scaffolds, larger 
arrays of closely related side-chain chemistries and combinations thereof may be 
explored. In this way, and possibly employing a high-throughput screening type 
process, a deeper assessment into how the side-chain chemistry imparts different 
biological activity could be achieved and may lead to a better understanding into the 
role of hydrophobicity, positive charge and biological antagonists in sequestering and 
physiology of V. cholerae. 
Quorum sensing is important for understanding bacterial responses induced by 
polymer-mediated aggregation and should be evaluated for Px-IMIx with respect to the 
reported response induced by P1 and P2 outlined in our previous work where a 
luminescent reporter strain for QS was employed.22  
Acyl hydrazones are dynamic and susceptible to hydrolysis at low pH. With this 
in mind, it would be of benefit to assess the fate of hydrazone-linked functional groups 
after interaction with bacteria to establish if these bonds remain intact, and if not, what 
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the implications of this are. Along similar lines, dynamic Investigations may be carried 
out to determine whether acyl hydrazones could serve as a route towards designing 
“re-writable” chemistries on Px so as to achieve biologically-instructed side-chain 
chemistry which may lead to polymers with higher and more specific affinity to a target.  
Finally, with regards to observed differences between cationic polymers P1 and 
P2, further work should be carried out to establish differences in stress response of V. 
cholerae, and whether stress (for example oxidative stress) can account for increased 
biofilm production. Furthermore, fluorescently labelled polymers and super resolution 
confocal microscopy may reveal to what extent P1 and P2 interferes with and 
potentially passes through the bacterial membrane.  
  
Chapter 2 
   126 
2.6 References  
1 Antibacterial agents in clinical development: an analysis of the antibacterial 
clinical development pipeline, including tuberculosis. Geneva: World Health 
Organization; 2017 (WHO/EMP/IAU/2017.12). Licence: CC BY-NC-SA 3.0 IGO. 
2 Barber, S. (2017) Antimicrobial resistance. House of Commons Library Briefing 
Paper no. 8141. London: House of Commons Library.3 The PLOS Medicine 
Editors, PLoS Med, 2016, 13, e1002130–3. 
4 R. C. Allen, R. Popat, S. P. Diggle and S. P. Brown, Nature Reviews 
Microbiology, 2014, 12, 300–308. 
5 A. E. Clatworthy, E. Pierson and D. T. Hung, Nat Chem Biol, 2007, 3, 541–548. 
6 A. M. Krachler and K. Orth, Virulence, 2014, 4, 284–294. 
7 E. P. Magennis, A. L. Hook, M. C. Davies, C. Alexander, P. Williams and M. R. 
Alexander, Acta Biomaterialia, 2016, 34, 84–92. 
8 D. Campoccia, L. Montanaro and C. R. Arciola, Biomaterials, 2013, 34, 8533–
8554. 
9 N. Perez-Soto, L. Moule, D. N. Crisan, I. Insua, L. M. Taylor-Smith, K. Voelz, F. 
Fernandez-Trillo and A. M. Krachler, Chem. Sci., 2017, 8, 5291–5298. 
10 X. Yan, A. Sivignon, N. Yamakawa, A. Crepet, C. Travelet, R. Borsali, T. 
Dumych, Z. Li, R. Bilyy, D. Deniaud, E. Fleury, N. Barnich, A. Darfeuille-
Michaud, S. G. Gouin, J. Bouckaert and J. Bernard, Biomacromolecules, 2015, 
16, 1827–1836. 
11 P. R. Secor, L. A. Michaels, A. Ratjen, L. K. Jennings and P. K. Singh, Proc Natl 
Acad Sci USA, 2018, 115, 10780–10785. 
12 C. Ergene, K. Yasuhara and E. F. Palermo, Polym. Chem., 2018, 9, 2407–2427. 
13 K. Kuroda, G. A. Caputo and W. F. DeGrado, Chem. Eur. J., 2008, 15, 1123–
1133. 
14 L. C. Paslay, B. A. Abel, T. D. Brown, V. Koul, V. Choudhary, C. L. McCormick 
and S. E. Morgan, Biomacromolecules, 2012, 13, 2472–2482. 
15 D. J. Phillips, J. Harrison, S.-J. Richards, D. E. Mitchell, E. Tichauer, A. T. M. 
Hubbard, C. Guy, I. Hands-Portman, E. Fullam and M. I. Gibson, 
Biomacromolecules, 2017, 18, 1592–1599. 
16 M. A. van Dongen, C. A. Dougherty and M. M. Banaszak Holl, 
Biomacromolecules, 2014, 15, 3215–3234. 
Chapter 2 
   127 
17 E. Blasco, M. B. Sims, A. S. Goldmann, B. S. Sumerlin and C. Barner-Kowollik, 
Macromolecules, 2017, 50, 5215–5252. 
18 S. Perrier, Macromolecules, 2017, 50, 7433–7447. 
19 G. Moad, E. Rizzardo and S. H. Thang, Aust. J. Chem., 2012, 65, 985–92. 
20 V. M. C. Coessens and K. Matyjaszewski, J. Chem. Educ., 2010, 87, 916–919. 
21 P. Zhang, H. Lu, H. Chen, J. Zhang, L. Liu, F. Lv and S. Wang, Anal. Chem., 
2016, 88, 2985–2988. 
22 N. Perez-Soto, O. Creese, F. Fernandez-Trillo and A. M. Krachler, ACS Chem. 
Biol., 2018, 13, 3021–3029. 
23 L. L. Foster, S.-I. Yusa and K. Kuroda, Antibiotics, 2019, 8, 61–16. 
24 P. Zhang, S. Li, H. Chen, X. Wang, L. Liu, F. Lv and S. Wang, ACS Appl. Mater. 
Interfaces, 2017, 9, 16933–16938. 
25 A. F. González Barrios, R. Zuo, Y. Hashimoto, L. Yang, W. E. Bentley and T. K. 
Wood, Journal of Bacteriology, 2006, 188, 305–316. 
26 C. M. Waters, W. Lu, J. D. Rabinowitz and B. L. Bassler, Journal of Bacteriology, 
2008, 190, 2527–2536. 
27 M. Jemielita, N. S. Wingreen and B. L. Bassler, eLife, 2018, 7, e1002210–25. 
28 J. K. Teschler, D. Zamorano-Sánchez, A. S. Utada, C. J. A. Warner, G. C. L. 
Wong, R. G. Linington and F. H. Yildiz, Nature Reviews Microbiology, 2015, 13, 
255–268. 
29 K. Drescher, J. Dunkel, C. D. Nadell, S. van Teeffelen, I. Grnja, N. S. Wingreen, 
H. A. Stone and B. L. Bassler, Proc Natl Acad Sci USA, 2016, 113, E2066–
E2072. 
30 G. A. O'Toole, JoVE, 2011, 1–2. 
31 E. F. Palermo, D.-K. Lee, A. Ramamoorthy and K. Kuroda, J. Phys. Chem. B, 
2011, 115, 366–375. 
32 D. N. Crisan, O. Creese, R. Ball, J. L. Brioso, B. Martyn, J. Montenegro and F. 
Fernandez-Trillo, Polym. Chem., 2017, 8, 4576–4584. 
33 O. Creese, P. Adoni, G. Su, A. Romanyuk and P. Fernández-Trillo, Polym. 
Chem., 2019, 124, 14922. 
34 D. T. Gentekos, R. J. Sifri and B. P. Fors, Nature Reviews Materials, 2019, 1–
14. 
35 R. Whitfield, N. P. Truong, D. Messmer, K. Parkatzidis, M. Rolland and A. 
Anastasaki, Chem. Sci., 2019, 10, 8724–8734. 
Chapter 2 
   128 
36 S. Raddatz, Nucleic Acids Research, 2002, 30, 4793–4802. 
37 E. A. Hoff, B. A. Abel, C. A. Tretbar, C. L. McCormick and D. L. Patton, Polym. 
Chem., 2017, 8, 4978–4982. 
38 L. Zhu, M. Zhou, S. Yang and J. Shen, IJMS, 2015, 16, 9078–9096. 
39 J. Engelke, J. Brandt, C. Barner-Kowollik and A. Lederer, Polym. Chem., 2019, 
10, 3410–3425. 
40 F. D. Halstead, M. Rauf, N. S. Moiemen, A. Bamford, C. M. Wearn, A. P. Fraise, 
P. A. Lund, B. A. Oppenheim and M. A. Webber, PLoS ONE, 2015, 10, 
e0136190–15. 
41 K. M. Wheeler, G. Cárcamo-Oyarce, B. S. Turner, S. Dellos-Nolan, J. Y. Co, S. 
Lehoux, R. D. Cummings, D. J. Wozniak and K. Ribbeck, Nature Microbiology, 
2019, 7, 3–12. 
42 T. M. Bartlett, B. P. Bratton, A. Duvshani, A. Miguel, Y. Sheng, N. R. Martin, J. P. 
Nguyen, A. Persat, S. M. Desmarais, M. S. VanNieuwenhze, K. C. Huang, J. 
Zhu, J. W. Shaevitz and Z. Gitai, Cell, 2017, 168, 172–185.e15. 
43 H. Konishi, A. Katayama, T. Ito, S. Tanaka and Z. Yoshii, Journal of 
Bacteriology, 1986, 168, 1476–1478. 
44 J. F. Fisher, S. O. Meroueh and S. Mobashery, Chemical Reviews, 2005, 105, 
395–424. 
45 B. R. Wucher, T. M. Bartlett, M. Hoyos, K. Papenfort, A. Persat and C. D. Nadell, 
Proc. Natl. Acad. Sci. U.S.A., 2019, 116, 14216–14221. 
46 A. J. Mason, C. Gasnier, A. Kichler, G. Prevost, D. Aunis, M. H. Metz-Boutigue 
and B. Bechinger, Antimicrob Agents Chemother, 2006, 50, 3305–3311. 
47 W.-L. Ng, Y. Wei, L. J. Perez, J. Cong, T. Long, M. Koch, M. F. Semmelhack, N. 
S. Wingreen and B. L. Bassler, Proc. Natl. Acad. Sci. U.S.A., 2010, 107, 5575–
5580. 
48 S. C. Page, R. E. Silversmith, E. J. Collins and R. B. Bourret, Biochemistry, 
2015, 54, 7248–7260. 
49 K. Heinrich, D. J. Leslie, M. Morlock, S. Bertilsson and K. Jonas, mBio, 2019, 10, 
162–17. 
50 K. Lienkamp, K.-N. Kumar, A. Som, K. Nüsslein and G. N. Tew, Chem. Eur. J., 
2009, 15, 11710–11714. 
Chapter 2 
   129 
51 X. Xue, G. Pasparakis, N. Halliday, K. Winzer, S. M. Howdle, C. J. Cramphorn, 
N. R. Cameron, P. M. Gardner, B. G. Davis, F. Fernandez-Trillo and C. 
Alexander, Angewandte Chemie International Edition, 2011, 50, 9852–9856. 
52 E. P. Magennis, F. Fernandez-Trillo, C. Sui, S. G. Spain, D. J. Bradshaw, D. 
Churchley, G. Mantovani, K. Winzer and C. Alexander, Nat Mater, 2014, 13, 
748–755. 
53 H. Dang and C. R. Lovell, Microbiol. Mol. Biol. Rev., 2015, 80, 91–138. 
54 J. Yan, A. G. Sharo, H. A. Stone, N. S. Wingreen and B. L. Bassler, Proc. Natl. 
Acad. Sci. U.S.A., 2016, 113, E5337–E5343. 
55 J. Sánchez, G. Medina, T. Buhse, J. Holmgren and G. Soberón-Chavez, Journal 
of Bacteriology, 2004, 186, 1355–1361. 
56 J. C. N. Fong, K. A. Syed, K. E. Klose and F. H. Yildiz, Microbiology, 2010, 156, 
2757–2769. 
57 K. L. Griffith and R. E. Wolf Jr., Biochemical and Biophysical Research 
Communications, 2002, 290, 397–402. 
  
 











Interaction and recognition of glycopolymers by Vibrio cholerae 
  
Chapter 3 
   131 
3.1 Background 
 Vibrio cholerae is a Gram negative, motile, comma shaped pathogen found in 
aquatic environments. V. cholerae persists in these environments by forming biofilm 
associated communities on crustaceans, the shells of which mainly comprise of the 
polysaccharide chitosan. V. cholerae is transmitted to humans usually through 
consumption of contaminated food, or in particular, water. Early stages of colonisation 
of the host epithelium relies heavily on motility of bacterium and it is believed that V. 
cholerae need to overcome the physical mucus layer in order to colonise the small 
intestine.1 Within the host, V. cholerae initially detect their surroundings non-
specifically via chemical interactions and physical forces acting on the flagellum and 
the pili.2 In this way V. cholerae “loiter” over areas of a surface more suitable for 
attachment,3 before adhering more strongly via a variety of adhesion factors, in 
particular protein – carbohydrate interactions. This adhesion step is associated with a 
switch from a motile to a sessile state and usually involves the formation of biofilm, 
although this is not well understood in vivo. 
 V. cholerae sense their surroundings not only to identify the mechanochemical 
environment which can dictate whether the bacterium can adhere to a surface, but also 
whether to deploy virulence factors.3 V. cholerae have also been shown to sense the 
presence of sugars as means of a chemical signal to determine the suitability for biofilm 
growth via a Phosphoenolpyruvate Phosphotransferase system (PTS) which was 
demonstrated to be essential for colonisation.4 
 A main factor in sensing the environment is the mannose sensitive 
haemagglutinin type IV pilus (MSHA), which in conjunction with the polar flagellar of V. 
cholerae counter rotates the cell body, allows for a “skimming” of the surface. 
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 The MSHA contacts the surface periodically and depending on the strength of 
the interaction, can generate orbiting motions which then lead to microcolony 
formation.2 The importance of this pilus in surface adhesion was demonstrated using 
mshA mutants (lacking genes to produce MSHA), indicating that V. choleae deficient 
in this pilus do not exhibit “orbiting” motility, but also display impaired biofilm formation.5 
The MSHA pilus has also been demonstrated to be critical for adhesion associated cell 
killing in caco-2 cells, and in the same study It was put forward that MSHA binds most 
strongly to glycans which feature a terminal or subterminal galactose and terminal or 
subterminal fucolyations.6 
We envisage linear polymers containing glycans as ideal compounds for 
competitive binding to glycan recognition sites on V. cholerae. Indeed, the multivalent 
nature of a glycopolymer has the potential to not only provide a locally high 
concentration of glycans to an active site on the bacteria, but also present a pathway 
for bacterial cross-linking and aggregation.7 
Our previous work has demonstrated that cationic polymers can aggregate and 
sequester V. cholerae at sub-inhibitory concentrations.8 Polymer-induced bacterial 
aggregates displayed increased levels of quorum sensing as well as a down regulation 
of virulence related genes and an upregulation of biofilm related genes.9 
These results taken together suggest that polymers can trigger a bacterial 
response which includes modulating gene expression. As such, we set out to assess 
not only the ability of glycopolymers to bind and aggregate bacteria, but whether V. 
cholerae responds differently to glycopolymers compared with cationic polymers. 
Furthermore, we were interested to determine whether the choice of sugar on the 
polymer backbone impacts bacterial responses. 
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Employing a polyhydrazide scaffold to access glycopolymers directly from 
unmodified sugars affords a significantly less time consuming and challenging 
synthetic strategy as opposed to methods requiring prior chemical modification of the 
sugar; for example, sugar containing monomers,10 and chemical handles for post-
polymerisation modification.11 Furthermore, glycopolymers prepared in this way can 
be screened for activity in situ to negate uncertainties over contribution of the polymer 
backbone to biological activity. 
3.2 Objectives 
The primary objective of this work was to synthesise a library of different sugar-
containing polymers derived from a single polymer scaffold. The synthesis and in situ 
screening of glycopolymers prepared from Px have not yet been reported in our labs 
so a focus here was on determining the applicability of this platform for screening 
glycopolymers in situ, thus reaction conditions and stability of the glycoconjugates 
would need to be accounted for. In this way, cationic polymers and glycopolymers 
could be directly accessed from the same polymer scaffold so that biological responses 
could be compared.  
Glycopolymers synthesised here were designed to evaluate the activities of 
polymers displaying mannose, glucose and galactose with respect to aggregating V. 
cholerae via specific carbohydrate-protein interactions. To explore bacterial responses 
to glycopolymers, growth curves, biofilm formation, optical imaging and gene 
expression will be assessed in order to determine whether a certain response can be 
attributed to a particular glycan displayed on the polymer chain. 
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3.3 Results and discussion  
3.3.1 Glycopolymer synthesis and characterisation 
It is well documented that reducing sugars can react with hydrazide groups via 
amine-carbonyl condensation.12,13 reducing sugars exist in a water-catalysed 
equilibrium between their open form which contains either an aldehyde or ketone 
functionality and their ring closed pyranose form.14 Interconversion gives rise to ⍺ and 
β anomers which can be identified in proton NMR and aid characterisation of 
conjugation products.13 
 The following work was performed on two polymerisations, targeting DP200 and 
DP50. To this end we synthesised a DP128 and a DP45 Px using our optimised RAFT 
polymerisation conditions described earlier (Chapter 1) with a very good dispersity (Đm 
= 1.23 and 1.21) (Figure 50). 
 
Figure 50. SEC trace (Lonza DPBS) for P128 and P45 described here. Mp, was 
calculated by monomer conversion, Mn and Mw were calculated by SEC using 
PEG/PEO standards, reported in g.mol-1.  
Initially, we attempted to conjugate monosaccharides; D-mannose, D-glucose 
and D-galactose using our previously reported conditions for aldehyde conjugation, 15 
however very low conjugation efficiencies were observed, with 25% loading for 
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conditions were not suitable for loading sugars onto the Px scaffold in the same way 
as described for aldehydes. Instead, focus was drawn to conditions reported by 
Bertozzi and co-workers for the synthesis of cyclic N-glycosides from poly(acryloyl 
hydrazide).16 The authors carried out the post-polymerisation modification at reduced 
pH (5.5) to promote stability of the polymer-sugar conjugate, and employed a 
significantly higher concentration of both sugar and hydrazide in order to increase the 
number of ring open species available for conjugation by the hydrazide groups of Px. 
In the same study It was reported that this post-polymerisation modification benefited 
from the addition of an aniline catalyst,16 a toxic additive that we believed could require 
removal after reaction, thus impacting on the ability for Px to be used in situ. Aniline is 
employed as a catalyst in hydrazone via the formation of a Schiff base intermediate, 
which greatly increases the rate of reaction at lower pH, without disturbing the 
equilibrium towards the formation of the hydrazone product.17,18 However, there is a 
lack of clarity in the literature as to the impact aniline has in catalysing the reaction 
between reducing sugars and poly hydrazides. 
 The use of Aniline was undesirable for our screening platform due to its 
toxicity,19 and could potentially interfere with the normal growth of V. cholerae. Using 
conditions outlined by Bertozzi, we evaluated the importance of Aniline for the 
conjugation of D-mannose to Px by proton NMR (Figure 51).   
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Figure 51. Proton NMR (D2O) for the conjugation reaction with and without addition of 
aniline (1mM) between P45 (0.25 M with respect to the hydrazide group) and 1 eq. D-
mannose (MAN) to form the glycoconjugate: P45-MAN. Conversion was calculated by 
reduction of anomeric mannose signals highlighted 1 compared with the proton regions 
highlighted (2,3) (total =7H). All samples were incubated for 24 hours at 50oC in 
Acetate buffer / D2O (pH 5.5).  
Pleasingly, conjugation efficiencies were unaffected by the presence of aniline 
and 35% of the sugar was calculated to be conjugated to the polymer backbone in both 
cases. With this in mind we concluded that at least under these conditions, aniline was 
not necessary for conjugation. 
Next we targeted different sugars and greater degrees of loading on the polymer 
by increasing the number of equivalents of sugar to hydrazide moiety under different 
buffering conditions. P128 was incubated with glucose, galactose and mannose with 
increasing equivalents (2, 4, 6) of sugar, and different buffers (100 mM acetate pH 5.5 
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Scheme 6. Proposed synthetic route for the synthesis of glycopolymers.  
The efficient chemistry afforded by the acyl hydrazide groups on Px, allowed for 
screening of different reaction conditions in parallel within a 96 well plate via simple 
incubation. The reactions described in Scheme 6 were carried out in D2O + buffer and 
incubated in a sealed 96 well plate for 24 hours at 50oC with shaking. For 
characterization, each sample was diluted in D2O and analyzed by NMR and GPC. 
The conversion of free sugar onto the polymer backbone was calculated by 
proton NMR for a total of 7 protons on integration of ⍺ and β anomeric protons for the 
free sugar against the region containing the ring protons of the free sugar and the new 
⍺ and β protons from the glycopolymer which can be observed as distinct broad peaks 
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Figure 52.Proton NMR (D2O) (left) for P128-MAN (2.eq. sugar, 88% conversion by 
integration) and (right) D-mannose prior to addition of P128.  
 
 
Figure 53. Proton NMR (D2O) (left) for P128-GLU (2.eq. sugar, 84% conversion by 
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Figure 54. Proton NMR (D2O) (left) for P128-GAL (2.eq. sugar, 80% conversion by 















































































   140 
 
Scheme 7. Reaction pathway for D-mannose with Px and possible small molecule 
cleavage product, highlighting the key proton signals (Figure 52) involved with 
determining conversion of the free sugar onto the polymer backbone.  
Distinct ⍺ and β proton signals for the free sugar, in the NMR spectrum (Figure 
52-54) and highlighted in red (Scheme 7, A,B) represent the two distinct stereoisomers 
possible for the cyclic form of the sugar. The ratio of these peaks, (total =1H), indicates 
the stability of each stereoisomer and is influenced by the anomeric effect which 
favours the ⍺ position, and steric and hydrogen bonding effects which favour the β 
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glycoconjugates for poly(acryloyl hydrazide)16 On glyosidic bond formation with Px 
(Scheme 7, D), the resulting conjugate predominantly exists in the ring closed form, 
(Scheme 7, F), as confirmed by new broad ⍺ and β proton signals (Figure 52, P128-
MAN, 4.17, 3.15 ppm), upfield of the corresponding signals for the free sugar (Figure 
52, D-mannose 5.07, 4.09 ppm). A small broad region at 7.6 ppm(Figure 52, P128-
MAN) corresponded to the proton adjacent to the acyl hydrazone bond for sugars 
residing in the open form on the polymer (Scheme 7, D),16 which accounted for roughly 
6% of the observed total loading for P128-MAN and P128-GAL but close to 0% for P128-
GLU presumably due to added stability of the ring closed form for this glycoconjugate. 
Interestingly, A sharp doublet signal in the proton NMR with a similar chemical shift to 
the open form region on the glycopolymer in the proton NMR was observed for all 
conditions (Figure 55).  
 
Figure 55. Proton NMR (D2O) for glycopolymers expanded to show signals associated 
with the open form glycoconjugate and the possible mono-hydrazone cleavage 
product. 
Work carried out in our labs using Px has previously reported the appearance 
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work here regarding Px-IMI and Px-2A3FP (Chapter 2) consistent with the formation 
of mono-hydrazones via the cleavage of the C-N bond of the Px hydrazone side chains. 
The mechanism for the formation of this impurity may be as a result of intramolecular 
nucleophilic attack of an unreacted hydrazide moiety on an adjacent acyl hydrazone 
conjugate, possibly with the inclusion of a water molecule in a protease-type 
mechanism.21 We reasoned that for glycopolymers described in this work, cleavage 
occurred predominantly via the ring-closed form of the glycoconjugate due to similar 
levels of the impurity being observed for P128-GLU, P128-MAN and P128-GAL despite a 
significantly lower abundance of the ring opened form for P128-GLU. In any case, this 
impurity accounted for less than 1% of the total loading and was expected to be more 
prominent at lower degrees of aldehyde loading.15  
Loading efficiencies of P128 with 2. eq. sugars were significantly higher than our 
observed loading with 1.0 eq. with 84% loading being achieved compared to 35% for 
P128-MAN described previously and we observed that loading could be increased 
marginally further to quantitative levels with the addition of 4 and 6 eq. (Table 8). 
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Table 8. Loading efficiencies for different sugars with P128 (24 hrs 50 oC). 
Sugar a Eq. sugar b Buffer  c Loading (%)  d Open form 
(%)  
e % open 
form 








Quantitative 0.01 6 
 








96 0.01 6 








86 0 <1% 
 








90 0 <1% 








Quantitative 0.01 6 
 








Quantitative  0.01 6 
a With respect to hydrazide groups, b prepared at 100 mM, c calculated by 1H NMR, d integral (1H NMR) 
corresponding to open sugar form on the polymer backbone (total = 7 protons), e calculated as a 
percentage of the total loading on the polymer by 1H NMR. 
 
Having quantified the conversion by NMR, next we evaluated changes in polymer size 
by SEC before and after loading of the sugar for conditions described in Table 8 to 
establish if conjugation with sugars resulted in an increase in polymer molecular mass 
or impacted the shape and intensity of the refractive index response as was 
demonstrated for aldehydes in Chapter 2 (Table 9, Figure 56).  
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Table 9. Molecular mass and dispersity (ĐM) for glycopolymers and P128, calculated by 





dMn(SEC)  dMw(SEC)  ĐM 
P128 0 n/a 11,232 15907 19616 1.23 








36115 12324 17902 1.45 
 








33350 12325 17860 1.45 








31046 11855 17328 1.46 
 








31968 12004 17650 1.47 








36115 9810 15228 1.55 
 








37497 10004 15481 1.55 
 
a With respect to hydrazide groups, b prepared at 100 mM, c calculated by monomer conversion, d 
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Figure 56. Molecular mass distribution (GPC, Lonza DPBS) for indicated 
glycopolymers, after reaction with sugars (24 hrs 50 oC) with increasing eq. of sugar 
and indicated buffers. 
Interestingly, glycopolymers displayed broadening of the dispersity ĐM and 
longer retention times in the column compared to the corresponding polymer scaffold 
(Px), resulting in lower experimental molecular mass despite a significantly larger 
theoretical molecular mass of the glycopolymer. We rationalised that direct comparison 
of molecular mass between modified and unmodified Px is unfeasible by SEC due to 
the differences in side-chain chemistry which may affect the hydrodynamic radius of 
the polymer. A recent review on the matter highlighted that shifts to longer retention 
times in SEC can indicated the collapse of a linear polymer to a more tightly packed 
polymer particle which may explain these observations.22  
Despite this, the observed shift in retention time for the Px treated with sugars 
provided some further evidence that glycopolymers had been prepared. In particular, 
a smaller shift in retention time for P128-GAL for 2 eq. compared to 4 and 6 eq was in 
agreement with regard to relative loadings calculated loading by NMR. 
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3.3.2 Stability of glycopolymers to hydrolysis  
Next, the stability of the glycoconjugate was evaluated, this was especially 
important given the dynamic nature of the acyl hydrazone bond,23 and the previously 
discussed possibility of intramolecular cleavage occurring on the polymer backbone 
(Figure 55). To this end loading of each sugar was monitored by proton NMR over a 
considerable period of time under standard reaction conditions, and after two serial 
dilutions in the corresponding buffer (Figure 57). 
 
Figure 57.Time-course analysis (proton NMR, D2O) of sugar loading on glycopolymers 
(2 eq. sugar) at varying pH and after dilution (2x and 4x as indicated on the graphs). 
Initial concentration was 0.25 M with respect to the hydrazide side-chain and 
glycopolymers were stored at RT between timepoints. 
After 6 days and prior to dilution, loading was largely unchanged for all 
glycopolymers, although loading was slightly increase between 24- and 48-hours 
incubation. After diluting samples by 50% with the same buffer, we noted a small 
decrease in loading for both P45-MAN and P45-GAL which appeared to be more 
prominent at pH 5.5, while P45-GLU remained largely unchanged after dilution. After 9 
days incubation, samples were diluted buy a further 50%, which resulted a greater 
reduction in loading was observed for P45-MAN, but overall, not a large decrease and 
after 13 days all glycopolymers displayed similar loadings ~60%. P45-MAN displayed 
the greatest reduction in loading between 2 days and 13 days indicating that N-linked 
Mannose may be more amenable to hydrolysis compared with glucose and galactose. 
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It should be noted that we observed no increase in signals possibly indicative of a 
mono-hydrazone cleavage product during the course of the stability experiment.  
In summary, stable glycopolymers containing side groups of mannose, glucose 
and galactose were prepared at high degrees of sugar loading onto the Px side chains 
without the need for catalytic aniline. 
3.3.3 Glycopolymer toxicity towards V. cholerae 
With confirmation that glycopolymers P128-MAN, P128-GLU and P128-GAL had 
been successfully prepared to a similarly high degree of loading, we investigated the 
biological responses of V. cholerae to different sugar displaying glycopolymers. Initially 
we assessed glycopolymers effect on the growth of GFP expressing V. cholerae A1552 
by monitoring bacterial growth by OD600 and fluorescence (GFP) (Figure 58, Figure 
59). 
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Figure 58. GFP expression as a proxy of bacterial growth for GFP-V. cholerae A1552 
incubated at 37oC in clear DMEM with 0.05 mg ml-1 glycopolymers prepared with 
different equivalents of the sugar as indicated. Initial OD600 = 0.02. Fluorescence was 
recorded every 30 minutes in the GFP channel.  
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Figure 59. OD600 growth curves for GFP-V. cholerae A1552 incubated at 37oC in clear 
DMEM with 0.05 mg ml-1 glycopolymers prepared with different equivalents of the 
sugar as indicated. Initial OD600 = 0.02. Optical density (OD600) was recorded every 30 
minutes. 
A concentration of 0.05 mg ml-1 was targeted as representative of the maximum 
sub-inhibitory concentration of Px towards V. cholerae (Chapter 2) and we observed 
low overall levels of growth inhibition of V. cholerae with glycopolymers tested. P128-
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MAN displayed relatively higher levels of toxicity towards V. cholerae, most noticeable 
by GFP expression, compared to P128-GLU and P128-GAL which displayed very little 
impact on V. cholerae growth. OD600 (Figure 59) displayed good correlation with GFP 
expression, although observable differences in toxicity were less obvious. Having 
established that at this concentration, glycopolymers were sub-inhibitory towards V. 
cholerae their ability to bind and sequester bacteria, possibly through sugar specific 
lectin-carbohydrate interactions was investigated. 
Given the high loading of Px with 2 eq. of sugar, we did not pursue further 
biological studies with glycopolymers prepared with higher excesses (4- or 6 eq.) in 
order to suppress biological effects such as lectin saturation, arising from an excess of 
free sugar during in situ screening.24 Acetate buffer (pH 5.5) was also concluded to be 
the most suitable buffer to perform conjugation reactions with sugars on account of 
higher overall loading observed for Px with sugars. 
3.3.4 Aggregation studies – Turbidity and flocculation 
To establish whether glycopolymers induce clustering of V. cholerae as reported 
for cationic polymers in our labs,8,9 a simple flocculation assay was employed which 
measures turbidity (OD600) and had been previously described for similar bacterial 
clustering applications in the literature (Figure 60).25,26  
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Figure 60. A) Description of a flocculation assay and B) a simulated example of 
bacterial turbidity after treatment of a polymer which induces bacterial clustering. 
V. cholerae were grown overnight in LB, transferred to clear DMEM, adjusted 
to an initial OD600 of 1.0 and treated with glycopolymers and the corresponding free 
sugar as a control. OD600 was measured at timepoints and the cuvettes were left at 
room temperature without shaking so that the effect of the clustering could be best 
observed (Figure 61). 
 
Figure 61. Turbidity of V. cholerae dispersed in clear DMEM, after addition of 0.05 mg 
ml-1 glycopolymers as indicated (concentration in respect to P128), polymer scaffold 
(P128) or representative concentration of free sugar (0.21 mg ml-1) from a starting OD600 
= 1.0. All polymer and sugar conditions were dissolved in 100 mM Acetate buffer.  
Glycopolymers induced a rapid increase in the turbidity of V. cholerae after 20 
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of turbidity would display some level of specificity to the sugar displayed on the 
glycopolymer, indicative of bacterial aggregation driven by specific interactions 
between the sugars on the glycopolymer and bacterial lectins. However, these 
observations indicated interactions were not specific to the type of sugar and may 
indicate a more general mechanism of binding or interacting with sugars.  
We rationalised that that V. cholerae may bind all three glycopolymers to a 
similar degree seeing how V. cholerae adhesion has been associated with galactose,27 
mannose,28 and glucose.29 We were encouraged that free sugars did not induce 
flocculation of bacteria, supporting the hypothesis that the observed increase in 
turbidity was driven by multivalency and in agreement with the “cluster glycoside 
effect”.7 Px did not induce flocculation of bacteria which was attributed to the low 
protonation of the hydrazide (pKa ~4.0) under physiological conditions.30 
Intriguingly, no decrease in the OD600 at longer timepoints was observed, 
suggesting sedimentation was not occurring or occurring at a level not detectable by 
this system, and certainly, to a much lower extent as was observed for polymers 
modified with imidazole (Chapter 2). 
We rationalized that this observation could be due to short-lived interactions 
between the glycopolymer and the bacteria, either due to the stability of the glyosidic 
bond or weak polymer-bacteria interactions. In order to evaluate this interaction in 
more detail V. cholerae incubated for 20 minutes with glycopolymers or sugars were 
imaged by microscopy (Figure 62).  
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Figure 62. A) Optical microscope images (DIC, 100X objective) for V. cholerae after 
20 minutes incubation with 0.05 mg ml-1 glycopolymers or corresponding free sugar 
and B) corresponding image of bacterial suspensions showing an area of high density 
after 20 minutes incubation with glycopolymers. Scale bars represent 10 μm. 
Effort was taken to ensure sampling from the same part of the cuvette, which 
included sampling from an area of higher density visible to the naked eye for 
glycopolymer treated samples (Figure 62 B) which we expected would identify the 
presence of bacterial clusters. However, we found no evidence of clustering, although 
higher densities of bacteria were observed for both glycopolymers and sugars 
compared with the untreated sample. It was also not clear what was responsible for 
area of higher bacterial density which can be observed with the naked eye and in OD600 
measurements (Figure 62, B). However these results taken together with data from 
the flocculation assay indicate that interactions between V. cholerae and 
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In an attempt to increase the activity of the glycopolymers towards bacterial 
aggregation, higher concentrations with P128-MAN was explored to asses impact on 
bacterial flocculation and sedimentation (Figure 63).  
 
 
Figure 63. Turbidity of V. cholerae dispersed in clear DMEM after addition of mannose 
glycopolymers P128-MAN and D-mannose. Initial OD600 = 1.0. 
We found that when increasing the concentration of P128-MAN to 0.5 mg ml-1 
the flocculation effect of V. cholerae was lost, and we reasoned that this could be due 
to increased toxicity, given Px was found to display increased toxicity towards V. 
cholerae at this concentration (Chapter 2). However, previous studies with cationic 
polymers demonstrated increased bacterial clustering moving from 0.05 mg ml-1 to 0.5 
mg ml-1 despite increased toxicity.8 Another possibility is that a higher concentration of 
unconjugated D-mannose in the more concentrated sample could result in a greater 
saturation of mannose-binding adhesins on the bacteria (for example MSHA3) and 
competitively inhibit multivalent interactions with the polymer which has been 
described for other glycopolymers where supplementation of 10 mM D-mannose 
completely inhibited the binding of Escherichia coli to a mannose-displaying 
glycopolymer.24 















D-mannose 2.1 mg ml-1
D-mannose 0.21 mg ml-1
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3.3.5 Biofilm response to glycopolymers 
Thus far it had been established that interactions between glycopolymers and 
V. cholerae resulted in a short-lived increase in turbidity, but no evidence of bacterial 
clustering. These findings suggested that the activity of glycopolymers was distinct to 
that of Px and the free sugars, as well as our previous work with cationic polymers.8 
We therefore considered that despite little evidence of bacterial aggregation, further 
investigation into other bacterial responses was warranted. 
Biofilm production in V. cholerae is associated as a response to many different 
environmental triggers such as adhesion, antibiotics, pH stress and nutrient levels 
including availability of certain sugars.3,4,32,33 Cationic polymers have previously been 
reported to increase biofilm production in aggregated V. cholerae,8 via a mechanism 
which may involve the upregulation of quorum sensing (QS).9 However since biofilm 
formation in V. cholerae is negatively regulated by QS,34 alternative regulatory 
pathways may be responsible, possibly independent of bacterial clustering. 
To determine if glycopolymers attenuated the production of biofilm in V. 
cholerae, residual biofilm was measured using crystal violet (CV) assay.35 Crystal violet 
staining is a simple and effective tool for detecting by absorbance (550 nm) 
components of a biofilm which remain adhered to surfaces after mechanical removal 
of bacterial cells. In the case of V. cholerae, the key biofilm components consist of 
Vibrio polysaccharide (VPS), a glycopolymer which is excreted on initial contact with 
the surface, vital to provide three-dimensional biofilm structure,36 and scaffolding 
proteins RbmA, RbmC and Bap1,37,3 which maintains the structure of the biofilm via 
cell-to-cell and cell-to-VPS binding. We assessed the progression of biofilm formation 
following 22 hours incubation with glycopolymers prepared in both acetate buffer and 
pyridine buffer with increasing eq. of sugars (Figure 64). 
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Figure 64. Relative production of biofilm determined by crystal violet staining of 
residual V. cholerae biofilm (Abs 550 nm) after incubation for 22 hours at 37oC with 
0.05 mg ml-1 glycopolymers prepared in acetate buffer (solid bars) or pyridine buffer 
(hashed bars). Significance = P < 0.04. 
Significantly higher levels of crystal violet staining were observed for conditions 
treated with P128-MAN and P128-GLU glycopolymers, and increased eq. of mannose 
appeared to have a positive but not statistically significant impact on biofilm formation. 
This trend was not as evident for P128-GLU and could suggest that free glucose does 
not have as large an impact as free mannose on the triggering of biofilm. Most notably, 
P128-GAL had a significantly lower impact on biofilm formation and in some cases a 
reduction over the untreated control sample of V. cholerae. 
To determine if these observations could be explained by differences in 
bacterial growth under these conditions at 22 hours, relative GFP expression of V. 
cholerae treated with glycopolymers was plotted as a percentage compared to the 
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Figure 65. Growth progression (GFP expression) of V. cholerae grown in clear DMEM 
at 22 hours, treated with 0.05 mg ml-1 glycopolymers prepared in either acetate buffer 
(solid bar) or pyridine buffer (dashed bar) as percentage growth of untreated V. 
cholerae.  
V. cholerae treated with P128-MAN and P128-GLU displayed slightly reduced 
growth and P128-GAL displayed almost no change in growth over the untreated 
sample. On account of this we reasoned that induction of biofilm formation observed 
for mannose and glucose glycopolymers may be linked to the observation that these 
glycopolymers also resulted in reduced growth. Under non-inhibitory conditions, 
growth curves of V. cholerae in a planktonic or biofilm associated growth mode have 
been reported by Bassler and co-workers to be similar,32 and thus, a reduction in 
growth and observation of biofilm may indicate a stress or other signaling response.38 
At this point it was important to rule out possible contributions to crystal violet 
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Figure 66. Crystal violet staining for residual biofilm or residual polymers after 22 hours 
incubation of glycopolymers (0.05 mg ml-1) with and without V. cholerae. 
Background crystal violet staining with glycopolymers was observed in all 
cases, and may interfere with reported values in the case of P128-GAL, However 
residual crystal violet staining originating from P128-MAN and P128-GLU was found to 
be sufficiently lower than with V. cholerae indicating that the increase in staining was 
indeed due to an increased level of adhesive biofilm factors produced by the bacteria. 
Finally, we tested if V. cholerae was responding to the glycopolymers on 
account of unreacted sugar in the polymer samples. A signaling pathway which was 
previously overlooked, namely, the phosphoenolpyruvate phosphotransferase system 
(PTS) of V. cholerae, acts as an environmental reporter of carbohydrate availability.4 
It has been previously reported by Watnick and co-workers that V. cholerae produce 
biofilm in response to availability of mannose, through PTS signaling, and in the same 
way, glucose was proposed to repress biofilm formation, most interestingly galactose 
was not recognised by PTS signaling pathway and did not impact biofilm formation.39 
It should be noted that minimal media with or without supplementation of 0.5 mg ml-1 
sugars was employed in the aforementioned study, whereas clear DMEM employed in 
this work is supplemented with 0.584 mg ml-1 glucose with additional 0.21 mg ml-1 
supplementation of sugar on addition of polymer conditions at 0.05 mg ml-1. Crystal 
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buffer controls, to better evaluate contribution to the production in biofilm from all 
constituents of transferred conditions (Figure 67).  
 
Figure 67. Crystal violet staining for residual biofilm of V. cholerae dispersed in clear 
DMEM incubated for 22 hours at 37 oC with A) glycopolymers prepared in acetate 
buffer with 2 eq. sugar, and corresponding free sugars and B) polymer scaffold (Px) 
and representative concentrations of acetate buffer. Significance was measured using 
a student’s t-test.  
The results initially suggested that sugars alone suppressed biofilm in all cases 
over that of the untreated condition. However, on closer inspection this may have been 
an effect of the corresponding concentration of acetate buffer, which was also found 
to negatively impact biofilm formation. Mannose and galactose at 0.5 mg ml-1 indicated 
a recovery of biofilm formation over that of acetate buffer, but glucose displayed 
suppression in this regard broadly in agreement that glucose suppresses biofilm 
formation in V. cholerae by PTS signaling.39 Although not statistically significant, but in 
agreement with our previous results, P128-MAN increased the production of biofilm over 
that of the untreated condition. Increase in biofilm production was especially apparent 
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staining compared to the corresponding mannose, buffer and polymer scaffold 
controls. 
Although more experiments will be required to determine if P128-MAN increases 
biofilm production in V. cholerae statistically significantly, it was concluded at this stage 
that the PTS signaling pathway was likely to be important, and that P128-MAN may 
attenuate this signal possibly through multivalent mannose-specific binding with 
transmembrane proteins of the PTS system.4 Further studies would be required to 
explore this. 
3.3.6 Gene expression  
Watnick and co-workers demonstrated that genes encoding the PTS are also 
coregulated with vps genes which are involved with the production of biofilm,40 and 
with this in mind it was expected that VpsR, the master regulator in the biofilm cascade 
would be affected if glycopolymers were triggering biofilm formation via the PTS 
system. If this was the case, it was considered that virulence may be attenuated in a 
similar way to previous observations with cationic polymers (Chapter 2). 
To this end reporter strains of V. cholerae containing promoter regions for 
ctxAB, vpsR, rbmA and rbmC were incubated with glycopolymers, so that expression 
of the reporter gene could be monitored by production of the enzyme β-galactosidase 
and its cleavage of ortho-Nitrophenyl-β-galactoside (ONPG) to yellow o-nitrophenol 
(Abs 420 nm) (Figure 68). 
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Figure 68. Promoter activities of ctxAB- vpsR- rbmA- rbmC-lacZ fusions following 
incubation at 37 oC with glycopolymers (0.05 mg ml-1) for 5 hours. Significance was 
calculated using a student’s t-test (*=p<0.05).data reported as transcriptional activity 
(Miller units). 
Initially transcriptional activity was evaluated at 5 hours incubation with 0.05 mg 
ml-1 glycopolymers previously shown in this current work to be the time at which 
maximum transcriptional activity of ctxAB is observed in solution (Chapter 2). 
Transcription for these genes indicated that P128-GAL had little impact on regulation 
compared to untreated bacteria, a similar trend to that of biofilm formation and relative 
growth seen previously. A slight but statistically significant increase in rbmA activity 
after incubation with Px-GAL was observed, notably, RbmA, a scaffolding protein 
involved with cell-to-cell and cell-to-biofilm adhesion is reported to bind in a specific 
manner to galactose,37 and therefore this may indicate a galactose specific response.  
Unexpectedly, and contrary to results of crystal violet staining, vpsR and rbmC 
was suppressed by both P128-MAN and P128-GLU, which may have been a result of 
the chosen time point, despite positive regulation of these genes observed after 5 
hours with cationic polymers (Chapter 3). Most noticeably, a significant induction of 
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mannose containing glycopolymers may trigger virulence responses in V. cholerae, 
seeing how the mannose binding pilus (MSHA) is linked to transduction of toxin 
regulation in V. cholerae.41 To investigate further the impact of P128-MAN on regulation 
of the cholera toxin and whether this was a general effect of mannose or specific to 
the glycopolymer a time course transcriptional assay was conducted (Figure 69).  
 
Figure 69. Promoter activities of ctxAB-lacZ fusions following incubation at 37 oC with 
P128-MAN (0.05 mg ml-1) at varying time points. A) Raw baseline corrected data Abs 
420 nm, B) corresponding OD600 of each condition tested, C) growth corrected values 
(Miller units).  
Time course analysis of ctxAB expression demonstrated maximum transcription 
at around 10 hours post incubation, roughly 4 hours after bacterial growth had 
plateaued according to OD600 but in this case there was no evidence that P128-MAN 
could induce production of the cholera toxin. We reasoned that this could be on 
account of biological variability and that further replicates would need to be conducted 
to determine if results described in Figure 68 were reproducible.  
3.3.7 Glycoconjugate purification  
Seeing how free D-mannose had been shown to decrease the clustering ability 
of a mannose containing glycopolymer due to saturation of the sugar-binding 
receptors,24 it was considered that the free sugar in conditions employed here (due to 
the in situ nature of the screening approach) may be interfering with the activity of the 
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glycopolymer to a similar extent. To assess the effect of glycopolymer isolation we 
attempted purification of glycopolymers prepared this time with a P48 by our usual 
dialysis method which involved dialysing ~1 mL of a glycopolymer solution (0.25 M with 
respect to hydrazide groups) against H2O (5 L) over the course of a week with one 
water change per day. The resulting mixtures were lyophilized to a white powder and 
analysed by proton NMR (Figure 70). 
 
Figure 70. Proton NMR (D2O) for glycopolymers after dialysis against H2O (5 L) for 
one week with one water change per day. 
After dialysis loading of sugars on P48-MAN, P48-GAL was reduced to just 5%, and 
20% respectively indicting that under this degree of dilution, hydrolysis of the glycosidic 
hydrazone bond was occurring. Interestingly P48-GLU retained 55% loading with a loss 
of just ~5% conjugated glucose. Interestingly, the Px backbone signals were broader 
for the -CH2 region but sharper at the -CH region, broadening of the backbone proton 
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altered hydrodynamic radius after post-polymerisation modification, possibly as a 
result of polymer chain folding or unfolding.22  
It was rationalised that these differences in levels of hydrolysis of the 
glycoconjugate are justified by the differences in stability of the closed form of the 
glycoconjugate sugar, where between 5-10% open form sugars for mannose and 
galactose conjugates were observed by proton NMR, but only 0-1% for glucose 
conjugates (Table 8) indicative of their greater overall stability. Free sugar in all 
samples was observed, despite standard dialysis conditions which could indicate 
further dialysis was required or reflect the dynamic nature of the glyosidic bond. In light 
of these results, it was concluded that dialysis was not best suited to purifying these 
materials and instead, purification by SEC could be performed as an alternative.  
3.4 Conclusions  
The synthesis and characterization of mannose, glucose and galactose 
glycopolymers via post-polymerisation modification of a poly(acryloyl hydrazide) Px 
scaffold has been achieved to universally high degrees of sugar loading under very 
mild conditions, without the need for catalytic aniline. The suitability of this platform to 
screen activities using a small library of glycopolymers in situ was tested to explore 
aggregation and physiology of V. cholerae. Overall, glycopolymers displayed very low 
levels of growth inhibition towards V. cholerae, but could induce a sharp increase in 
turbidity in bacterial dispersions after 20 minutes incubation, which is usually 
associated with the formation of clusters. However, evidence for cluster formation was 
not found by microscopy indicating that polymer-mediated interactions between 
bacterial cells may be weak or short-lived. Mannose containing glycopolymers had a 
pronounced effect on biofilm production, with an increase in biofilm formation observed 
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in all replicate experiments. Biofilm production was found to be dependent on the type 
of sugar suggesting that V. cholerae was responding to glycopolymers as a result of 
attenuation of the PTS pathway, which is reported to upregulate biofilm formation in 
response to mannose availability, and downregulate biofilm formation in response to 
glucose. Mannose glycopolymers induced increased biofilm production over that of the 
controls, suggesting that this glycopolymer may interfere with or activate the PTS 
pathway. 
3.5 Future work 
Preliminary results suggest that glycopolymers may modulate expression of 
virulence and biofilm related genes, however further studies are needed to confirm 
this. In particular the effect of glycopolymers on biofilm gene expression at varying time 
points should be conducted and may justify the increased biofilm observed in crystal 
violet after 22 hours.  
Work continuing from this study should focus on the purification of these 
compounds, to evaluate the effect that purified glycopolymers have on clustering, 
biofilm formation and gene expression. The result of this should determine whether in 
situ screening is appropriate for glycopolymers when competitive binding to the 
corresponding small molecule may be predicted to mask the activity of the 
glycopolymer.  
On a longer timescale, hydrophobic polymer scaffolds for example Px-IMI0.75 
(Chapter 2) which form mucus-like fibers under physiological conditions, and 
displayed very high affinity for V. cholerae, may be co-functionalised with glycans to 
prepare a “synthetic mucus” which may result in interesting and potentially useful 
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physiological changes in bacteria, as was recently reported by Ribbeck and co-
workers.42 
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4.1 Background 
Fluorescence is an extremely important photochemical property whereby 
fluorescent molecules (fluorophores) absorb light (for example in the UV region), and 
then emit at a different, lower energy, resulting in the emission of longer wavelengths, 
often in the visible region. Absorption (λex) and emission (λem) wavelengths depend on, 
and are specific to the fluorophore in question, and light emitted from these molecules 
can be detected at very low abundance, down to single molecule detection depending 
on the brightness of the fluorophore and detector.1,2 Fluorophore brightness, and thus 
the sensitivity of detection, governed by its molar extinction coefficient ε, and its 
quantum yield Φ, describes the amount of absorbed light by the fluorophore and the 
efficiency of the emission respectively.3  
4.1.1 Fluorescence labelling in biology  
In biochemical research, the properties of fluorescent molecules make them 
ideal probes or labels in chemical sensing and optical imaging applications. Such 
applications include mapping DNA sequences,4,5 single molecule imaging of complex 
biological processes in real time,6,7 activity and mechanism in drug delivery,8,9 and in 
sensing of biomolecules.10 
Linear polymers and nanoparticles are extensively researched for biological 
applications in the field of nanomedicine,11 and as such, new ways of covalently 
attaching fluorophores to macromolecules are now widely reported.12 Fluorescent 
labelling of macromolecules can reveal mechanisms of activity and location within a 
biological setting,13 which can otherwise be hard to predict from first principles.14 
Macromolecules such as polymers are deemed especially well-suited to fluorescent 
labelling as the fluorescent label is considered to account for a small chemical and 
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physical “footprint” on the overall properties and activity of the macromolecule.15 That 
being said, fluorescent labelling of shorter flexible polymers with bulky and hydrophobic 
fluorophores is predicted to have an unavoidable impact on the chemical and physical 
properties of the polymer as has been reported. 15,16 Therefore critically assessing the 
impact of the fluorescent label on the activity of the macromolecule is an important and 
often overlooked design parameter. With this in mind, quantifying and controlling the 
degree of polymer labelling as well as the location of the label with respect to the 
polymer is highly desired and can help towards standardising potential effects arising 
from heterogenous labelling.16 
The preparation of fluorescent polymers is highly attractive given their potential 
biological applications, and can be accessed via a variety of synthetic routes. 
Fluorescent polymers can broadly be classed into three groups on account of the 
location of the fluorophore (Figure 71). 
 
Figure 71. Simplified representative strategies for fluorescent polymer design.  
4.1.2 Fluorescent conjugated polymers.  
Polymers containing fluorescent conjugated backbones allow access to 
materials whereby fluorescence is an intrinsic property of the polymer without the need 
for further modification or evaluation. The first and simplest example of a fluorescent 
conjugated polymer backbone is that of poly(acetylene), however the synthesis of 
more extensively conjugated systems have led to the preparation of cationic polymers 
and glycopolymers capable of simultaneous bacterial imaging and clustering.17-19 
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There are inherent challenges associated with the synthesis of fluorescent conjugated 
polymers which can make them unsuitable in some applications. These include 
incompatibility with controlled polymerisation techniques used for alkene monomers, 
relying rather, on the use of transition metal catalysts such as W, Rh and Mo in their 
preparation,20 and controlling both fluorescent and functional properties of the polymer 
independently.21 
4.1.3 Side-chain modification  
The modification of polymer side chains to incorporate a fluorescent molecule 
is a very popular labelling strategy, owing to its applicability to a wide range of 
polymers. This can be achieved by direct copolymerisation with a fluorescent 
monomer,22 or employing monomers capable of undergoing subsequent chemo-
selective post-polymerisation modification with a fluorescent compound possessing 
compatible conjugation chemistry, in co- and homo-polymerisations (Figure 72).23,24  
 
Figure 72. Polymer side-chain fluorescent labelling strategies.  
Robin and O’Reilly recently described an elegant synthetic route to controlled 
and responsive side-chain fluorescence in polymethacrylates by the direct 
copolymerisation of monomers containing fluorescent dithiomaleimide or non-
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dithiomaleimide via a thiol-exchange reaction.25 To aid with polymer-bacteria 
colocalization, fluorescent cationic polymers have been prepared by the post-
polymerisation modification of a tertiary amine containing homopolymer with a 
carboxylic acid coumarin dye, mediated by 2-bromo ethyl ester,24 while fluorescent 
glycopolymers were prepared by CuAAc of an alkyne-containing homopolymer with 
azide-derivatized Fluorescein and mannose.24,26  
4.1.4 End group modification 
Polymer end groups are often chemically distinct from main chain monomer 
groups, and this can allow for specific fluorescent labelling of the end group, achieved 
either pre or post-polymerisation, in a similar way to side-chain modification (Figure 
73).  
 
Figure 73. Polymer end group fluorescent labelling strategies.  
Rather than the use of a fluorescent monomer (as with side-chain modification), 
pre-polymerisation strategies rely on the use of fluorescently modified chain transfer 
agents (CTA),27 which control the polymer molecular mass and reside in the end 
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Reversible addition-fragmentation chain transfer (RAFT) agents which offer 
significantly improved control over the polymer dispersity and molecular mass, as well 
as affording very good retention of the fragmented RAFT agent at the end groups of 
the resulting polymer.28,29 Employing a fluorescent RAFT agent is one strategy to 
achieve end group fluorescent labelling of a polymer, although this can be challenging 
due to stringent chemical requirements of the RAFT agent with respect to compatibility 
with the monomer to afford a controlled radical polymerisation process.29,30 Despite 
this, fluorescent RAFT agents have been successfully synthesised,31 and reported for 
some monomers, one example, in the polymerisation of poly tertbutyl acrylate, poly 
methyl methacrylate and triethyleneglycol monomethyl ether acrylate. In this case the 
RAFT agent was conjugated to dibromomaleimide and could be converted post-
polymerisation to fluorescent dibromomaleimide by simple conjugate addition of a 
thiol.32 
The alternative strategy to end group fluorescent labelling lies in post-
polymerisation end group modification and provides a route to fluorescently label the 
end group without the need to modify the choice of CTA. Well-defined end-groups as 
is the case for RAFT derived polymers, can be modified to yield polymers with new 
chemical handles, for example, reduction of RAFT agents to give thiol functionality 
affords the potential to undergo subsequent modifications such as thiol-ene and 
disulfide formation.33 McCormick and co-workers demonstrated end group labelling of 
polyNIPAM synthesised by RAFT after reduction of the trithicabonate with NaBH4 to 
the thiol, and subsequent thio- maleimide coupling with N-(1-pyrenyl)Maleimide.34 End 
group labelling via post-polymerisation modification suffers from additional reaction 
and purification steps, each requiring characterization. However, this strategy does 
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allow for greater versatility over the choice of fluorescent dye, and does not impact on 
the polymerisation process itself. 
4.1.5 Summary 
Aside from polymers possessing fluorescent backbones, fluorescent polymers 
can be prepared via covalent conjugation of fluorescent dyes with compatible chemical 
groups on the side-chain or end group of the polymer. Labelling can be carried out pre-
polymerisation or post-polymerisation, the latter, extending the versatility of the 
material, but generally requiring additional synthetic and purification steps. Side-chain 
labelling benefits from the ability to tune the amount of fluorophore on the polymer, for 
example, increasing the number of fluorescent molecules with increasing degree of 
polymerisation (DP). However, side-chain modification can result in greater uncertainty 
over the precise location of the fluorophore on the polymer chain, which may have 
implication in regards to its application. End group modification affords the possibility 
to fluorescently label a polymer without impacting on the chemistry of the side-chain 
which can be particularly important for polymer scaffolds designed to undergo 
subsequent post-polymerisation modifications. A drawback of this strategy is the 
inability to tune the amount of fluorophore on the polymer, which in the case of higher 
DPs could result in lower relative brightness compared with polymers of smaller DP.  
Independent of the labelling method, the purity, stability and impact that the 
fluorescent dye has on the activity of the compound needs to be taken into 
consideration. This is especially important if designing polymers for quantitative 
analysis by fluorescence. In all cases, efficient predictable chemistries such as click 
chemistry when matched with controlled polymerisations and robust characterisation 
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methods can negate some of the uncertainties associated with preparing these 
materials. 
4.2 Objectives  
The primary objective in this chapter was to develop a convenient synthetic 
route and assaying method for efficient and quantifiable end group labelling of 
previously reported poly(acryloyl hydrazide) (Px) scaffold. In this way, labelling of 
iterations of these scaffolds can be tightly controlled such that the loading degree of 
the fluorescent dye on the polymer can be quantified and easily reproduced. End group 
labelling of Px offers a simple route to multi-coloured variants from the same parent 
polymer which are then able to undergo subsequent post-polymerisation modifications. 
Predictable end group labelling in this way will allow for quantifiable screening of 
polymer chemistries by fluorescence for a wide range of biological application.  
A secondary objective was to demonstrate via fluorescence, the location the 
polymers involved with the aggregation of bacteria in biological assays, in order to 
better understand the role of the bacteria-polymer interaction. 
4.3 Results and Discussion 
Cationic polymers such as poly(N-(3-aminopropyl) methacrylamide) (P1) and 
poly(N-[3-(dimethylamino) propyl] methacrylamide) (P2) induce rapid clustering of V. 
cholerae,35 which is driven by multivalent electrostatic interactions between the 
positively charged polymer and the negatively charged bacterial cell membrane.36 The 
mechanism for the interaction between polymer and bacteria is unknown and it is not 
clear if the polymer exists solely between bacterial cells or whether it crosses the cell 
membrane. In order to identify the location of the cationic polymer within clusters of 
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bacteria, P1 was synthesised and purified according to our previously reported 
methods,35 and fluorescently side-chain labelled using commercially available CF405S 
(Biotium) used in biology for labelling proteins via amine linkage resulting in the random 
co-polymer LP1 (Scheme 8).  
 
Scheme 8. Synthetic route for poly(N-(3-aminopropyl) methacrylamide) (P1) and 
resulting fluorescent random co-polymer after post-polymerisation modification with 
CF405S dye (LP1). 
 
CF405S was employed here due to its ability to be excited by the 405 nm laser 
and emit in the blue region (461 nm), making it suitable to use alongside SYTO 9 and 
propidium iodide (PI) which are commonly used to stain live and dead bacteria. To this 
end, we evaluated the colocalisation of clusters of V. cholerae and cationic polymer 

































Figure 74. Optical images (63 x oil objective) of V. cholerae after incubation with 0.05 mg ml-1LP1 (Blue). Bacteria were LIVE/DEAD stained 
with Propidium iodide (PI) (Red) and SYTO 9 (Green) prior to fixing onto the microscope slide. 
Chapter 4 
 181 
Images displayed colocalisation of blue (CF405S) channel with green (SYTO 9) 
and red (PI) channels in the case of bacterial clusters, indicating that the labelled 
polymer is indeed associated with the formation of bacterial aggregates and supports 
the hypothesis that bacterial aggregates are mediated by cationic polymers. 
Although using a dye labelling kit in this way can give very good results with 
regards to brightness and photostability, there is limited control available over the 
chemistry and quantification of the conjugation with P1 and the exact chemical 
structure of CF405S is not freely available.  
Having demonstrated the merit of employing fluorescence to determine polymer 
location in the case of polymer-mediated bacterial clustering, we next sought to 
fluorescently label Boc-protected poly(acryloyl hydrazide) boc-Px in an efficient and 
quantifiable manner, so that better control over the labelling could be achieved,  without 
impacting on the polymers ability to undergo aldehyde-hydrazide post-polymerisation 
modification on deprotection to Px.  
Building on our work in chapter 1 towards improving the control over the 
synthesis of boc-Px, thus increasing its versatility further, we set out to develop an 
optimised synthetic route and characterisation assay in order to install a linker capable 
of conjugating different fluorescent dyes in a simple, controlled, and reproducible 
manner (Scheme 9).  
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4.3.1 Overall synthetic strategy.  
 
Scheme 9. Proposed synthetic route towards fluorescently labelled Px (Px-Flu) and 
subsequent post-polymerisation modification of Px-Flu with aldehydes.  
4.3.2 Installation of ethylene diamine (EDA) linker  
The end group fidelity of polymers synthesised by RAFT, allowed for a 
convenient chemical handle for which to undergo further modification such as 
fluorescent labelling, and in the case of boc-Px, The trithiocarbonate containing Z group 
of RAFT agent (CTA) can be easily reduced to yield a thiol end group which can be 
further modified via maleimide derivatives.34 However, previous initial work in the group 
exploring this route demonstrated poor labelling efficiency, which was attributed to the 
reversibility of the maleimide-thiol conjugate bond during the deprotection step in TFA. 
Therefore, focus was set on an alternative labelling strategy towards transformation of 
the carboxylic acid end group functionality of boc-Px to amine functionality boc-Px-NH2 
(Scheme 9), affording a route to labelling of the polymer with more readily available 
dyes such as those containing carboxylic acid and aldehyde group chemical handles. 
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be this chemistry could be utilised in future applications for the modification of gold 
nanoparticles,37,38 or surfaces (Scheme 10).39 
 
Scheme 10.Synthetic route for the installation of EDA linker group to the carboxylic 
acid end group of boc-Px to afford boc-Px-NH2. 
During the synthesis, of boc-Px-NH2, a large excess of EDA was used, typically 
1000 equivalents, in order to avoid cross linking of the polymer chains, and purification 
of the compound was carried out by dialysis with a 1 kDa cut-off with regular water 
changes over the course of a week. The modified polymer was obtained by 
lyophilisation to yield a white powder with good mass retention (90 %). All traces of the 
pale-yellow colour of the starting material were lost which indicated that that the 
trithiocarbonate end group had been cleaved by addition of the EDA. It was important 
to assess the purity of the polymer for traces of EDA which had not removed during 
the dialysis step, in this regard proton NMR was carried out to evaluate the presence 


























Figure 75. Proton NMR for EDA showing CH2 signals at 2.47 ppm (bottom) and 
representative proton NMR for EDA modified boc-Px after purification showing no trace 
of residual EDA protons (top). Representative NMR for the corresponding un-modified 
boc-Px-NH2 (middle). * indicates proton signals for EDA. 
No trace of unreacted EDA was observed at 2.47 ppm in the proton NMR for boc-Px-
NH2 after purification, suggesting complete removal of the free diamine by this method. 
At this stage we evaluated whether treatment with EDA could cause structural 
changes in the polymer, possibly as a result of crosslinking between primary amines 
and carbonyls on the polymer backbone, or between modified and un-modified end-
groups despite the use of excess amine. In order to evaluate this, purified Px, was 




Figure 76. Representative GPC trace (DMF LiBr 0.05 M) for boc-Px (DP55) before 
(dashed line) and after (solid line) reaction with EDA. 
Modification with EDA is associated with a theoretical net loss of 62 g mol-1 due 
to the cleavage of the trithiocarbonate group, which was expected to be too small to 
be detected by gel permeation chromatography (GPC), however shifts in retention time 
towards larger molecular masses, and broader mass distributions (Đm), could indicate 
that cross-linking was occurring. Pleasingly, no change in the appearance of the GPC 
trace was observed for this modification step.  
Table 10. Molecular mass data for boc-P55 and boc-P55-NH2.  
 
aDegree of polymerisation calculated by proton NMR, b theoretical molecular mass estimated from 
monomer conversion, c Number average and weight average molecular mass calculated by GPC (DMF 
LiBr 0.05 M) (g.mol-1). 
GPC data indicated that no significant structural change had occurred during 
the synthesis of boc-P55-NH2 and with this in mind we proceeded to investigate 
whether new peaks associated with the installation of EDA on the polymer could be 






















Entry aDP(NMR) bMp(theo)  cMn(GPC)  cMw(GPC)  ĐM  
boc-P55 55 10468 9331 14877 1.59 




Figure 77. Proton NMR in DMSO 6d for unmodified boc-Px (bottom) and EDA modified 
boc-Px-NH2 (top) with new broad region visible at 3.17 ppm (3). 
Proton NMR revealed new broad peaks for boc-P55-NH2 at 3.17 ppm (Figure 
77, top, 3) which was broadly in-line with predicted values for a small molecule 
analogue containing two peaks; 3.46 and 2.81 ppm. The new signal displayed an 
integration of 2.41 protons compared with the terminal dimethyl group at 1.0 ppm 
(Figure 77, 1) (6 protons). The disappearance of a smaller broad peak at 12 ppm 
(Figure 77, 4) visible in the proton NMR for boc-P55 was observed, which was 
assigned as the terminal hydroxyl proton, displaying an integration of 0.87 compared 
to the terminal dimethyl group at 1.0 ppm (6 protons). EDA modification could be better 
observed by proton NMR in CDCl3 allowing for an estimate of EDA loading by 
integration of the broad signal at 3.2 ppm against the dimethyl end groups for a Px with 










































Figure 78. Proton NMR (CDCl3) for boc-P44-NH2.  
Integration of the new signal at 3.25 ppm (3) against the dimethyl end group of 
the polymer (1) appeared to overestimate the loading at over 250 %, and we reasoned 
that this was likely due to the broadness of the peaks and overlapping regions resulting 
in a high degree of error.  
While proton NMR provided encouraging evidence that the end group 
modification with EDA had been successful given the appearance of a new broad 
signal around 3.2 ppm, it was concluded that NMR was not a reliable measure of the 
degree of EDA loading. With this in mind the use of an alternative method to quantify 
the number of amines on the polymer and hence, the efficiency of the end group 
modification reaction was explored. In this regard, a Fluram assay which employs 
fluorescamine (Fluram) as a chemical probe for amines, was explored as a potential 







































Fluram is commonly used to quantify primary amines present on proteins and 
amino acids in biology,40 the detection of small biomolecules,41 and more recently for 
the quantification of primary amines in polymers and polymer nanoparticles.42,43 The 
Fluram assay relies on non-fluorescent compound fluorescamine, which reacts rapidly 
at room temperature with primary amines to yield highly fluorescent compounds (λex 
390 nm, λem 475 nm) (Scheme 11).44  
 
Scheme 11. Structural change in fluorescamine on reaction with primary amines to 
yield the corresponding fluorophore.  
Primary amine concentration can be quantified in the picomole range with low 
background, owing the non-fluorescent starting material (Fluram) and hydrolysis 
products.44 Fluorescamine is inexpensive and as such, the Fluram assay is a cost-
effective tool which can be applied to high throughput style microplate assays.45 Firstly, 
parameters such as a suitable calibration standard, reaction conditions and excitation 
and emission wavelengths were investigated so as to best apply this assay for our 
system and provide optimal reproducibility and accuracy. Calibration curves were 
carried out using a model amine containing small molecule, tert-Butyl N-(2-aminoethyl) 
carbamate (boc-NH2), which displayed a linear relationship between [boc-NH2] and 















In order to be confident of optimal λex and λem for our model amine boc-NH2, 
emission was monitored using a spectrofluorometer at different excitation wavelengths 
for boc-NH2 after incubation with Fluram (Figure 79).  
 
Figure 79. left: Fluram (12.4 μM) emission spectrum after reaction with boc-NH2 (6.22 
μM) at varying emission wavelengths.  
Optimal emission was observed at 475 nm with an excitation of 390, and these 
parameters were then reassessed using a CLARIOstar plus (BMG Labtech) microplate 
reader for both boc-NH2 and EDA modified polymer (boc-Px-NH2) to establish the 
suitability of the plate reader for this application and simultaneously evaluate 
differences between fluorescent signals originating from the small molecule model 
amine, and from the amine-containing polymer (Figure 80).  










































Figure 80. A) Heat map of the fluorescence intensity for boc-NH2 (6.22 μM) and boc-
Px-NH2 (5.92 μM) after reaction with Fluram (2 eq.) in dry DMSO, recorded using a 
CLARIOstar plus plate reader. B) fluorescent spectrum (λex 390 nm) for boc-NH2 (6.22 
μM) and boc-Px-NH2 (5.92 μM) after reaction with Fluram (2 eq.). 
Crucially, fluorescence intensity for these compounds revealed that while both were 
excited at the same wavelength (λex 390 nm), emission maximum was shifted for boc-
Px-NH2 to λem 465 nm compared to λem 475 nm for boc-NH2.  
Next, optimal reaction time and conditions were assessed in order to establish 
the point of maximum conversion of Fluram to the fluorescent Fluram-amine conjugate 
for both model amine and polymer. 2 eq. of Fluram with respect to primary amine were 


































































subsequently carried inside a plate reader at RT in a black 96 well plate and monitored 
by fluorescence (Figure 81).  
 
Figure 81. A) fluorescent spectra (λex 390 nm) for boc-NH2 at increasing reaction time 
with fluram (2 eq. RT), and B), kinetic curves of fluorescent intensity (λex 390 nm, λem 
475 nm) for boc-NH2 ([NH2] 6.22 μM) and boc-Px-NH2. ([NH2] 5.92 μM) with reaction 
time (Fluram, 2 eq. RT), carried out in a black 96 well plate. 
Both polymer and model amine initially displayed slightly different reaction rates 
with Fluram under these conditions, but reassuringly both compounds converged to a 
stable level of maximum fluorescence, and thus, maximum conversion to the Fluram-
amine conjugate between 20 and 40 minutes. This observation confirmed that 
fluorescence for calibration standards and modified polymer could be measured 
simultaneously and compared at these timepoints. Interestingly, boc-NH2 displayed a 
gradual reduction of fluorescence after 50 minutes indicating that the small molecule 
analogue was more susceptible to hydrolysis and/or repeated cycles of excitation.  
Based on evaluation of the parameters discussed above, the Fluram assay was 
carried out on sequential concentrations of boc-Px-NH2 with a maximum theoretical 
[NH2], and hence the efficiency of the EDA end group modification of the polymer was 
assessed by comparison of the theoretical and the experimental values for [NH2]. The 
latter was determined by interpolation of the fluorescence intensity (λex 390 nm) at λem 
465 nm against a calibration curve of fluorescence intensity (λem 465 nm) for known 

















































concentrations of boc-NH2. For each condition, [Fluram] to [NH2] was kept consistent 
at 2 eq. ([Fluram]/[NH2]), and under these conditions, complete consumption of the 
amine to form the fluorescent Fluram-amine conjugate was achieved after 20 minutes 
at RT, and thereafter, produced stable levels of fluorescence for a further 20 minutes 
at which point measurements could be taken. [NH2] between 2 μM and 15 μM were 
prepared by serial dilutions in DMSO, allowing for pipetting volumes compatible with 
96 well plates.  
Table 11. Representative experimental layout for a typical Fluram assay as described 
here.a 
Sample b c d DMSO (μL)  
b (μg·mL-1) d(μM) c (μM) d(μM) [Fluram]/ [NH2] Total volume 
Blank 
 
0 0 200 




11.0 2.5 187 
  
4.23 2.00 2.12 200 
Cal 2 
 
22.0 5.0 173 
  
8.46 4.00 2.12 200 
Cal 3 
 
33.0 7.5 160 
  
12.69 6.00 2.12 200 
Cal 4 
 
44.0 10.0 146 
  
16.92 8.00 2.12 200 
Cal 5 
 
55.0 12.5 133 
  
21.15 10.00 2.12 200 
Cal 6 
 
66.0 15.0 119 
  
25.38 12.00 2.12 200 
Cal 7 
 
77.0 17.5 106 
  
29.61 14.00 2.12 200 
Pol 1 20 30 
 
150 45.00 5.35 11.54 
 
2.16 200 
Pol 2 40 60 
 
100 90.00 10.70 23.08 
 
2.16 200 
Pol 3 50 75 
 
75 112.50 13.38 28.84 
 
2.16 200 
a Cal 1-7 represents conditions for the production of the standard curve using boc-NH2, and Pol 1-3 
represents sequential concentrations of boc-Px-NH2. b boc-Px-NH2 (54 μM) (μL), c Fluram (80 μM) (μL) d 
boc-NH2 (160 μM) (μL).  
 
Each calibration condition (Cal 1-7) and polymer condition (pol 1-3) was pipetted 
in triplicates with DMSO serving as a solvent only control in a 96 well plate which was 
covered in foil and gently rocked for 30-40 minutes before recording the data using a 




Figure 82. Data collected from a typical Fluram assay: A), standard concentrations 
with boc-NH2 B), emission of boc-Px-NH2 C), example of interpolated values for boc-
Px-NH2 against a standard curve. 
Employing the Fluram assay, EDA loading on the polymer was evaluated for a 
DP55 boc-P55-NH2 (Table 12) and then repeated for boc-Px-NH2 at a range of different 
DPs (Table 13). 
Table 12. Experimental data from a Fluram assay, for boc-P55-NH2 for calculated 






2.30 1.26 55 
4.61 3.24 70 
6.91 5.21 75 
Average loading (%) 67 
a Calculated by estimated Mp of the polymer (monomer conversion) b Calculated by interpolation of a 




















































































Table 13. Estimated loading efficiency of EDA on boc-Px-NH2 prepared at different 
DPs by RAFT. 
 
Entry aMp(theo)  bMn(GPC)  cEDA loading  
boc-P55 10467 9200 67% 
boc-P38 7292 - 68% 
boc-P162 30342 21220 68% 
boc-P44 8408 8190 60% 
a monomer conversion by H1 NMR (g.mol-1), b number average molecular weight by GPC (DMF LiBr 
0.05 M) c Determined by Fluram assay  
 
An acceptable degree of consistency was observed between samples and loading of 
EDA appeared to be independent of DP, although the loading was not quantitative. 
The explanation for the observed lower than quantitative efficiency may be as a result 
of poor availability of the end group to react with the linker. 
4.3.3 Synthesis of green fluorescent polymer scaffold: Px-Flu 
With evidence of predictable installation of EDA onto boc-Px, the next step 
involved fluorescently labelling the polymer via the EDA linkage, and quantifying the 
labelling degree. Fluorescein isothiocyanate (FITC), which was readily available and 
capable of efficient conjugation to primary amines was chosen to explore fluorescently 
labelling the polymer. At this point It was important to consider the reaction of thiols 
with isothiocyanate groups,46 which could lead to labelling at both the amine and thiol 
end groups of boc-Px-NH2. However, compared to the thiourea derivative formed with 
amines, the resulting dithiocarbamate is known to be reversible under physiological 
conditions,47,48 and therefore it was hypothesised that dithcarbamate-linked FITC 
would likely be cleaved during the deprotection step with neat TFA. 
To fluorescently label the polymer, boc-Px-NH2 was mixed with an excess of 




Scheme 12. Synthetic route to fluorescently labelled boc-Px-Flu. 
The reaction proceeded for 12 hours at RT while shielded from the light using foil. 
Following this, the crude was condensed using a high-pressure vac line and isolation 
of the labelled polymer from the free dye was carried out using a sephadex LH-20 
column in DMF and fractions were analysed by fluorescence GPC (Figure 83).  
 
Figure 83. Fluorescent GPC (λem 510 nm) traces (DMF LiBr 0.05M) for fractions 
(numbered) collected after separation of boc-P91-Flu from FITC using a sephadex LH-
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Reasonable separation was observed at this point during the purification 
process as assessed by analysis of each fraction collected from the column; fractions 
2-4 for a DP91 boc-Px displayed a good degree of separation from FITC, with the 
appearance of small impurity at 18 minutes likely to be small oligomers of the polymer 
rather than the free FITC, justified by the decreases in the observed impurity between 
fractions 3 and fractions 6 and the observation of two peaks, impurity and FITC in 
fraction 7. Overlap between boc-P91-Flu and FITC was apparent after fraction 7 which 
accounted for the reduced yield (22 %) upon combination of pure fractions (1-6). 
 Separation by this method was considerably worse for boc-Px targeting lower 
DPs, and we therefore explored alternative methods of purification. By quenching 
unreacted FITC with further portions of EDA, and dialysing the crude until no traces of 
FITC were observed in the dialysis mixture, lyophilised boc-Px-NH2 was isolated from 
free FITC at a significantly improved yield (70 %).  
To affirm that the installation of the amine linker EDA was indeed crucial for 
labelling with FITC, a labelling reaction was carried employing both boc-P55-NH2 and 
its unmodified parent boc-P55 as a control sample, crudes of the reaction were 
compared by fluorescence GPC in order to assess levels of non-EDA associated 




Figure 84. Fluorescent GPC (λem 510 nm) traces (DMF,LiBr 0.05M) of crude of 
reaction between boc-P55 and FITC, with (solid line) and without (dashed line) prior 
installation of EDA linker. Dot-dash line represents boc-P55-NH2 without the addition 
of FITC. Concentration of polymer in each case was 2 mg ml-1. 
The GPC trace indicated a clear increase in loading of FITC in the polymer 
region (~14-17 minutes) in the case of the EDA modified polymer, and also revealed 
that FITC could be incorporated onto the polymer without this modification, although 
to a significantly lower degree. It was reasoned that “background” labelling could be 
due to a degree of cleavage of the trithiocarbonate end group and reaction of FITC 
with the resulting thiol. This observation brought to our attention the difficulty in 
quantifying the fluorescent labelling contribution from amine compared to the thiol at 
this stage of the reaction. 
Despite the possibility of labelling with FITC occurring at both ends of boc-Px, 
the purity of the dialysis-isolated polymer with respect to unreacted FITC was 
evaluated by proton NMR (Figure 85).  





























Figure 85. Proton NMR (DMSO d6) for boc-Px-FITC after purification by dialysis 
(middle). And corresponding starting materials (top / bottom). 
Proton NMR of boc-Px-Flu displayed new broad signals around 6.6 ppm 
consistent with conjugated FITC protons. There was no evidence of sharp signals 
associated with FITC especially from hydroxyl protons (1) at 10.18 ppm which 
suggested that the polymer-FITC conjugate was isolated from unreacted FITC. The 
loading of FITC onto the polymer was quantified at this stage by proton NMR, by 
integration of the FITC signal at 6.7ppm (6 protons) against the hydrazide region on 



























































Figure 86. Proton NMR (DMSO d6) for A) FITC B) boc-P55-Flu and C) boc-P38-Flu, 
highlighting key proton signals involved with calculation of FITC loading.  
 
Table 14. Quantification data for boc-Px-Flu described in this section. 
EntryDP aMp(Theo)  bMn(GPC)  cEDA 
loading %  
d
FITC 
loading %  
boc-P55 10467 9199 67 140 
boc-P38 7292 - 68 121 
a Theoretical polymer molecular weight based on monomer conversion (g.mol-1) b Number average 
molecular weight determined by GPC (DMF, LiBr 0.05 M) (g.mol-1), c Calculated using a Fluram 
assay,
 d
 calculated by proton NMR. 
 
Values obtained for the loading of FITC by proton NMR were roughly double the 
estimated loading of EDA (Table 14), which could be rationalised as a result of FITC 
labelling via the thiol end group as was predicted and could account for a theoretical 
maximum loading via this quantification method of ~170%. Given the uncertainty over 
the contribution of the thiol end group with respect to the labelling step, we assessed 





























































































but possessing end group analogous to boc-Px-NH2 in order to evaluate labelling 
strictly via the amine linkage. A model boc-PFRP was then prepared by free radical 
polymerisation (FRP) targeting a DP50 Px, but substituting of the RAFT agent for 
cysteamine as a chain transfer agent (CTA) (Scheme 13).  
 
Scheme 13. Synthetic route taken in the synthesis of boc-PFRP by free radical 
polymerisation, and subsequent labelling with FITC under identical conditions as for 
boc-Px-NH2.  
The resulting polymer was expected to be capped by two primary amine-
containing cysteamine groups. In this way the total concentration of NH2 on the 
polymer would be determined by the ratio of [monomer]:[CTA]:[initiator] ([100][2][0.4]) 
with no contribution from thiol end groups or uncertainty over installation of the linker. 
In accordance previously described experimental conditions FITC was allowed react 
with boc-PFRP at different molar equivalents with respect to [NH2], and crudes of the 
reaction mixture were analysed by GPC (Abs495 nm) prior to the addition of the polymer, 
and after 24 hours (Figure 87). Polymer absorption at 495 nm around 12 minutes 
retention time and quantification of the purified compounds by proton NMR 







































Figure 87. A) GPC trace (DMF LiBr 0.05M) of FITC before and B) after addition of 
boc-PFRP. C) Proton NMR (DMSO) for isolated boc-PFRP after reaction with increasing 
equivalents of FITC and D) Expanded proton NMR displaying integrals used to 
calculate number of monomer units per FITC molecule from integrating FITC signal at 
6.5 ppm (2 X 6 protons) and hydrazide protons ~9.0 ppm (DP/2 protons).  
Polymer absorption at 495 nm (10-16 minutes retention time) indicated 
increased loading of the dye onto the polymer with increasing FITC equivalents with 
respect to the theoretical end group functionality afforded by cysteamine. Maximum 
loading was observed between 0.78 eq. and 1.68 eq with little to no increase in loading 
observed when increasing from 1.28 to 1.68 eq. These observations were corroborated 
by integrating the hydrazide backbone signals against the FITC signals (highlighted *) 
for purified boc-PFRP-Flu which followed a similar pattern to the GPC trace, allowing 
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Table 15. Calculated ratios of FITC to monomer unit for boc-PFRP-Flu described in this 
section 






a With respect to estimated moles of NH2 available for reaction on the polymer, b calculated by integration 
of FITC signal (2X6H) against hydrazide region in the polymer backbone (3H). 
 
These results confirmed the ability to label the boc-protected polymer scaffold 
with FITC via amine containing end-groups, and with this in mind the focus was set to 
establishing whether FITC remained conjugated to the polymer after the critical 
deprotection step with TFF. 
Deprotection of boc-Px yields Px, capable of undergoing post-polymerisation 
modification with aldehydes and sugars and as such, retention of the fluorescent label 
during this step is critical for the primary application of Px as a screening platform. 
Deprotection of boc-Px-Flu was carried out in the dark on addition of neat TFA 
and isolation of the purified fluorescent polymer was carried out in the dark via 
purification by dialysis. Despite the removal of FITC from the protected polymer during 
the previous step, it was apparent during the dialysis step that free FITC was present 
in the dialysis water indicating a degree of cleavage of the fluorescent dye. It was 
rationalised that this was expected and represented cleavage of the FITC molecule 
from the thiol end group of the polymer the linker on account of the unstable nature of 
the linkage under acidic pH. Despite some loss of FITC during dialysis, reassuringly, 
a water-soluble fluorescent orange powder was recovered (55%) after lyophilisation 
and GPC analysis of the compound using refractive index, absorbance and 




Figure 88. Representitive GPC trace (Lonza DPBS) for purified P91-Flu recorded by 
A) refractive index, B) emission (λex 490 nm, λem 510 nm) and C) absorption (λabs 495 
nm). 
GPC analysis confirmed isolation of the deprotected polymer, although a small 
non-fluorescent impurity was observed at a retention around 20 minutes which may 
indicate the presence of small oligomers of Px without the required chemistry to 
undergo fluorescent labelling. Absorption at 495 nm confirmed that FITC was still 
conjugated to the polymer, and emission (510 nm) confirmed that the fluorophore was 
still able to fluoresce after excitation at 495 nm.  
At this stage, the loading of FITC on Px-Flu was assessed by proton NMR 
(Figure 89). 






























































Figure 89. Proton NMR (D2O) for a P44-Flu highlighting the key proton signals involved 
with quantifying the loading of FITC 
For a DP44 Px-Flu, FITC loading after deprotection was calculated as 53% total 
loading with respect to moles of the polymer, or 88% with respect to the respective 
estimated EDA installation. The calculated loading was in-line with expected FITC 
loading via the EDA linker compared with the previously discussed over labelling for 
the boc-protected polymer, further supporting our rational that FITC conjugation via the 
thiol had been cleaved during the deprotection step. In order to further corroborate the 
NMR results, the loading of FITC on Px-Flu was characterised by interpolation of a 
























































Figure 90. A) Absorbance spectrum for FITC and B) Px-Flu at increasing 
concentrations. C) Corresponding standard curve for FITC concentrations at 500 nm. 
UV-Vis was chosen here to measure the amount of FITC on Px-Flu rather than 
fluorescence to better negate the effects of photobleaching, and encouragingly, the 
values obtained by this method were generally in agreement with the calculated 
loading of EDA and in this regard were “quantitative” for two of the three samples 
analysed (Table 16).  
4.3.4 Post polymerisation of Px-Flu 
Finally, and in accordance with the primary objectives set out in this chapter, we 
investigated the ability of Px-Flu to undergo post-polymerisation modification reactions, 
in order to access and screen new polymer chemistries originating from the fluorescent 
scaffold. In this regard, imidazole-4-carbaldehyde (IMI) was employed as model 
aldehyde due its previously-studied reaction with Px.49 On addition of the aldehyde 
under mildly acidic conditions (100 mM acetic acid), a new broad region between 8.5 











































































and 6.4 ppm was observed as well as a decrease in the aldehyde signal (9.6 ppm) and 
corresponding hydrate (6.0 ppm) indicating that Px-Flu was able to undergo post-
polymerisation modification with IMI. Loading was calculated by integration of the 
sharp aldehyde signals of the free aldehyde and hydrate compared to the entire 
imidazole region (3H) (Figure 91). 
 
Figure 91. Proton NMR (D2O) for Px-Flu-IMI1.0 A), highlighting integrals used to 
calculate conversion of the aldehyde onto the polymer and B), stacked NMR spectrum 
for Px-Flu-IMI1.0 and corresponding starting materials; IMI, Px-Flu.  
After incubation of Px-Flu with 1.1 equivalent of IMI, the loading of the aldehyde 
was calculated at 68% and 59 %. by proton NMR. Equivalence of the aldehyde was 
calculated with respect to moles of hydrazide side chains, accounting for the molecular 
weight contribution of FITC, RAFT agent and EDA linker (12% for a DP55 Px-Flu). 
Reassuringly, these values were consistent with those previously reported for Px-IMI 
(66%),49 indicating that fluorescent end group modification did not impact on the ability 
to undergo subsequent side-chain modification. A summary of the transformations 
discussed thus far for the modification of boc-Px at different calculated molecular 




















































































Table 16. Summary data for Px-Flu-IMI described in this study. 








P91-Flu-IMI 17150 10749 225% 8396 5213 109 % 67 % 
P55-Flu-IMI 10467 9199 67% 5229 9753 91 % 59 % 
P38-Flu-IMI 7292 n/a 68% 3837 8694 38 % n/a % 
a boc-Px, g.mol-1(1H NMR), b boc-Px, g.mol-1, (GPC, DMF, LiBr 0.05 M). c Px-Flu (SEC, Lonza DPBS) d 
determined by UV-Vis standard curve, e calculated by Fluram assay f calculated by 1H NMR. 
4.3.5 Synthesis of blue polymer scaffold: Px-MCCA 
After synthesis and characterisation of fluorescent FITC labelled polymer 
scaffold Px, with good control and reproducibility over fluorescent loading, this synthetic 
route was further evaluated towards synthesis of different “coloured” scaffolds. Our 
focus then turned to preparing Px capable of emission in the blue/violet region. A dye 
capable of emitting in this region was especially important for work with bacteria in 
order to distinguish between polymer emission and emission of a green fluorescent 
protein (GFP) producing strain of V. cholerae which was a strain predominantly used 
for assessment of growth. 
The fluorophore; 7-methoxycoumarin-3-carboxylic acid (MCCA) which absorbs 
in the UV-region (330 nm) and emits in the blue/violet region (402 nm) was chosen for 
the labelling of Px-NH2. Furthermore, MCCA had been previously reported in the 
labelling of polymers containing amines and for similar applications involving clustering 
of bacteria by polymers. 36 MCCA has a lower molar extinction coefficient compared to 
FITC (20,000 vs 77,000 cm-1 M-1),50 therefore efficient labelling and extra care to avoid 
photobleaching needed to be considered for biologically useful materials. In addition, 
compared to reactions with isocyanates (FITC), carboxylic acid conjugation with 
amines require more forcing conditions due to the lower reactivity of the carbonyl 
group. Despite this, successful conjugation had been reported for MCCA and polymers 
containing primary amine side chains, and thus a synthetic route was targeted based 
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that reported in the literature,51 but employing DMF rather than propinonitrile to 
maintain solubility of boc-Px (Scheme 14). 
 
Scheme 14. Synthetic route for the preparation of Px-MCCA and subsequent post 
polymerisation modification with a model aldehyde (IMI). 
To assess whether MCCA had been successfully conjugated to boc-Px-NH2 via 
this method, crudes of boc-Px-NH2 after reaction with MCCA, and respective 
unmodified control boc-Px were analysed by fluorescence GPC. (Figure 92). 
 
Figure 92. GPC trace (DMF LiBr 0.05 M) for crude of boc-Px and boc-Px-NH2 after 
reaction with MCCA (4 eq.).  
As with FITC labelling, a control whereby MCCA was reacted with boc-Px lacking the 
EDA end group confirmed that the linker was crucial for this reaction (EDA modification 
efficiency by Fluram = 68%). Under these conditions, the thiol is not amenable to 
























































of the polymer which lacked the EDA linker was observed and accounted for 5% of the 
total fluorescent signal by GPC.  
Purification of crude boc-Px-MCCA was initially carried by dialysis as before, 
and lyophilised to a brown powder (51%), however analysis of the purified compound 
by proton NMR revealed sharp peaks, presumably from a mixture of small molecule 
derivatives of unreacted MCCA (Figure 93). 
 
Figure 93. Proton NMR (DMSO d6) for unreacted MCCA (top) and boc-Px-MCCA after 
dialysis (bottom). 
It was rationalised that the presence of these impurities was likely due to the very low 
solubility of MCCA in water, and as such, it was concluded that dialysis was not a 
suitable method for isolation at this stage despite being the only purification method 
reported in the literature protocol.51 
Given, the previously low yields afforded on purification by column 
chromatography, and the inability to perform a liquid separation due to the incompatible 
solubilities of both MCCA and boc-protected polymer, boc-deprotection was carried 





































out in neat TFA as before, and this time an acidic work up was carried out to extract 
unreacted MCCA into chloroform. Washing was repeated in this way until no further 
fluorescent compound could be detected in the organic phase. The aqueous phase 
containing Px-MCCA was then dialysed and lyophilised to a pale brown powder (50%), 
purity and fluorescent labelling of the compound was confirmed by SEC (Figure 94).  
  
Figure 94. SEC trace (Lonza DPBS) for purified P162-MCCA (2 mg ml-1) A), Normalised 
emission at 402 nm, representative of polymers containing MCCA and B), Normalised 
absorbance at 254 nm, associated with carbonyl absorption of Px. 
Emission SEC confirmed the presence of the MCCA fluorophore on the polymer 
and the emission trace was consistent with the absorbance trace at 254 nm, 
associated with the absorption at this wavelength by carbonyl groups present in Px 
side chains. There was no presence of free MCCA in the proton NMR after 
deprotection, however, although MCCA is detectable by NMR in D2O, this method 
cannot be used as a conclusive indication of purity due to the low solubility of MCCA 
in H2O. Furthermore, the presence of new peaks indicative of MCCA conjugated to the 
polymer were not detected by proton NMR which may have been as a result of their 
low abundance on the polymer, or possibly due to shielding of the hydrophobic 
fluorophore in the proton NMR (Figure 95). 









































At this point no further assessment of purity of Px-MCCA or degree of MCCA 
loading was carried out, and focus was moved towards evaluating the ability to 
conjugate imidazole- IMI to the Px-MCCA scaffold (Figure 95).  
 
Figure 95. Proton NMR (D2O) for A) P38-MCCA and B) crude P38-MCCA-IMI (right) 
after reaction with 1.1 equivalent of Imidazole-4-carbaldehyde. 
Pleasingly Px-MCCA was able to undergo post-polymerisation modification with IMI, 
although a lower degree of loading of 44% was observed on incubation with 1.1 
equivalent of aldehyde to hydrazide. It was rationalised that reduced IMI loading may 











































































































deprotection step. With this in mind purifying boc-Px-MCCA by SEC may therefore 
offer a more attractive means of purifying this compound.  
4.3.6 Biological testing with Px-MCCA 
To assess whether labelling of Px with MCCA had yielded a fluorescent polymer 
sufficiently bright enough for use in standard biological applications, P38-MCCA-IMI 
was incubated with GFP expressing V. cholerae under standard bacterial clustering 
conditions (covered in more detail in Chapter 2) to evaluate polymer-bacteria 
colocalisation by fluorescence (Figure 96).  
 
Figure 96. Optical images (20 x magnification) captured after 0 hours incubation of A) 
untreated V. cholerae and B) V. cholerae + 0.5 mg ml-1 P38-MCCA-IMI1.1 (OD600 = 
0.02). To the end, images were captured in brightfield, and fluorescence using the GFP 
and DAPI filter set at 0- and 5-hours incubation at 37oC 
Images identified that P38-MCCA-IMI1.1 initially formed mucus-like precipitates 
in the growth media (clear DMEM) as was routinely observed for Px-IMI (Chapter 3) 
and these precipitates were easily distinguishable by fluorescence (DAPI) from the 
bacteria (GFP), confirming that there was no overlap between these fluorescent 





channels. After 5 hours of incubation, V. cholerae were observed predominantly 
adhered to the polymer precipices (Figure 97).  
 
Figure 97. Optical images (20 x magnification) of A), untreated V. cholerae and B), V. 
cholerae + 0.5 mg ml-1 P38-MCCA-IMI captured after 5 hours incubation at 37oC. 
After 5 hours incubation at 37 oC, colocalisation of V. cholerae on the P38-
MCCA-IMI1.1 precipitate was clearly apparent. Fluorescence of P38-MCCA-IMI1.1 
allowed for a more detailed evaluation of the complex 3D polymer network. Z-stacks 
in the GFP channel further demonstrated the 3-dimensional nature of the bacteria-
polymer aggregates which we hope may be explored in future work using confocal 
microscopy (Figure 98). 






Figure 98. Z-Stacked GFP fluorescent images from conditions described in Figure 25 
showing location of V. cholerae adhered to P38-IMI1.1. Images were taken every 3 μm 
though 90 um and rendered in 3D using NIS elements (Nikon) using the AlphaBlend 
render mode.  
4.4 Conclusions  
Fluorescently labelling macromolecules is a key step to understanding their 
mechanisms of action in biological settings. However, evaluation into the location and 
purity, stability and degree of labelling of the labelled nanomaterial is often overlooked 
and can lead to uncertainty over the observed activity.  
The primary aim was to synthesise a fluorescently labelled polymer scaffold Px 
with a quantifiable and reproducible degree of fluorophore loading, in order to 
investigate the mechanism of polymer-driven aggregation of bacteria. To this end, a 
synthetic and characterisation strategy for fluorescently labelling poly(acryloyl 
hydrazide) (Px), has been developed, with a particular focus on the installation and 
characterisation of an amine linker via end group modification to afford the option of 
labelling with a wide variety of fluorescent dyes depending on the application. It was 
demonstrated that the installation of the linker can be quickly and efficiently assessed 
using a Fluram assay which was optimised for use in microtiter plates. The labelling of 
Px-NH2 with FITC correlated well with the calculated loading of EDA although 
quantitative labelling of Px-NH2 was not realised, and Px-Flu was able to undergo 
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subsequent post-polymerisation reactions to the same degree as the non-fluorescent 
Px. Px-Flu prepared using this strategy.  
As an example of the versatility of this screening platform, Px-NH2 was labelled 
with a blue fluorescent dye and subsequently further modified with cationic aldehyde 
imidazole-4-carbaldehyde in order to co-localise cationic polymer with GFP expressing 
V. cholerae. Fluorescent microscopy revealed that the mucus-like precipitate was 
indeed as a result of precipitating polymer, confirming the polymers role in the 
sequestration of V. cholerae. 
4.5 Future work  
Work should be carried out to quantify and optimise the loading of MCCA after 
reaction with Px-NH2, which has not been covered yet in this research, and to explore 
the use of alternative blue dyes. MCCA is significantly less bright than FITC, and initial 
work to synthesise Px-MCCA-IMI suffered from an inability to detect fluorescent 
emission when taking the polymer forward into biological experiments. Poor brightness 
of the material was most likely as a result of photobleaching, but may in part have been 
influenced by DP. There may also be scope to optimise the reaction for labelling with 
MCCA, and this would be aided by quantification of fluorophore loading, which could 
then be assessed in the same as for Px-Flu by UV-vis or fluorescence standard curves. 
Alternative blue dyes with greater photostability and more amenable chemical handles 
(for example, isothiocyanates or isocyanates) for conjugation via the amine linker may 
also be usefully explored. 
Initial biological work with Px-MCCA-IMI revealed a complex 3-dimentional 
matrix of polymer fibers, capable of sequestering V. cholerae. Further investigations 
could be carried out using fluorescent polymers with a variety of different side-chain 
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chemistries to probe the impact chemistry has on the nature of this matrix and whether 
this influences the polymers’ ability to aggregate bacteria. There would be benefit in 
carrying out future imaging using super resolution confocal microscopy, so that Z-
stacks can be represented with greater fidelity and a detailed evaluation of the 
bacteria-polymer interaction can be established.  
There would be merit in preparing a red fluorescent Px using the same method, 
to demonstrate the strengths of linking colour to polymer functionality. In future 
screening assays, the use of RBG (red blue green) polymers may be employed to 
differentiate between different binding efficiencies for certain polymer parameters; for 
example, polymer molecular weights and chemical nature of the side-chain. This 
methodology would open up the potential for using these materials in a biosensing 
capacity and to aid high-throughput screening for bacterial clustering (Figure 99).  
 
Figure 99. Potential route to screen polymer side group chemistry for affinity to 
bacteria by measuring concentration of fluorescently labelled polymers with differing 
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5.1 Final conclusions  
 The use of synthetic linear polymers as bacterial antiadhesives is a growing but 
as yet undeveloped field, this is due in part to complexities in controlling both biological 
and chemical systems as well as a lack of continuity between synthesis and biological 
testing. Despite this, recent work outlined in the introduction of this thesis demonstrates 
the potential that synthetic polymers have as multivalent biological mimics to bind to, 
and interfere with normal bacterial processes. The focus of this work has been towards 
the development and application of a simple polymer screening platform based on 
poly(acryloyl hydrazide) to allow the efficient discovery of new chemistries for 
sequestering pathogens via convenient post-polymerisation modification of the 
polymer backbone with aldehydes and sugars which can be tested for activity in-situ. 
This thesis represents efforts towards understanding and controlling both polymer 
chemistry and microbiology assays in order to lay the foundation for a larger scale high 
throughput screening in future work.  
 Controlled radical polymerisation techniques, such as RAFT can reduce 
uncertainty with respect to polymer structure and the observed biological activity and 
allow for “tuning” of the polymer system. In Chapter 1, the RAFT polymerisation of 
acryloyl hydrazide was optimised through choice of polymerisation temperature and 
radical initiator. Optimisation resulted in the synthesis of poly(acryloyl hydrazide) with 
a lower molecular weight dispersity and an ability to synthesise larger polymers with 
only a small loss of control. As a result of these optimisations, the effect of molecular 
weight of poly(acryloyl hydrazide) on the response of Vibrio cholerae could be better 
evaluated (Chapter 2). In Chapter 2, poly(acryloyl hydrazide) was functionalised with 
aromatic cationic groups, 2-amino-3-formylpyridine and imidazole carbaldehyde, 
which possess similar protonation states and hydrophobicity, to yield cationic polymers 
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with well-defined degrees of functionalisation. Time-lapse microscopy revealed how 
increasing degree of functionalisation with imidazole carbaldehyde increased the 
hydrophobility of the resulting polymer and also resulted in a material to which V. 
cholerae could be observed binding to. Poly(acryloyl hydrazide) with ≥ 75% imiadazole 
moieties installed was able to sequester and greatly reduce the concentration of 
planktonic V. cholerae in liquid media and also induced a phenotypic change, whereby 
it was observed that the production of the Cholera toxin was downregulated and the 
production of biofilm was upregulated. 
 The versatility of poly(acryloyl hydrazide) owing to the hydrazide chemistry 
allowed for a small library of glycopolymers to be prepared in order to compare 
glycopolymers bearing lectin recognition motifs to cationic polymers (Chapter 3). Such 
direct comparisons from the same parent polymer are traditionally difficult to achieve 
without chemical manipulation of the polymer backbone or the ligating group. It was 
found that, while stable glycoconjugate were able to be formed under optimised 
conditions, no evidence for irreversible bacterial clustering was observed. Despite this, 
flocculation assays indicated a sharp but short-lived increase in optical density at 20 
minutes post incubation which may indicate bacterial interaction with the glycopolymer. 
It was noted that treated V. cholerae with mannose displaying glycopolymers increased 
the production of biofilm over those treated with free mannose alone, and to a greater 
extent than glucose, galactose glycopolymers or poly(acryloyl hydrazide).  
Finally, a systematic approach to installing a green or blue fluorescent probe 
onto the end group of poly(acryloyl hydrazide) was developed, allowing for a good 
estimation of fluorescent labelling degree and purity (Chapter 4). Here, a fluorescent 
poly(acrlyolyol hydrazide) emitting in the blue region was functionalised with imidazole 
carbaldehyde revealing the location of the polymer within the clusters of bacteria.  
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5.2 Future work  
Controlled synthesis of polymers is important for determining structure-activity 
relationships. Higher molecular weight poly(acryloyl hydrazide) with lower dispersity 
may be possible with further optimisation of the RAFT polymerisation conditions. This 
could be achieved through the use of a photoinitiator and UV irradiation, for the rapid 
generation of radicals at room temperature and should be explored as a follow-up to 
work carried out in Chapter 1.  
The experiments set out in this work have laid the foundation for a more 
thorough exploration of the polymer chemical space via hydrazone linkage and may 
be useful in determining a general set of “ideal” chemistries and polymer architectures 
to sequester a variety of different pathogens as well as triggering interesting and useful 
bacterial phenotypes. Future work should focus on developing a larger scale high-
throughput process for screening arrays of modified poly(acryloyl hydrazide) under 
identical experimental conditions for a number of different pathogens. This 
methodology will be better suited for determining trends in polymer chemistry and 
biological activity and may help identify compositions which can increase specificity for 
a particular pathogen. Polymers possessing fluorescent probes of different colours 
may offer a convenient way of quickly identifying which chemistries are preferable for 
bacterial clustering using fluorimetry (Chapter 4, Figure 99).  
Cell work should be carried out to determine the potential protective effect of 
these polymers against pathogenic bacteria verses their possible cytotoxicity to host 
cells which was not carried out in this work. Poly(acryloyl hydrazide) modified with 
imidazole may be a good initial candidate for this given the observed rapid adherence 
of V. cholerae to the polymer precipitates.  
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In Chapter 3, evidence of aggregation of V. cholerae remained inconclusive with 
the prepared glycopolymers. Future work with glycopolymers should focus on purifying 
these materials to avoid background interference of excess carbohydrate which may 
reduce the ability of the glycopolymer to bind bacterial lectins. Furthermore, the stability 
of the glycoconjugate in purified polymers should be assessed as the glycoconjugate 
formed between sugars and hydrazides is expected to be less favourable compared 
with that with aldehydes.  
Given the lack of evidence for bacterial clustering with the glycopolymers 
reported in this work, there may be merit in preparing poly(acryloyl hydrazide) with a 
longer spacer group between the hydrazide and the polymer backbone in order to 
reduce steric hindrance and increase degrees of freedom when binding lectins. This is 
something that has been shown to benefit the binding of glycopolymers with model 
lectins as discussed in the introduction chapter. Indeed, studies using model lectins 
such as Concanavalin A (ConA) may help initially identify ideal carbohydrate densities 



















 2-((Ethylthio)carbonothioyl) thio-2-methylpropanoic acid (CTA) was synthesised 
according to protocols described in the literature.1,2 t-Butyl carbazate and N-3(-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC) was purchased from 
Fluorochem. 2,2′-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride (VA-044) was 
purchased from Fluorochem and used without further purification. N-[3-
(dimethylamino)propyl]methacrylamide (DMAPMAm) and  N-(3-
aminopropyl)methacrylamide (APMAm) were purchased from Sigma®, and used 
without further purification. 4,4’-azobis(4-cyanovaleric acid) (ACVA) and 2,2'-azobis(2-
methylpropionitrile) (AIBN) were purchased from Sigma® and used without further 
purification. Ethylene diamine (EDA) was purchased from Sigma-Aldrich. D-Mannose 
was purchased from Alfa Aesar®, D-Glucose was purchased from Fisher Scientific® 
and D-Galactose was purchased from Acros®, all were used without further 
purification. Imidazole-4-carboxaldehyde (IMI) and 2-amino-3-formyl pyridine (2A3FP) 
were purchased from Fluorochem and used without any further purification. Crystal 
violet was purchased from VWR and used as a 1% solution in H2O. 2-Nitrophenyl β-
D-galactopyranoside (ONPG) was purchased from Sigma-Aldrich®. Fluorescein 
isothiocyanate (FITC) and 7-methoxycoumarin-3-carboxylic acid (MCCA) was 
purchased from Sigma®, Flourescamine was purchased from VWR. All solvents were 
Reagent grade or above, purchased from Sigma-Aldrich®, Fisher Scientific® or 
VWR®, and used without further purification. LB and clear DMEM used in growth and 
maintenance of Vibrio cholerae was purchased from Sigma® Tetracycline and 
spectinomycin were purchased from Sigma®. All solvents were Reagent grade or 




6.2 Bacterial strains used in this study  
Strains of Vibrio cholerae O1 Inaba serotype used in this study were kindly donated by 
Dr. Perez-Soto:  
Strain Description 
NPMW1 A1552 carrying pMW-gfp plasmid; SpectR 
NP5001 A1552 pRW50-oriT promoterless; TetR 
NP5003 A1552 pRW50-oriT containing upstream region of 
ctxAB promoter; TetR 
NP5008 A1552 pRW50-oriT containing upstream region of 
vspR promoter; TetR 
NP5009 A1552 pRW50-oriT containing upstream region of 
rbmA promoter; TetR 
NP5010 A1552 pRW50-oriT containing upstream region of 
rbmC promoter; TetR 
 
Strains were supplemented with antibiotics; Tetracycline (10 μg mL-1), NP5001-010 or 
Spectinomycin (50 μg mL-1), NPMW1.  
Media LB (Sigma): 10 g/L tryptone, 10 g/L NaCl and 5 g/L yeast extract, clear DMEM 
(Sigma): 0.265 g/L CaCl2, 0.0001 g/L Fe(NO3)3, 0.09767 g/L MgSO4, 0.4 g/L KCl, 3.7 
g/L NaHCO3, 6.4 g/L NaCl,0.109 g/L NaH2PO4, 0.084 g/L L-Arg, 0.0626 g/L L-Cys, 
0.03 g/L Gly, 0.042 g/L L-His, 0.105 g/L L-Iso, 0.105 g/L L-Leu, 0.146 g/L L-Lys, 0.03 
g/L L-Met, 0.066 g/L L-Phe, 0.042 g/L L-Ser, 0.095 g/L L-Thr, 0.016 g/L L-Trp, 0.12037 
g/L L-Tyr, 0.094 g/L L-Val, 0.004 g/L choline chloride, 0.004 g/L folic acid, 0.0072 myo-
inositol, 0.004 g/L niacinamide, 0.00404 g/L pyridoxine, 0.004 g/L D-pantothenic acid, 




Nuclear Magnetic Resonance (NMR) spectra were recorded on either a Bruker Avance 
III 300 MHz or a Bruker Avance NEO 400 MHz spectrometer. Chemical shifts are 
reported in ppm (units) referenced to the following solvent signals: dimethylsulfoxide 
(DMSO)-d6 H 2.50 and deuterium oxide (D2O) H 4.79. Gel Permeation 
Chromatography (GPC) was performed with a Shimadzu Prominence LC-20A fitted 
with a Thermo Fisher Refractomax 521 Detector and a SPD20A UV-vis Detector. 
poly(N’-(tert-butoxycarbonyl)acryloyl hydrazide) (boc-Px) was analysed using 0.05 M 
LiBr in dimethylformamide (DMF) at 60 °C as the eluent, and a flow rate of 1 mL min−1. 
The instrument was fitted with a Polymer Labs PolarGel guard column (50 × 7.5 mm, 
5 μm) followed by two PLGel PL1110–6540 columns (300 × 7.5 mm, 5 μm). Molecular 
weights were calculated based on a standard calibration method using 
polymethylmethacrylate standards (Agilent®). Poly(acryloyl hydrazide) Px and 
glycopolymers Px-MAN, Px-GAL Px-GLU  were analysed using Dulbecco’s Phosphate 
Buffered Saline 0.0095 M (PO4) without Ca and Mg at 35°C as the eluent and a flow 
rate of 1 mL min−1. The instrument was fitted with a PL aquagel-OH guard column (50 
× 7.5 mm, 8 μm) followed by two Agilent PL aquagel-OH columns (300 × 7.5 mm, 8 
μm). Molecular weights were calculated based on a standard calibration method using 
poly(ethylene glycol) and poly(ethylene oxide) standards (Agilent®). Px-IMI and Px-
2A3FP were analysed using 100 mM AcOH/ deionised water at 40 °C as the eluent 
and a flow rate of 0.6 mL min-1, the instrument was fitted with a guard column (Shodex 
Asahipak GF-1G 7B) followed by a Shodex Asahipak GF-510 HQ and a Shodex 
Asahipak GF-310 HQ. UV and Fluorescence data was recorded on a BMG Labtech 
FLUOstar omega plate reader. Dialysis was carried out in deionised water at room 
temperature for a minimum of 48 hours using a Spectra/Por 6 1000 Molecular weight 
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cut-off (MWCO) 38 mm width membrane. Optical images and time-lapse images for 
Px-IMI and Px-2A3FP were captured using a Nikon Eclipse Ti inverted microscope with 
a 100 X oil objective or 20 X air objective in DIC (30 ms exposure) or fluorescence 
(800 ms exposure) incubation at 37 oC was used in the case of time-lapse images. 
Time-lapse imaging of V. cholerae incubated with P1 and P2 was carried out using an 
oCelloScope (BioSense solutions) at 37oC and the respective growth curves were 
generated using the inbuilt software. Fluorescent time-lapse imaging of V. cholerae in 
the presence of IMI was carried out using a JuLI Stage (NanoEntek) using the GFP 





6.4.1 Synthesis of p(APMAm) (P1)  
 
N-(3-aminopropyl)methacrylamide (APMAm) hydrochloride (505.0 mg, 2.770 mmol), 
4,4’-azobis(4-cyanovaleric acid) (ACVA) (12.4 mg, 0.033 mmol) and 2-
mercaptoethanol (1.0 μL, 0.014 mmol) were dissolved in MilliQ water (2.2 mL). This 
solution was degassed under argon for 10 minutes and then heated at 70 °C under 
stirring for 17 hours. After this time, the reaction flask was opened to the air and the 
crude was precipitated three times into diethyl ether (50 mL). The precipitate was 
freeze-dried and a crystalline white solid was obtained (70.0 mg, 14% yield). 1H-NMR 
(300 MHz, D2O) d (ppm): 3.11 (br, 3H, CH3 backbone), 2.93 (br t, J= 7.0 Hz, 2H, CO-
NH-CH2), 1.78 (br, 2H, -CH2-NH2), 1.63 (br, 2H, -CH2-CH2-NH2), 0.98 (br, 1H, CH2 




















6.4.2 Synthesis of p(DMAPMAm) (P2).  
 
N-[3-(dimethylamino)propyl]methacrylamide (DMAPMAm) (2.2 mL, 12.025 mmol), 
2,2'-azobis(2-methylpropionitrile) (AIBN) (19.6 mg, 0.117 mmol) and 2-
mercaptoethanol (4.0 μL, 0.056 mmol) were dissolved in toluene (9.5 mL). This 
solution was degassed under argon for 10 minutes and then heated at 70 °C under 
stirring for 18 hours. After this time, the reaction flask was opened to the air and the 
crude was precipitated twice: first into diethyl ether (200 mL) and then into a diethyl 
ether/ hexane mixture (1:1) (100 mL). The precipitate was freeze-dried and a 















d6) d (ppm): 7.51 (br, 1H, CO-NH), 2.96 (br, 2H, CO- NH-CH2), 2.19 (br, 5H, CH2-N-
(CH3)2 + CH3 backbone), 2.11 (br, 6H, N-(CH3)2), 1.50 (br, 2H, CH2-CH2-N), 0.78 







6.4.3 Labelling P1 with CF405S 
 
 
poly(N-(3-aminopropyl) methacrylamide) (P1) (5 mg) was dissolved in 0.1 M NaHCO3 
(2 mL) meanwhile, anhydrous DMSO (0.1 mL) was to a defrosted vial of CF405S 
(Biotium) and vortexed to form a 10 mM stock solution of the dye. To the solution 
containing P1, 50 uL of the dye stock solution was added dropwise and the resulting 
mixed rocked for 1 hours at room temperature. Purification was carried out firstly using 
a sephadex G-25 column followed by a sephadex G-10 column. Separation was 
confirmed by TLC (H2O) and the material was used without any further purification or 
characterisation.  
6.4.4 Synthesis of tert-Butyl-2-acryloylhydrazine-1-carboxylate (1) 
 
Acrylic acid (3.77 mL, 54.96 mmol), t-Butyl carbazate (6.00 g, 45.00 mmol) was 
dissolved in 2:1 H2O:THF mixture (180 ml). N-3(-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC) (12.29 g, 64.11 mmol) was added in portions 











































with EtOAc (3 x 75 ml) and the organic layer washed with saturated NaHCO3 (3 x 75 
ml) and water (1 x 50 ml) and dried with NaSO4. The solvent was removed under 
reduced pressure to afford a crude product as an off-white solid which was purified by 
recrystallisation from hot EtOAc (70oC to r.t.) to afford a white crystalline powder (4.5 
g, 49%). 1H-NMR (300 MHz, DMSO-d6) d (ppm) 9.77 (s, 1H), 8.74 (s, 1H), 6.18-6.20 
(m, 2H), 5.69 (dd, 3JH,H= 7.5, 4.5 Hz, 1H), 1.42 (s, 9H) . 13C-NMR (400 MHz, DMSO-





























































































6.4.5 Representative synthesis of Poly(tert-butyl-2-acryloylhydrazine-1-
carboxylate) (boc-Px)  
 
2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044) (3.0 mg, 0.01 
mmol), 2-ethylthiocarbonothioylthio-2-methylpropanoic-acid (CTA) (10.0 mg, 0.045 
mmol) and N’-(tert-butoxycarbonyl)acryloyl hydrazide (1) (1.666g, 8.950 mmol) were 
dissolved in DMSO (10.0 mL) and a 100 µL sample was taken at this stage to calculate 
conversion (ρ). The solution vessel was sealed with a septum and electrical tape, and 
degassed by bubbling with argon for 25 minutes. The sealed solution was then left to 
react at 65oC for 2 hours. The reaction was stopped by allowing the tube to cool using 
a water bath and exposing it to air. A 100 μL aliquot was taken at this stage to calculate 
conversion (ρ) and for GPC analysis. The resulting mixture was diluted with H2O before 
transferring to dialysis tubing (100 kDa) and dialysed against H2O. The resulting 
precipitate was firstly dried by lyophilisation and then in a desiccator with P2O5 to afford 
an off-white solid (835 mg) (boc-Px), monomer conversion 62% by proton NMR, 80% 
yield. 1H-NMR (300 MHz, DMSO-d6) d (ppm) 1.4 (br,11H, 9H in C(CH3)3, 2H in 
CHCH2), 2.1 (br, 1H, CH2CH), 8.5 (br, 1H, NH) 9.3 (br, 1H, NH) GPC (DMF 0.05M 




































6.4.6 Representative synthesis of poly(tert-butyl-2-acryloylhydrazine-1-
carboxylate) N-(2-aminoethyl) propionamide (boc-Px-NH2) 
 
 
boc-Px (1 g, 0.13 mmol), and ethylene diamine (5 ml, 150 mmol) were dissolved in 
DMSO (10 ml). EDC (4 g 20.87 mmol) was added in portions at 0 hr 1hr and 2hr and 
the mixture stirred at r.t for 3 hours. The resulting mixture was purified by dialysis 
against H2O and lyophilized to a white powder (90 %) 1H-NMR (300 MHz, DMSO-d6) 
d (ppm) 1.4 (br,11H, 9H in C(CH3)3, 2H in CHCH2), 2.1 (br, 1H, CH2CH), 3.17 (br, 4H, 

























6.4.7 Representative synthesis of FITC-poly(tert-butyl-2-acryloylhydrazine-1-




boc-Px-NH2 (201 mg), fluorescein isothiocyanate (FITC) (50 mg 0.128 mmol) and 
DIPEA (50 uL 0.286 mmol) were dissolved in DMF (5 ml) and stirred at RT. After 
dissolution, a further portion of DMF (5 ml) was added and the resulting mixture was 
reacted for 18 hours in the dark. An aliquot (100 uL) of the resulting crude mixture 
was taken for fluorescent GPC analysis before purification of the fluorescent polymer 
by dialysis against H2O (5 liters) and lyophilization to yield an orange/yellow solid (70 
%). The labelling was confirmed by UV-vis (λmax495 nm) and fluorescence GPC, 
(λex,490 nm λem 510 nm) 1H-NMR (300 MHz, DMSO-d6) d (ppm) 1.4 (br,11H, 9H in 
C(CH3)3, 2H in CHCH2), 2.1 (br, 1H, CH2CH), 8.5 (br, 1H, NH) 9.3 (br, 1H, NH) 6.6 

































6.4.8 Representative synthesis of FITC-poly(acryloyl hydrazide) N-(2-
aminoethyl) propionamide (Px-MCCA) 
 
 
Working in the dark, Trifluoroacetic acid (TFA) (5 mL) was added dropwise to FITC-
N’-(tert-butoxycarbonyl) acryloyl hydrazide boc-Px-FITC (200 mg) and stirred at RT 
for 24 hrs. Excess TFA was evaporated by blowing a steady stream of argon over the 
solution to a viscous oil which was further diluted with H2O (5 mL), neutralised with 
NaHCO3 until effervescence was no longer observed and dialysed against H2O (5 L) 
for one week. The purified compound was obtained as an orange, water soluble 
powder after lyophilization (55%). Presence of the fluorophore was confirmed by 
fluorescence emission (λem 510 nm) 
1H-NMR (300 MHz, D2O) δ (ppm)6.5 (br m, 6H) 1.19-2.28 (br m, (3·DP) H), 0.97 (s, 





































6.4.9 Representative synthesis of MCCA-poly(tert-butyl-2-acryloylhydrazine-1-




Working in the dark, boc-Px-NH2 (100 mg, 0.011 mmol), 7-methoxycoumarin-3-
carboxylic acid (10 mg, 0.045 mmol) and EDC (10 mg, 0.052 mmol) was dissolved in 
DMF/triethylamine (10 mL 1:1, v/v). In an ice bath and with stirring, DMAP (1 mg, 0.01 
mmol) was added and the resulting mixture was left to react overnight. The crude 
mixture was purified by dialysis against H2O (5 liters) and lyophilised to yield a light 
brown solid (70 %). 
6.4.10 Representative synthesis of MCCA-poly(acryloyl hydrazide) N-(2-
aminoethyl) propionamide (Px-MCCA) 
 
 
Working in the dark, Trifluoroacetic acid (TFA) (2 mL) was added dropwise to MCCA-
N’-(tert-butoxycarbonyl) acryloyl hydrazide boc-Px-MCCA (100 mg) and stirred at RT 























































solution to a viscous oil which was further diluted with H2O (5 mL) and washed with 
chloroform (10 x 5 mL) until no traces of MCCA could be detected in the organic 
phase. The washed aqueous phase was neutralised with NaHCO3 until 
effervescence was no longer observed and dialysed against H2O (5 L) for one week. 
The purified compound was obtained as a brown, water soluble powder after 
lyophilization (50%). Presence of the fluorophore was confirmed by fluorescence 
emission (λem 402 nm). 1H-NMR (300 MHz, D2O) δ (ppm) 1.19-2.28 (br m, (3·DP) H), 
0.97 (s, 3H) 0.92 (s, 3H) 
6.4.11 Representative synthesis of poly(tert-butyl-2-acryloylhydrazine-1-
carboxylate) (boc-PFRP) by free radical polymerisation 
 
 
In a typical experiment 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-
044) (27.0 mg, 0.07 mmol), cysteamine  (27.6 mg, 0.36 mmol) and N’-(tert-
butoxycarbonyl)acryloyl hydrazide (1) (3.333g, 17.900 mmol) were dissolved in DMSO 
(20.0 mL) and a 100 µL sample was taken at this stage to calculate conversion (ρ). 
The solution vessel was sealed with a septum and electrical tape, and degassed by 
bubbling with argon for 25 minutes. The sealed solution was then left to react at 65oC 
for 2 hours. The reaction was stopped by allowing the tube to cool using a water bath 





























(ρ) and for GPC analysis. The resulting mixture was diluted with H2O before 
transferring to dialysis tubing (100 kDa) and dialysed against H2O. The resulting 
precipitate was firstly dried by lyophilisation and then in a desiccator with P2O5 to afford 
an off-white solid (835 mg), monomer conversion 90% by proton NMR, 80% yield. 1H-
NMR (300 MHz, DMSO-d6) d (ppm) 1.4 (br, 2H in CHCH2), 2.1 (br, 1H, CH2CH), 8.5 
(br, 1H, NH) 9.3 (br, 1H, NH) GPC (DMF 0.05M LiBr): Mn =59.63 kg.mol-1 Đm = 3.43 
6.4.12 Representative synthesis of poly(acryloyl hydrazide) (Px)  
 
Trifluoroacetic acid (TFA) (6 mL) was added dropwise to N’-(tert-butoxycarbonyl) 
acryloyl hydrazide (boc-Px) (600 mg) and stirred at RT for 24 hrs at which point excess 
TFA was evaporated by blowing a steady stream of argon over the solution until an oil 
had formed. The oil was diluted with H2O (6 mL) and neutralised with NaHCO3 until 
effervescence was no longer observed, at which point the solution was transferred to 
a dialysis membrane, dialysed against H2O and freeze-dried to a white powder (139 
mg 50%) 1H-NMR (300 MHz, D2O) δ (ppm) 1.19-2.28 (br m, (3·DP) H), 0.97 (s, 3H) 




















6.4.13 Representative conjugation of Px with aldehydes: Synthesis of Px-IMIx and 
Px-2A3FPx 
 
In a typical experiment, a solution of Px (300 μL, 0.116 M, 0.0348 mmol) in AcOH/D2O 
(100 mM pH 2.9), was added to either 75 μL ( 0.25 eq. 0.0088 mmol), 150 μL (0.5 eq. 
0.0175 mmol), 175 μL (0.75 eq. 0.0261 mmol) or 300 μL (1.0 eq. 0.0348 mmol) of IMI 
(0.116 M) or 2A3FP (0.116 M) in AcOH/D2O (100 mM pH 2.9) and the final volume 
made was up to 600 μL in the same buffer. Samples were stirred at 60 oC for 24 hours. 
At this point samples were transferred to NMR tubes for calculation of degree of 
modification by proton NMR. The compounds were used in biological experiments 
described in this study without further purification. 
6.4.14 Representative synthesis of Glycopolymers: Px-MAN, Px-GLU and Px-GAL 
 
In a typical experiment, in a 96 well plate, a solution of Px (150 μL 0.075 mmol) in 
acetate buffer (100 mM pH 5.5), was added to 50 μL ( 2 eq. 0.15 mmol), 100 μL (4 eq. 
0.3 mmol) or 150 μL (6 eq. 0.45 mmol) of D-mannose, D-glucose or D-galactose (3 M) 


















































plate was sealed and incubated at 50 oC for 24 hours. The compounds were used in 
biological experiments without further purification. 
6.4.15 Fluram Assay  
To serial dilutions of boc-Px-NH2 and tert-Butyl N-(2-aminoethyl)carbamate boc-NH2 
in DMSO was added fluorescamine in DMSO (2 eq.). The resulting mixtures were left 
to react for 30 minutes in the dark with shaking. Fluorescence was recorded using a 
BMG ClARIOstar plate reader (λex 390 nm). Concentration of NH2 (boc-Px-NH2) was 
calculated by interpolation of fluorescence (λem 465 nm) against a standard curve for 
boc-NH2 (λem 475 nm). 
6.4.16 FITC determination by absorbance  
Stock solutions of fluorescein isothiocyanate (FITC) (isopropanol:DPBS 50:50 v/v, 0.4 
mmol) and Px-Flu (isopropanol:DPBS 50:50 v/v, 510 μg ml-1) were serially diluted in 
the same solvent at ranges 12 mM - 45 mM and 25 -102 ug ml-1 
respectively.Absorbance was recorded on a BMG clariostar plate reader  
 [FITC] for Px-Flu was calculated by interpolating absorbance values at 490 nm against 
a standard curve for FITC (abs 490 nm).  
6.4.17 Imaging V. cholerae bacterial clustering by LP1 
V. cholerae WT were grown in LB overnight and diluted to an OD600 of 1.0 in clear 
DMEM LP1 was added at a concentration of 0.05 mg mL-1. Images of the clustering 
were taken after 30 and 60 minutes by mounting 10 μL of sample on microscopy slides, 
staining with LIVE/DEAD BacLightTM kit (Thermo Scientific) as per the manufacturer’s 
instructions and visualizing using a Zeiss Axio Observer.Z1 microscope with 63X/1.4 
Plan Apocromat objective coupled with Apotome2 (Zeiss) using SYTO 9 (λex/λem 
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485/495), PI (λex/λem 535/617) and DAPI (λex/λem 385/617)  filter set. Image acquisition 
was carried out using Zen Pro Software (Zeiss) and further processed in imageJ. 
6.4.18 General procedure for 96 well plate imaging assays  
V. cholerae NPMW1 (A1552 containing pMW-gfp plasmid) were grown overnight in LB 
+ 50 mg ml-1 spectinomycin and diluted to an OD600 of 0.02 in clear DMEM + 50 μg 
mL-1 spectinomycin. Bacterial suspensions were transferred to a black 96 well plate 
with a clear bottom and mixed with polymers (0.5 mg ml-1 or 0.05 mg ml-1). At this point 
wells were incubated at 37 oC imaged every 30 minutes using a Nikon-Eclipse ti 
microscope with a 20x objective in DIC (30 ms exposure time) and fluorescence (800 
ms exposure time) with either GFP or DAPI filter set. Image acquisition was carried out 
using Nikon NIS-Elements software and final images processed with ImageJ.  
6.4.19 V. cholerae growth curves  
In a costar clear-bottomed black 96 well plate, colonal overnight cultures of GFP-
expressing V. cholerae were diluted in clear DMEM with 50 μg ml-1 spectinomycin to 
an OD600 of 0.02 for a final volume of 200 μL, to which glycopolymer solutions (0.47 
μL) prepared as described above, were added to give a final polymer concentration of 
0.05 mg ml-1. All conditions were made up to 200 μL with clear DMEM + 50 mg ml-1 
Spectinomycin. The 96 well plate was sealed with a BEM-1 breathe easy gas-
permeable membrane (Sigma) and incubated at 37 oC with shaking at 200 rpm (double 
orbital) inside an FLUOstar Omega plate reader. OD600 and GFP fluorescence intensity 
was recorded every 30 minutes for 15-24 hours using a FLUOstar Omega plate reader. 
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6.4.20 V. cholerae flocculation assay  
Colonal overnight cultures of GFP-expressing V. cholerae were diluted in clear DMEM 
with 50 μg ml-1 spectinomycin to an OD600 of 1.0 inside plastic cuvettes polymer 
condition were added at and cuvettes were sealed with parafilm. Turbidity was 
measured (OD600) using a benchtop spectrophotometer at varying timepoints. between 
timepoints cuvettes were secured in a cuvette holder at room temperature without 
shaking. 
6.4.21 Crystal Violet Assay 
As described by O’Toole3, non-adhered V. cholerae were firstly removed by turning 
over the plate and dumping the liquid followed by submerging the whole plate in a 
small tub of distilled water and gently shaking out the water into a separate container. 
This was repeated until no further loose bacterial debris could be removed.  
200 μL of 1% w/v crystal violet solution in dH2O was added to each condition and left 
at room temperature for 30 minutes to ensure complete staining of the biofilm. Crystal 
violet was removed by submerging the plate in dH2O and washing until no more crystal 
violet could be visibly washed from the plate. 200 μL of 95% ethanol was added to 
each condition to solubilise the crystal violet and the plate was stood for 10 minutes at 
room temperature. Finally, sonication of the plate was carried out for 10 seconds in a 
water bath to ensure homogeneous mixing of the crystal violet and dislodging of any 
remaining adhered biofilm. CV staining was quantified by absorbance at 550 nm in a 
FLUOstar Omega plate reader with 95% ethanol as a blank.  
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6.4.22 Transcriptional assay: β-galactosidase assay 
To monitor the expression of genes related to virulence, adhesion factors and biofilm 
formation, various reporter strains of V. cholerae A1552 containing the pRW50 oriT 
plasmid were constructed and kindly donated by Dr. Perez-Soto.4 
-Buffer and reagent preparation  
Prior to the assay, Z-Buffer and ONPG (O-Nitrophenyl-β-D-galactopyranoside) 
solution were prepared according to a protocol used in the Grainger group 
(Birmingham). Z-buffer was prepared according to the following recipe: 0.80 g 
Na2HPO4.7H2O (0.06M) 0.28g NaH2PO4.H2O (0.04M) 0.5 mL 1M KCl (0.01M )0.05 mL 
1M MgSO4 (0.001M) were dissolved in 40 mL deionised water, adjusted to pH 7.0 and 
finally made up to 50 mL.  
ONPG solution was prepared by dissolving 160 mg ONPG in 200 mL Z-buffer with 270 
μL 2-mercaptoethanol. The bottle was covered in foil to protect from light and stored 
at 4 oC for a maximum of a week.  
-Assay protocol 
Overnight cultures (1 mL) of the desired reporter strains grown in LB were pelleted by 
centrifugation (7000 rpm, 5 minutes) and the supernatant replaced 1 mL DMEM + 
Tetracycline (10 μg ml-1). The concentration of the bacterial suspension was measured 
in each case and adjusted to a starting OD600 of 0.2 in 1 mL of supernatant + polymer 
in Eppendorf tubes. Each condition was prepared in a separate tube and incubated at 
37oC with shaking. At the desired timepoint, the OD600 was measured for each 
condition and cells were lysed by adding 10 μL toluene, 10 μL 1% sodium deoxycholate 
and vortexing. Tubes were left open to allow excess toluene to evaporate for 20 
minutes, after which each condition was vortexed and 100 μL of the lysate added to 5 
mL developing tubes in triplicates. Using a timer, 2500 μL of ONPG solution was added 
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to each developing tube every 10 seconds. After 20 minutes the reaction was 
quenched by addition of 1 mL of 1M Na2CO3 to each tube every 10 seconds as before. 
300 μL of each condition was transferred into a 96 well plate and the absorbance at 
420 nm was measured. ONPG solution was used as a blank and care was taken to 
avoid transferring bacterial debris to the well plate which would interfere with the 
reading. Growth adjusted readings were reported in miller units using the equation:  
β − #$%$&'()*+$),	$&'*.*'/	(1*%%,2	34*'))
= 	1000 ∗ 2.5 ∗ '('$%	2,$&'*(4	.(%=>, ∗ ?@)!"#	4>4.5 ∗ '*>, ∗ %/)*)	.(%=>, ∗ BC$##
 
1000/4.5 is a conversion factor to convert the absorbance at 420 nm into moles of o-
nitrophenol. 2.5 is used to convert OD600 into mg of dry protein based on an assumption 
that OD600 of 1.0 corresponds to 0.4 mg/mL of dry bacterial mass. Time is expressed 
in minutes and volumes are in mL. 
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